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RIASSUNTO 
 
Il mio lavoro di tesi ha riguardato lo studio, mediante tecniche di risonanza magnetica 
nucleare (NMR) e di modellistica molecolare (docking), di alcune proteine di 
interesse biotecnologico, coinvolte in processi fisio-patologici, contenenti domini Sam 
(Sterile alpha motif). 
Le interazioni proteina-proteina sono essenziali per l’ assemblaggio, la regolazione e 
la localizzazione di complessi proteici nella cellula. L’ analisi di tali interazioni a livello 
molecolare risulta di grande interesse in applicazioni biotecnologiche, in quanto 
fornisce informazioni utili alla progettazione di sistemi capaci di mimare i siti di 
interazione, e che quindi possono essere potenzialmente utilizzati in campo 
terapeutico. Le associazioni tra proteine sono mediate da specifici domini, tra i quali i 
domini Sam, che sono stati scelti come sistemi modello per gli studi riportati in 
questa tesi. 
I domini Sam sono piccoli moduli proteici di circa 70-80 amminoacidi generalmente 
strutturati in 5 α-eliche (Figura 1), presenti in tutti gli organismi, dal lievito all’ uomo 
(Qiao et al., 2005). Malgrado abbiano strutture molto simili tra loro, i domini Sam 
presentano un’ ampia versatilità relativamente alle interazione intermolecolari (Kim 
and Bowie, 2003). Essi possono infatti sia interagire tra loro, formando omo-, etero-
dimeri, e polimeri (Meruelo and Bowie, 2009), che legare proteine prive di domini 
Sam (Zhang et al., 2000; Matsuda et al., 2004), l’ RNA (Aviv et al., 2003; Green et 
al., 2003; White et al., 2012) e i lipidi (Barrera et al., 2003; Inoue et al., 2012; Li et al., 
2007). 
 
 
 
Figura 1. Modello a nastro rappresentante la struttura tridimensionale dei domini Sam. 
 
 
Il lavoro sperimentale di tesi si è articolato secondo tre fasi successive, descritte di 
seguito, correlate all’ analisi di interazioni tra proteine mediate da domini Sam, e allo 
studio delle proprietà conformazionali in soluzione di peptidi riproducenti le 
corrispondenti superfici di legame. 
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1) Determinazione della struttura in soluzione del primo dominio Sam di Odin e 
studi di interazione con il dominio Sam del recettore EphA2. 
 
Il recettore tirosina chinasi EphA2 (Ephrin receptor A2) è in grado di regolare 
importanti processi biologici legati alla motilità cellulare (Egea and Klein, 2007; 
Himanen et al., 2007; Pasquale, 2005) e svolgere un ruolo fondamentale e 
controverso in processi patologici quali il cancro (Pasquale, 2008). In particolare, il 
processo di endocitosi recettoriale, che avviene in seguito al legame con le efrine, e 
all’ attivazione di alcune proteine citosoliche ad attività chinasica che mediano 
diverse risposte cellulari, è ampiamente studiato per la sua possibile implicazione nei 
processi tumorali (Pasquale, 2010; Surawska et al., 2004). Infatti, in molti tipi di 
cancro, in cui EphA2 risulta overespresso, è stata analizzata la potenziale 
correlazione tra il processo di endocitosi e conseguente degradazione recettoriale, e 
la diminuzione della malignità tumorale (Pasquale, 2010). La regolazione dell’ 
endocitosi recettoriale in alcuni casi avviene ad opera di proteine che legano EphA2 
mediante interazioni eterotipiche di tipo Sam-Sam (Kim et al., 2010; Zhuang et al., 
2007), per cui si ipotizza che peptidi o piccole molecole in grado di interferire con la 
formazione di questi complessi molecolari potrebbero essere potenziali agenti 
terapeutici. 
In particolare, è stato riportato che la fosfatasi lipidica Ship2 (Src homology 2 
domain-containing phosphoinositide-5-phosphatase 2) è in grado di inibire il 
processo di endocitosi di EphA2, con conseguente aumento dell invasività tumorale 
e del potenziale metastatico, e che l’ interazione tra le due proteine avviene tra i 
rispettivi domini Sam (Zhuang et al., 2007). In precedenza sono stati riportati studi di 
interazione tra il dominio Sam di Ship2 (Ship2-Sam) e il dominio Sam di EphA2 
(EphA2-Sam), effettuati mediante tecniche NMR e di calorimetria isotermica di 
titolazione (ITC) (Leone et al., 2008), i quali hanno dimostrato che il complesso 
EphA2-Sam/Ship2-Sam si forma con un’ alta affinità di legame, adottando una 
topologia comune a diversi altri complessi di tipo Sam-Sam riportati in letteratura 
(Kurabi et al., 2009; Rajakulendran et al., 2008; Ramachander et al., 2004; Stafford 
et al., 2011), denominata “Mid-Loop/End-Helix”. Questo modello prevede che una 
delle proteine partecipi all’ interazione con la porzione centrale del proprio dominio 
Sam (Mid-Loop), mentre l’ altra opera il legame principalmente mediante l’ elica 5 
C-terminale ed i loop ad essa adiacenti (End-Helix) (Figura 2). Inoltre, studi di 
docking molecolare hanno evidenziato che tale complesso è stabilizzato 
principalmente da interazioni di tipo elettrostatico tra residui carichi positivamente 
sulla superficie di EphA2-Sam e amminoacidi carichi negativamente della superficie 
di Ship2-Sam. 
Un recente lavoro indica che l’ endocitosi recettoriale di EphA2 è regolata anche 
dalle proteine della famiglia ANKS (Ankyrin repeat and Sam domain containing) (Kim 
et al., 2010). Questa classe di proteine include Odin e AIDA1b (AβPP intracellular 
domain-associated protein 1B), ed è caratterizzata dalla presenza di due domini Sam 
in tandem. In particolare il primo dominio Sam di Odin (Odin-Sam1) presenta un’ alta 
omologia di sequenza (circa il 69%) con Ship2-Sam. Da queste premesse è scaturita 
l’ intenzione di analizzare l’ eventuale interazione tra Odin-Sam1 ed EphA2-Sam. 
Il primo fondamentale passo di questo progetto ha previsto lo studio della struttura in 
soluzione di Odin-Sam1 mediante tecniche NMR. Al fine di ottenere le assegnazioni 
delle risonanze per gli atomi H, C e N del backbone e delle catene laterali dei singoli 
amminoacidi della proteina, mediante l’ acquisizione di esperimenti NMR bi- e tri-
dimensionali, sono stati espressi campioni uniformemente marcati con 15N, e 
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doppiamente marcati con 15N/13C. In seguito sono stati analizzati esperimenti 3D di 
tipo NOESY (Nuclear Overhauser Effect Spectoscopy) per ottenere vincoli 
conformazionali di distanza utili al calcolo della struttura di Odin-Sam1. Tale struttura 
consiste di 5 -eliche e rappresenta un canonico ripiegamento di tipo Sam (Figura 
3). 
 
 
 
Figura 2. Modello tri-dimensionale del complesso EphA2-Sam/Ship2-Sam (codice PDB: 2KSO (Lee et 
al., 2011)).  
 
 
 
 
Figura 3. (A) Modello a nastro relativo al primo conformero della struttura NMR di Odin-Sam1 (codice 
PDB: 2LMR (Mercurio et al., 2012)). (B) Rappresentazione delle 20 strutture NMR di Odin-Sam1 
sovrapposte sugli atomi del backbone dei residui 30-90 (RMSD (Root Mean Square Deviation)= 
0.26±0.07 Å).  
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In seguito, sono stati effettuati studi di interazione con EphA2-Sam. In particolare, 
tecniche SPR (Risonanza Plasmonica di Superficie) ed ITC hanno fornito misure 
quantitative riguardanti la formazione del complesso, indicando un’ affinità di legame 
tra le due proteine nell’ ordine del basso micromolare. Esperimenti NMR di 
perturbazione del chemical shift (Pellecchia, 2005) sono stati poi condotti e hanno 
consentito di individuare le reciproche superfici di interazione tra Odin-Sam1 ed 
EphA2-Sam, e di effettuare ipotesi circa i residui principalmente coinvolti nella 
formazione del complesso. Questi dati sono stati utilizzati per successivi studi di 
docking molecolare, mediante i quali sono stati costruiti dei modelli tri-dimensionali 
rappresentanti le possibili modalità di legame tra le proteine. Tali modelli presentano 
delle similitudini con il complesso EphA2-Sam/Ship2-Sam, e con altri complessi 
Sam-Sam riportati in letteratura (Kurabi et al., 2009; Rajakulendran et al., 2008; 
Ramachander et al., 2004; Stafford et al., 2011). Infatti anche in questo caso la 
topologia di legame è risultata quella “Mid-Loop/End-Helix”, in cui Odin-Sam1 
fornisce la superficie Mid-Loop che interagisce con l’ interfaccia End-Helix di EphA2-
Sam, e le interazioni responsabili della formazione del complesso sono 
principalmente di tipo elettrostatico (Figura 4).  
 
 
 
 
Figura 4. Modello tri-dimensionale rappresentante il complesso EphA2-Sam/Odin-Sam1. Le rispettive 
superfici di interazione dei domini e le regioni in cui avvengono variazioni conformazionali, 
determinate mediante studi NMR, sono evidenziate in rosso. 
 
 
I modelli ottenuti sono stati validati mediante esperimenti di mutagenesi. In 
particolare è stato progettato un triplo mutante di EphA2-Sam (K38A/R78A/Y81S) 
(Leone et al., 2008), in cui è stata perturbata la distribuzione di carica nella regione 
End-Helix mediante opportune sostituzioni amminoacidiche, che presenta solo bassa 
capacità di legare Odin-Sam1. 
Le informazioni strutturali ottenute in questo progetto rappresentano il punto di 
partenza per una successiva progettazione di molecole di natura peptidica in grado 
di interferire con la formazione del complesso Odin-Sam1/EphA2-Sam. 
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2) Studio dell’ interazione tra Odin-Sam1 ed Arap3-Sam. 
 
Arap3 (Arf GAP, Rho GAP, Ankyrin repeat and PH domains) è una proteina coinvolta 
nelle vie di segnalazione della fosfoinositolo-3-chinasi (PI3K) che contiene un 
dominio Sam nella propria sequenza primaria (Krugmann et al., 2002). E’ stato 
riportato che tra le proteine provviste di domini Sam, sia Ship2 che Odin possono 
interagire con Arap3-Sam (Raaijmakers et al., 2007). La formazione del complesso 
Ship2-Sam/Arap3-Sam è stata già caratterizzata in dettaglio: l’ interazione avviene 
con alta affinità, mediante topologia “Mid-Loop/End-Helix”, ed è mediata da specifici 
contatti di tipo elettrostatico (Leone et al., 2009). Considerata l’ alta omologia di 
sequenza tra Arap3-Sam ed EphA2-Sam (circa il 58%), abbiamo ritenuto 
interessante analizzare l’ eventuale formazione del complesso Odin-Sam1/Arap3-
Sam. A tal fine abbiamo utilizzato metodiche molto simili a quelle adoperate nello 
studio relativo al complesso Odin-Sam1/EphA2-Sam. In prima analisi, gli esperimenti 
SPR ed ITC hanno rivelato un’ affinità di legame tra le due proteine, nell’ ordine del 
basso micromolare. In seguito, abbiamo ipotizzato quali residui all’ interfaccia dei 
domini siano responsabili dell’ interazione mediante esperimenti NMR di 
perturbazione del chemical shift (Pellecchia, 2005). Infine, abbiamo utilizzato i dati 
ottenuti per costruire dei modelli 3D del complesso Odin-Sam1/Arap3-Sam. Le due 
proteine interagiscono mediante il modello “Mid-Loop/End-Helix”, stabilizzato da 
interazioni elettrostatiche, comune agli altri complessi qui citati (Figura 5). 
 
 
Figura 5. Modello del complesso Arap3-Sam/Odin-Sam1, in cui le interfacce interagenti dei domini e i 
residui che subiscono variazioni conformazionali in seguito alla formazione del complesso, sono 
colorate in arancio. 
 
Anche in questa indagine esperimenti di mutagenesi hanno validato le ipotesi 
formulate riguardo la superficie di interazione di Arap3-Sam nei confronti di Odin-
Sam1. Infatti è stato progettato un triplo mutante (H37D, R77D, R80D) (Leone et al., 
2009), in cui sono state inserite sostituzioni amminoacidiche nella regione End-Helix 
di Arap3-Sam, al fine di distruggere interazioni elettrostatiche all’ interfaccia del 
complesso Sam-Sam. Tale proteina mutata perde la capacità di legare Odin-Sam1. 
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Le informazioni strutturali ottenute in questo secondo studio, saranno utilizzate per 
generare antagonisti di natura peptidica delle interazioni eterotipiche Sam-Sam 
coinvolgenti Arap3. 
 
3) Studi strutturali in soluzione del peptide Sam3. 
 
Dopo aver analizzato in dettaglio i fattori strutturali caratteristici dei complessi Odin-
Sam1/EphA2-Sam (Paragrafo 1) ed Odin-Sam1/Arap3-Sam (Paragrafo 2), nel 
gruppo di ricerca in cui ho svolto la mia tesi sono stati progettati diversi peptidi, di 
dimensioni variabili, includenti le regioni putative di interazione tra domini Sam. Uno 
di questi peptidi, denominato Sam3, è stato analizzato più nel dettaglio in soluzione 
mediante tecniche NMR. 
Sam3 è un peptide di 43 residui, la cui struttura primaria è riportata in Figura 6, 
riproducente la sequenza della regione 715-758 di Odin-Sam1 (codice UniprotKB 
Q92625) che include la porzione centrale del dominio Sam di Odin che negli studi 
precedenti si è ipotizzato fosse implicata nella formazione dei complessi con EphA2-
Sam ed Arap3-Sam, insieme all’ elica 5 C-terminale (Figura 6). 
 
 
Sam3: Ac-SKLLLNGFDDVHFLGSNVMEEQDLRDIGISDPQHRRKLLQAAR-NH2 
 
Figura 6. Sequenza primaria di Sam3 e un modello a nastro di Odin-Sam1 con evidenziata in giallo la 
regione rappresentata dal peptide. 
 
La sequenza corrispondente all’ elica 5, esterna alla regione putativa di interazione, 
è stata inserita per facilitare la strutturazione del peptide in una modalità analoga a 
quella riscontrata nel dominio Odin-Sam1 intatto.  
Sam3 è stato sintetizzato in batch utilizzando protocolli standard di sintesi in fase 
solida, purificato con RP-HPLC (Cromatografia Liquida a Fase Inversa ad Alte 
Prestazioni) e caratterizzato con LC-MS (Cromatografia Liquida-Spettrometria di 
Massa). Con questo campione sono stati acquisiti spettri NMR bi-dimensionali 
7 
 
protonici utili all’ assegnazione delle risonanze dei singoli residui, e all’ ottenimento di 
vincoli conformazionali che saranno utilizzati per il calcolo della struttura tri-
dimensionale. Gli spettri NMR sono stati dapprima acquisiti in tampone fosfato; in 
tale sistema solvente il peptide risulta piuttosto disordinato e privo di elementi 
canonici di struttura secondaria. In seguito, ulteriori esperimenti sono stati registrati in 
presenza di trifluoroetanolo (TFE), che è di frequente utilizzato quale agente 
strutturante in studi conformazionali di peptidi (Cammers-Goodwin et al., 1996). I dati 
raccolti indicano la propensione di Sam3 ad adottare strutture organizzate del tipo 
elicoidale in presenza di TFE. 
Sono in corso studi per valutare la possibile interazione tra Sam3 e i partner di 
legame di Odin-Sam1, ossia EphA2-Sam ed Arap3-Sam.  
 
Conclusioni. 
 
In questa tesi abbiamo intrapreso un approccio interdisciplinare coinvolgente 
differenti tecniche sperimentali e computazionali (quali: NMR, SPR, ITC, docking 
molecolare, mutagenesi) per studiare in dettaglio la struttura in soluzione e le 
interazioni intermolecolari di alcuni domini Sam. I risultati ottenuti hanno consentito di 
ampliare le conoscenze sui dettagli conformazionali responsabili della formazione di 
complessi eterotipici di tipo Sam-Sam. Sulla base di queste evidenze lo stadio 
successivo sarà quello di progettare librerie di molecole di natura peptidica e peptido-
mimetica per applicazioni biotecnologiche, capaci di interferire selettivamente con la 
formazione dei complessi Odin-Sam1/EphA2-Sam oppure Odin-Sam1/Arap3-Sam. In 
particolare, riteniamo che antagonisti dell’ interazione Odin-Sam1/EphA2-Sam 
possano modulare l’ endocitosi del recettore EphA2, e svolgere un ruolo di agenti 
terapeutici in malattie quali il cancro. Tali ipotesi saranno validate mediante opportuni 
saggi in cellula. Per quanto concerne invece il complesso Odin-Sam1/Arap3-Sam, le 
molecole progettate verranno implementate in saggi cellulari per identificare nuove 
funzioni biologiche ascrivibili ad Arap3-Sam. 
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SUMMARY 
 
My PhD thesis has been focused on studies carried out by different experimental and 
computational techniques, such as NMR (Nuclear Magnetic Resonance), SPR 
(Surface Plasmon Resonance), ITC (Isothermal Titration Calorimetry), molecular 
docking, mutagenesis, of Sam (Sterile alpha motif) domains containing proteins that 
play important roles in physiological or pathological processes. 
Protein-protein interactions are essential for the assembly, regulation, and 
localization of functional protein complexes in the cell. The analysis of these 
interactions at molecular level is of great interest in many biotechnological fields, as it 
provides useful information for the design of molecules able to mimic the binding 
sites and thus, presenting potential therapeutic applications. Protein-protein 
associations are mediated by specific domains, such as Sam domains. 
Within this thesis two heterotypic Sam-Sam interactions were studied in details:  
1) the EphA2-Sam/Odin-Sam1 complex; 2) the Odin-Sam1/Arap3-Sam association.  
The tyrosine kinase receptor EphA2 plays a fundamental role in tumorigenesis. The 
process of EphA2 endocytosis and consequent degradation has been investigated as 
potential route to reduce tumor malignancy. Odin belongs to the ANKS (Ankyrin 
repeat domain containing and Sam) protein family; it contains two Sam domains in 
tandem (Sam1 and Sam2), and is able to regulate EphA2 receptor endocytosis. 
Instead, Arap3 (Arf GAP, Rho GAP, Ankyrin repeat and PH domains) is a protein 
involved in the phosphoinositol-3-kinase (PI3K) signaling pathways, which regulates 
biological processes connected to cell motility.  
Firstly, by multidimensional (2D and 3D) NMR methods, the solution structure of 
Odin-Sam1 was determined. It consists of five -helices and represents a canonical 
Sam domain fold. Afterwards, binding studies with EphA2-Sam, and Arap3-Sam 
were conducted. SPR and ITC experiments revealed a low micromolar binding 
affinity of Odin-Sam1 for both EphA2-Sam and Arap3-Sam. The reciprocal interaction 
surfaces of these Sam domains were identified by NMR chemical shift perturbation 
experiments, and 3D models of the complexes were built by molecular docking 
techniques. These studies suggested that Odin-Sam1/EphA2-Sam and Odin-
Sam1/Arap3-Sam complexes might adopt the canonical Sam-Sam interaction 
topology called "Mid-Loop/End-Helix", where the central portion of Odin-Sam1 and 
the C-terminal helix of either Arap3-Sam and EphA2-Sam contribute the binding 
surfaces.  
A peptide, named Sam3, which encompasses the central portion of the Odin-Sam1 
involved in complexes formation with EphA2-Sam and Arap3-Sam, together with its 
C-terminal helix, was synthesized and analyzed by 2D NMR techniques. The peptide 
reveals unstructured in phosphate buffer, whereas it shows propensity to adopt more 
ordered helical structures in water/trifluoroethanol mixtures. 
Based on the new structural insights gained within my thesis, libraries of molecules 
(peptides and peptido-mimetics), that could selectively interfere with Odin-
Sam1/EphA2-Sam or Odin-Sam1/Arap3-Sam associations, and prove useful in 
therapeutic and diagnostic applications, will be designed in the near future.  
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ABBREVIATIONS 
 
Amino Acids: 1 and 3 letters code 
 
A Ala    Alanine 
N Asn   Asparagine 
R Arg    Arginine 
D Asp   Aspartic Acid 
Q Gln    Glutamine 
G Gly    Glycine 
E Glu    Glutamic Acid 
H His    Histidine 
I Ile    Isoleucine 
L Leu    Leucine 
K Lys    Lysine 
M Met    Methionine 
F Phe    Phenylalanine 
P Pro    Proline 
S Ser    Serine 
T Thr    Threonine 
W Trp    Tryptophan 
Y Tyr    Tyrosine 
V Val    Valine 
 
 
AIDA-1b   APP Intracellular Domain-Associated protein 1B 
ANKS    Ankyrin repeat and Sterile alpha motif domain protein 
Arap3    Arf GAP, Rho GAP, Ankyrin repeat and PH domain 
Arap3-Sam   Sam domain of Arap3 
DOSY    Diffusion Ordered Spectroscopy 
DQFCOSY   Double Quantum-Filtered Correlated Spectroscopy 
EH    End-Helix 
EphA2   Ephrin A2 receptor 
EphA2-Sam   Sam domain of the EphA2 receptor 
FPLC    Fast Performance Liquid Cromatography 
HSQC   Heteronuclear Single Quantum Coherence 
IPTG    Isopropyl β-D-thiogalactopyranoside 
ITC    Isothermal Titration Calorimetry 
KD     Dissociation Constant 
KEGG   Kyoto Encyclopedia of Genes and Genomes 
LB    Luria Broth 
LC-MS   Liquid Chromatography-Mass Spectrometry 
ML    Mid-Loop 
NMR    Nuclear Magnetic Resonance 
NOE    Nuclear Overhauser Effect 
NOESY   Nuclear Overhauser Effect Spectroscopy 
OD    Optical Density 
Odin-Sam1   N-terminal Sam domain of Odin 
Odin-Sam2   C-terminal Sam domain of Odin 
PBS    Phosphate Buffer Saline 
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PDB    Protein Data Bank 
ppb    parts per billion 
ppm    parts per million 
PSGE    Pulsed Gradient Spin-Echo  
RMSD   Root Mean Square Deviation 
RP-HPLC   Reversed Phase-High Performance Liquid Chromatography 
RU    Resonance Units 
Sam    Sterile alfa motif 
Ship2    Src homology 2 domain-containing Phosphoinositide-5-phosphatase 2 
Ship2-Sam   Sam domain of Ship2 
SMART    Simple Modular Architecture Research Tool 
SPR    Surface Plasmon Resonance 
TFE    Trifluoroethanol 
TOCSY   Total Correlation Spectroscopy 
TSP    Trimethylsilyl Propionic acid 
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1. INTRODUCTION 
 
1.1. Sam domains 
Sam (Sterile alpha motif) domains were initially identified on the basis of the 
conservation of a small module made up of approximately 70 amino acids in 14 
eukaryotic proteins (Ponting, 1995). The domain was named the Sterile alpha motif 
domain because of its presence in yeast proteins crucial for sexual differentiation, 
and the predicted high α helix content (Ponting, 1995; Schultz et al., 1997) (Figure 
1).  
 
 
 
Figure 1. Ribbon representation of the Sam domains 3D structure. 
 
The SMART (Simple Modular Architecture Research Tool) (http://smart.embl.de/) 
(Shultz et al., 1998) database now identifies more than 4000 Sam domain containing 
proteins in all genomes. These domains are categorized as protein binding modules; 
however, unlike others protein modules, such as SH2 (Src Homology 2), SH3 (Src 
Homology 3) and PDZ (Post synaptic density protein, Drosophila disc large tumor 
suppressor, and Zonula occludens-1 protein) domains, which have conserved 
functions, Sam domains are not easily categorized (Kim and Bowie, 2003; Qiao and 
Bowie, 2005).  
In fact, although it has been suggested a role in developmental regulation due to the 
presence of Sam domains in many proteins involved in these processes (Schultz et 
al., 1996), they just present similar structures but a variety of functions (Table 1) (Kim 
and Bowie, 2003). This behavior is explained by the fact that Sam domains are 
present in all sub-cellular locations, exist in a wide number of stoichiometries, and 
are able to bind different partners (Kim and Bowie, 2003). 
In particular, Sam domains have been shown to homo-, hetero-oligomerize, and 
polymerize (Meruelo and Bowie, 2009), forming multiple self-association 
architectures, and also bind to proteins lacking Sam domains (Matsuda et al., 2004; 
Zhang et al., 2000), RNA (Aviv et al., 2003; Green et al., 2003; White et al., 2012), 
and lipids (Barrera et al., 2003; Inoue et al., 2012; Li et al., 2007).  
 
α1
α2
α3
α4α5
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Table 1. Information based on mapping of SMART genomic protein database to KEGG (Kyoto 
Encyclopedia of Genes and Genomes) orthologous groups (http://www.genome.jp/kegg) (Kanehisa et 
al., 2012). KEGG is a database of gene catalogs from completely sequenced genomes which are 
linked to cell functions. Percentage points are related to the number of proteins with SAM domains 
which could be assigned to a KEGG orthologous group, and not all proteins containing SAM domain. 
Proteins can be included in multiple pathways, i.e. the numbers above will not always add up to 100%. 
 
Several Sam domains have been observed to form dimers with other Sam domains 
in both homo and heterotypic modes, by means of head-to-head (Walker et al., 
unpublished results), tail-to-tail (Rajakulendran et al., 2008; Stapleton et al., 1999; 
Thanos et al., 1999), and head-to-tail (Kurabi et al., 2009; Leone et al., 2008; Leone 
et al., 2009; Mercurio et al., 2012; Mercurio et al., 2013; Rajakulendran et al., 2008; 
Stafford et al., 2001) orientations (Figure 2). For example, the Ephrin B4 kinase 
(PDB code: 2QKQ- Walker et al., unpublished results) Sam domain has been 
crystallized in a head-to-head configuration, while the Ephrin B2 (PDB code: 1B4F- 
Stapleton et al., 1999) receptor forms a homodimer in a tail-to-tail mode. Drosophila 
proteins Ph and Scm bind to each other in a head-to-tail topology (PDB code: 1PK1-
Kim et al., 2005), also called “Mid-Loop/End-Helix” (Leone et al., 2008; Leone et al., 
2009; Mercurio et al., 2012; Mercurio et al., 2013; Rajakulendran et al., 2008), which 
is the most conventional interaction mode encountered in Sam-Sam complexes.  
% proteins involved Description
43.62 Axon guidance
7.98 Phosphatidylinositol signaling system
4.79 Glycerophospholipid metabolism
4.79 Glycerolipid metabolism
4.26 Fc epsilon RI signaling pathway
4.26 Inositol phosphate metabolism
4.26 MAPK signaling pathway
4.26 T cell receptor signaling pathway
4.26 Natural killer cell mediated cytotoxicity
3.72 Tight junction
3.72 p53 signaling pathway
2.66 Tryptophan metabolism
1.06 Benzoate degradation via CoA ligation
0.53 GnRH signaling pathway
0.53 Apoptosis
0.53 Olfactory transduction
0.53 Insulin signaling pathway
0.53 Taste transduction
0.53 Wnt signaling pathway
0.53 Gap junction
0.53 Calcium signaling pathway
0.53 Long-term potentiation
0.53 Melanogenesis
0.53 Hedgehog signaling pathway
0.53 Progesterone-mediated oocyte maturation
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Figure 2. Three examples of different Sam-Sam interactions. 
Sam domains often self-associate by forming polymeric structures. For instance, 
polymeric Sam domains have been characterized in transcriptional repressors (Kim 
et al., 2001; Kim et al., 2002; Kim et al., 2005; Qiao et al., 2004), scaffolding proteins 
(Baron et al., 2006; De Rycker et al., 2003), and regulatory enzymes (Harada et al., 
2008). Among transcriptional regulators, TEL (Translocation Ets Leukemia) has been 
frequently linked to human leukemias, and it is thought that these diseases arise 
because Sam mediate polymerization constitutively activates mitogenic proteins 
(Carrol et al., 1996; Golub et al., 1996). 
Sam domains also appear to possess the ability to bind RNA (Aviv et al. 2003; Green 
et al., 2003; White et al., 2012). An example is the Sam domain of human SAMHD1 
protein, a retroviral HIV restriction factor expressed in myeloid cells, which is 
dispensable for retroviral restriction, oligomerization, and RNA binding of the protein 
(White et al., 2012). 
In a few cases Sam domains can also bind lipids (Barrera et al., 2003; Inoue et al., 
2012; Li et al., 2007). Recently it has been reported that Sam and DDHD domains of 
A1 KIAA0725p, a member of the intracellular phospholipase A1 family of proteins 
implicated in organelle biogenesis and membrane trafficking, are essential for protein 
phosphoinositide binding and phospholipase activity (Inoue et al., 2012). 
 
 
1.2. Ephrins and Eph receptors 
Ephs are the largest family of receptor tyrosine kinases (RTKs) in the animal 
kingdom (Pitulescu and Adams, 2010). Together with their ligands (ephrins), 
represent an important cell communication system with well-known roles in 
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physiological and pathological processes (Pasquale, 2008). In humans Eph receptors 
are fourteen and, on the basis of sequence homology, have been classified into two 
groups: EphA (EphA1-8 and EphA10) and EphB (EphB1-4 and EphB6) (Eph-
Nomenclature-Committee, 1997). The ephrins have the singularity of being 
membrane-bound; in particular ephrins belonging to subclass A (ephrin A1-5) are 
linked to membrane by means of a GPI (Glycosylphosphatidylinositol) linkage, while 
ephrins of subclass B (ephrin B1-3) are transmembrane proteins (Figure 3). EphA 
receptors typically bind ephrins A, and EphB receptors bind ephrins B (Gale et al, 
1996); also limited cross-binding between members of the two classes are reported 
(Himanen et al., 2004). 
The Eph receptors have a ligand binding domain at the N-terminus (Labrador et al., 
1997), followed by a central cysteine-rich region, and two fibronectin type III repeats 
near the membrane-spanning segment (Pasquale, 1997). The cytoplasmatic region 
of the Eph receptors contains a short juxtamembrane region with several conserved 
tyrosine residues, followed by a Sam domain, and a C terminal PDZ-binding motif 
(Pasquale, 1997) (Figure 3). 
 
 
 
 
 
Figure 3. Domain structures of Eph receptors and ephrins, with tyrosine phosphorylation sites 
indicated by the symbol P. 
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Generally Eph receptors interact with the cell surface-associated ephrins at sites of 
cell-cell contacts (Pasquale, 2010). The activation of Eph receptors by means of 
ephrins gives rise to a bi-directional signal: a forward signal, spreading into receptor-
expressing cell, which determines Eph receptor autophosphorylation on specific 
tyrosine residues, activation of its kinase activity, and association with various 
effector proteins; and a reverse signal, that propagates in ephrin-expressing cells, 
which partially depends on tyrosine phosphorylation of the ephrin cytoplasmatic 
region, and on association with other proteins (Pasquale, 2008). In many cases 
Eph/ephrin interactions generate repulsive signals that are involved in cell migration 
and movements in a wide range of processes, such as axon guidance in the nervous 
system (Wilkinson, 2001), cell positioning in the intestinal epithelium (Battle et al., 
2002), and angiogenesis (Adams and Klein, 2000).  
A mechanism that terminates Eph/ephrin interactions, with consequent cell 
separation, is endocytosis (Pitulescu and Adams, 2010). During this process, the 
intact receptor-ligand complex, together with the surrounding plasma membrane, can 
be internalized into the Eph- or ephrin- expressing cell (Marston et al., 2003; Zimmer 
et al., 2003). Some studies suggest that c-Cbl, a RING finger E3 ubiquitin ligase, 
participates in induction of Eph receptors degradation (Fasen et al., 2008). 
Eph receptors direct cell movements by regulating the actin cytoskeleton and the 
associated cell-matrix adhesions (Miao et al., 2000; Carter et al., 2002). Eph/ephrin 
signaling is often coupled to regulation of the activity of small Rho family GTPases, 
such as Rac, Rho, or Cdc42 that connect bidirectional receptor-ligand interactions to 
changes in the actin cytoskeleton (Groeger and Nobes, 2007; Noren and Pasquale, 
2004). 
 
Eph receptors are involved in the pathogenesis of many diseases, above all cancer 
(Pasquale, 2008). In fact, besides their expression in normal tissues, Eph receptors 
result present, and often over-expressed, in almost all types of cancer cells (Ireton 
and Chen, 2005; Noren and Pasquale, 2007), with consequent increasing of 
angiogenesis and tumor vasculature (Surawska et al., 2004). The up-regulation of 
Eph receptor is mainly observed in the more aggressive stages of tumor progression 
(Dodelet and Pasquale, 2000). However, decreased Eph receptor levels have also 
been reported in a few malignant cancer cell lines (Battle et al., 2005; Hafner et al., 
2006; Li et al., 2009). Probably, an initial Eph receptor over-expression, due to 
oncogenic signaling pathways activation, is followed by an epigenetic silencing in 
more advanced stages of tumoral progression (Battle et al., 2005). Receptors 
expression levels can also be regulated by alterations and changes in mRNA stability 
(Huusko et al., 2004; Winter et al., 2008); indeed, several Eph receptor genes are 
located in chromosomal regions that are frequently lost in cancer cells (Sulman et al., 
1997; Huusko et al., 2004), whereas others Eph genes are located in amplified 
regions (Kang et al., 2009). Due to the evident connection of Eph receptors with 
tumoral pathogenesis, they are considered promising therapeutic agents in cancer 
(Pasquale, 2010).  
 
 
1.2.1. The EphA2 receptor 
 
The EphA2 receptor (EphA2) is involved in a large number of physiological and 
pathological processes, which it regulates by means of complex and still poorly 
understood mechanisms (Surawska et al., 2004).  
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A few receptor physiological activities are well known: EphA2 stimulation induces 
activation of RhoA GTPase through a PI3K (Phosphoinositol-3-kinase) dependent 
pathway, that regulates cell migration (Fang et al., 2005; Miao et al., 2003), and 
reduces FAK (Focal Adhesion Kinase) phosphorylation, resulting in the inhibition of 
integrin-mediated cell adhesion (Miao et al., 2000).  
Due to the evident EphA2 connection to many types of cancer (such as breast, 
prostate, lung, ovarian, cervical, esophageal and colorectal cancers, and malignant 
melanoma (Ireton and Chen, 2005)), this protein is receiving great attention as 
possible anti-tumoral target (Pasquale, 2010). It has been reported that EphA2 over-
expression is sufficient to generate tumorigenesis in mammalian epithelial cells, 
when EphA2 fails to bind its ligands (ephrins A1-5), whereas receptor stimulation by 
soluble ephrin A1 reverses growth and invasiveness of EphA2 transformed cells 
(Zelinski et al., 2001). EphA2 over-expression in cancer does not affect cells 
proliferation but changes their malignant behaviour, since the receptor is not able to 
bind its ligands, with a consequent increasing of extracellular matrix adhesion and 
higher metastatic potential (Ruoslahti, 1999).  
EphA2 has also been implicated in tumor invasion of blood vessel, (Brantley et al., 
2002). In fact, in vivo studies support an important role for EphA2 as regulator of 
VEGF (Vascular Endothelial Growth Factor)-mediated angiogenesis (Cheng et al., 
2002).  
 
A specific process related to EphA receptors, the endocytosis and subsequent 
degradation, is considered to be critical in regulation of cell repulsive events (Cowan 
et al., 2005). In the specific case of EphA2, the connection between endocytosis and 
pro-cancer activities is under investigation; indeed, enhanced receptor internalization 
and degradation are associated with decreased malignant cell behavior (Zhuang et 
al., 2007). A few strategies to reduce EphA2 pro-cancer activity by inducing its 
endocytosis have already been developed, and rely on monoclonal antibodies 
(Carles-Kinch et al., 2002), ephrin-mimetic peptides (Koolpe et al., 2002), or 
adenovirus-expressing the ephrin-A1 ligand (Noblitt et al., 2004).  
Proteins which normally interact with EphA2 as downstream effectors in cancer cells 
can affect receptor endocytosis (Kim et al., 2009; Zhuang et al., 2007).  
An example is the lipid phosphatase Ship2 (Src homology 2 domain-containing 
phosphoinositide-5-phosphatase 2), which, together with the PI3K kinase, is 
supposed to act as a regulator of Rho family GTPase in response to EphA2 
activation (Zhuang et al., 2006). Ship2 is provided like EphA2 with a Sam domain. 
Upon ephrin binding to EphA2, Ship2 is recruited at the receptor site by an 
heterotypic Sam-Sam association. In vitro experiments, performed in MDA-MB-231 
mammary carcinoma cells, have demonstrated that Ship2 over-expression increases 
EphA2 stability by inhibiting its endocytosis and degradation, with a consequent 
rising of tumor malignancy, while suppression of Ship2 expression by small 
interfering RNA-mediated gene silencing (siRNA) enhances receptor internalization 
and degradation (Zhuang et al., 2007). 
The NMR (Nuclear Magnetic Resonance) solution structure of the Ship2 Sam domain 
(Ship2-Sam) (PDB code: 2K4P) was previously reported, together with binding 
studies with the EphA2 receptor Sam domain (EphA2-Sam) (Leone et al., 2008; Lee 
et al., 2012). ITC (Isothermal Titration Calorimetry) studies have shown that EphA2-
Sam binds Ship2-Sam with a low micromolar binding affinity. Binding studies have 
indicated that these proteins bind by adopting a topology common to several Sam-
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Sam complexes, called "Mid-Loop/End-Helix" (Leone et al., 2008; Lee et al., 2012) 
(See Paragraph 1.1).  
EphA2 endocytosis is also regulated by the ANKS (Ankyrin repeat domain containing 
and Sam) protein family (Kim et al., 2009). In particular it has been revealed that 
Odin (See Paragraph 1.4), a member of this protein family, in human breast 
carcinoma cells is critically involved in preventing EphA2 receptor degradation, and 
this activity is mediated by Odin Sam domains (Kim et al., 2009).  
 
The EphA2 receptor is also involved in pathologies different than cancer. For 
example, EphA2 activation has been shown to mediate inflammation during injury, 
ischemia, and other chronic inflammatory conditions (Ivanov and Romanovsky, 2006; 
Kitamura et al., 2008) by promoting vascular permeability (Cercone et al., 2009); in 
particular, recently EphA2 has been related to exacerbation of ischemic brain injury 
(Thundyil et al., 2013). 
A few studies have shown that mutations or deletions affecting the Sam domain of 
EphA2 receptor lead to cataract formation in humans and mice (Shiels et al., 2008). It 
has been proposed that these mutations influence protein stability through changes 
of solubility and folding efficiency, which may cause cellular disorganization and lens 
opacity (Park et al., 2012). 
As described above, a few EphA2 pathological activities involve its Sam domain, 
which thus could be considered a novel target for the development of therapeutic 
compounds. 
 
 
1.3. The PI3K effector protein Arap3 
 
Arap3 (Arf GAP, Rho GAP, Ankyrin repeat and PH domains) is a dual GTPase 
activating protein for Arf6 and RhoA, containing five PH (Pleckstrin Homology) 
domains and a Sam domain (Krugmann et al., 2002) (Figure 4). 
 
 
 
Figure 4. Domain organization of the protein Arap3.  
 
Human Arap3 has been originally identified using an affinity-based method to purify 
proteins which specifically bind PtdIns(3,4,5)P3 (Phosphatidylinositol-3-P) (Krugmann 
et al., 2002). PtdIns(3,4,5)P3 is generated through phosphorylation of PtdIns(4,5)P2 
(Phosphatidylinositol-2-P) operated by the PI3K kinase (Vanhaesebroeck et al., 
1997). Upon binding to PtdIns(3,4,5)P3 with its N-terminal PH domain (Craig et al., 
2010) (Figure 4), Arap3 translocates to the plasma membrane into proximity of its 
substrates, RhoA-GTP and Arf6-GTP, and activates them (Krugmann et al., 2004). 
Activation of these small GTPases is implicated in growth factors and PI3K kinase-
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mediated signaling pathways, controlling lamellopodia formation, cell adhesion and 
spreading, regulation of actin cytoskeleton (I et al., 2004; Krugmann et al., 2006). 
Recently new Arap3 functions have been reported : it is a regulator of developmental 
sprouting angiogenesis (Gambardella et al., 2010), and a suppressor of peritoneal 
dissemination of scirrhous gastric carcinoma cells (Yagi et al., 2011). 
In a yeast two-hybrid screen the lipid phosphatase Ship2 has been identified as 
binding partner for Arap3; this interaction is mediated by dimerization of Sam 
domains from the two proteins (Raaijmakers et al., 2007).  
The NMR solution structure of the Arap3 Sam domain (Arap3-Sam) (PDB code: 
2KG5) and its interaction with Ship2-Sam have been characterized (Leone et al., 
2009; Raaijmakers et al., 2007). The Sam-Sam heterodimerization between proteins 
occur by means of the "Mid-Loop/End-Helix" topology (Leone et al., 2009) (See 
Paragraph 1.1), with a dissociation constant in the high nanomolar range 
(Raaijmakers et al., 2007). Arap3-Sam presents a sequence homology of about 58% 
with EphA2-Sam, and competes with it for binding to Ship2-Sam (Leone et al., 2009) 
(See Paragraph 1.2.1). 
Ship2 is a negative regulator of the PI3K kinase pathway; since binding of Arap3 to 
PtdIns(3,4,5)P3 is required for efficient membrane localization of the protein (Craig et 
al., 2010), dephosphorylation of PtdIns(3,4,5)P3 by Ship2 implies a reduced affinity of 
Arap3 for the plasma membrane (Raaijmakers et al., 2007). 
 
 
1.4. Odin: a member of the Anks family of proteins 
 
The ANKS (Ankyrin repeat domain containing and Sam) protein family includes Odin 
and AIDA-1b (AβPP intracellular domain-associated protein 1B), both consisting of 
six ankyrin repeat domains at the N-terminus, two Sam domains in tandem, and a 
phosphotyrosine binding domain (PTB) at the C-terminus (Pandey et al., 2002; 
Ghersi et al., 2004) (Figure 5). 
 
 
 
Figure 5. Domain arrangement of ANKS protein family. 
 
Odin is a cytosolic adapter protein that negatively regulates PDGF (Platelet-Derived 
Growth Factor)-mediated cell proliferation (Pandey et al., 2002).  
It has recently been reported a potential role of Sam domains of ANKS family 
proteins as inhibitors of EphA2 receptor degradation (Kim et al., 2010). In particular, 
Odin over-expression in MDA-MB-231 human breast carcinoma cells and MEFs 
(Mouse Embryonic Fibroblast) inhibits EphA2 internalization and degradation after 
ligand stimulation, whereas a Sam domain deletion mutant of Odin impairs this 
function (Kim et al., 2010). It has been suggested a fine regulation of EphA2 receptor 
signaling by a balance between the activity of c-Cbl E3 ubiquitin ligase (a positive 
regulator of Eph degradation) and ANKS proteins (Kim et al., 2010).  
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Sam domains of Odin have also been identified as binding partners of Arap3-Sam, 
but the possible function of these interactions remains unclear (Raaijmakers et al., 
2007).  
Before starting our studies the only structure information available in the PDB 
(Protein Data Bank) on Sam domains from the ANKS family concerned with AIDA-1b. 
In detail, the structures of the first Sam domain of AIDA-1 (PDB code: 2KE7- 
Donaldson, not published) and its Sam domain tandem (PDB code: 2KIV- Kurabi et 
al., 2010) had already been solved by NMR.  
The AIDA-1b Sam domain tandem has a head-to-tail organization in which the Mid-
Loop and End-Helix surfaces are provided by Sam1 and Sam2 respectively (Figure 
6). 
 
 
 
 
Figure6. NMR structure of the tandem Sam domain of AIDA-1 (first conformer of the NMR ensemble). 
 
 
My research, as will be better describe below, focused on the first Sam domain of 
Odin. 
 
 
1.5. Aims of the present PhD thesis 
 
My thesis rely on an extensive analysis at molecular level of Sam domains-mediated 
protein-protein interactions, in order to lay the foundations for the design of libraries 
of biotechnological relevant molecules which, by mimicking the interaction surfaces 
and thus, selectively interfering with the formation of Sam-Sam complexes, could 
prove useful for either therapeutic and diagnostic applications. 
In particular, I focused my studies on the solution structure and the intermolecular 
interactions of a few Sam domain containing proteins that play important roles in 
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physiological or pathological processes, and the analysis of solution conformational 
properties of peptides reproducing the corresponding binding sites.  
This work is arranged into three main work packages: 
1) The NMR solution structure of the first Sam domain of Odin and its interaction with 
the EphA2 receptor (Chapter 2). 
The first Sam-Sam interaction I have characterized is the complex formation between 
the tyrosine kinase receptor EphA2 (Ephrin receptor A2), which is able to regulate 
important biological processes and play a fundamental role in tumorigenesis, and 
Odin, a protein belonging to the ANKS (Ankyrin repeat domain containing and Sam) 
family which possesses two Sam domains in tandem. 
2) Studies of the heterotypic Sam-Sam association between Odin and Arap3 
(Chapter 3). 
Another Sam-Sam interaction which has been object of my studies is that occurring 
between Odin and Arap3 (Arf GAP, Rho GAP, Ankyrin repeat and PH domains), a 
protein involved in the phosphoinositol-3-kinase (PI3K) signaling pathways. 
3) NMR structural characterization of the Sam3 peptide (Chapter 4). 
A peptide, named Sam3, which includes the central portion of the Odin-Sam1 
domain, that is mainly responsible, as demonstrated by my previous results, of the 
association with EphA2-Sam and Arap3-Sam, together with the 5 C-terminal helix, 
was designed (See Figure 1, Chapter 4). The C-terminal helix was added to induce 
the peptide folding in a similar way with respect to the intact Odin-Sam1 domain. I 
have analyzed the conformational properties of the peptide in buffer and H2O/TFE 
(Trifluoroethanol) mixtures. 
 
To achieve the above described goals, a multidisciplinary approach involving 
different experimental and computational techniques, such as NMR (Nuclear 
Magnetic Resonance Spectroscopy), SPR (Surface Plasmon Resonance), ITC 
(Isothermal Titration Calorimetry), docking, mutagenesis, was undertaken.  
The knowledge acquired from these studies could be effectively the starting point for 
the design of biotechnological relevant molecules (like peptides and peptido-
mimetics) interfering with Odin-Sam1/EphA2-Sam or Odin-Sam1/Arap3-Sam 
associations. Particularly, antagonists of Odin-Sam1/EphA2-Sam interaction could 
modulate EphA2 receptor endocytosis and play a role as therapeutic agents in 
diseases such as cancer. With regard to the Odin-Sam1/Arap3-Sam complex, the 
designed molecules could be implemented in cellular assays to identify new 
biological functions related to Arap3-Sam. 
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2. THE NMR SOLUTION STRUCTURE OF THE FIRST SAM DOMAIN OF ODIN 
AND ITS INTERACTION WITH THE EPHA2 RECEPTOR 
 
2.1.  BACKGROUND 
The EphA2 receptor belongs to a large subgroup of receptor tyrosine kinase family 
(Eph) playing relevant functions in several physiological and pathological events. In 
particular, EphA2 has long been related to cancer (Pasquale, 2010; Surawska et al., 
2004), and recently has been associated to cataracts (Cooper et al., 2008; Jun et al., 
2009; Zhang et al., 2009) and inflammation processes (Coulthard et al., 2012). These 
pathological functions of EphA2 have made it an attractive target in drug discovery 
(Koolpe et al., 2002; Noberini et al., 2008; Tagnolini et al., 2012). 
With regard to EphA2 pro-cancer activities, the potential correlation between the 
process of receptor endocytosis and subsequent degradation, and the decrease of 
tumor malignancy, has been analyzed in many types of cancer in which EphA2 is 
over-expressed (Pasquale, 2010; Surawska et al., 2004). Recent studies have 
reported that the EphA2 endocytosis regulation is effected by some proteins, 
including the lipid phosphatase Ship2 (Zhuang et al., 2007). In fact, in vitro 
experiments have demonstrated that Ship2 over-expression in malignant breast 
cancer cells increases EphA2 stability, with a consequent enhancement in tumor cell 
invasiveness and metastatic potential, while decreased levels of Ship2 facilitate 
receptor internalization and degradation. This regulation process occurs as a result of 
an heterotypic interaction in between the Sam domain of Ship2 (Ship2-Sam) and the 
Sam domain of EphA2 (EphA2-Sam) (Zhuang et al., 2007). 
The NMR (Nuclear Magnetic Resonance) solution structure of Ship2-Sam (PDB 
code: 2K4P) was previously reported, together with binding studies with the EphA2-
Sam receptor (Leone et al., 2008). In particular, ITC (Isothermal Titration 
Calorimetry) studies were carried out and showed that EphA2-Sam binds Ship2-Sam 
with an affinity in the low micromolar range. Chemical shift perturbation studies have 
revealed the reciprocal binding interfaces of Ship2-Sam and EphA2-Sam, and shown 
that these proteins interact by adopting a topology common to several Sam-Sam 
complexes, called "Mid-Loop/End-Helix " (Leone et al., 2008).  
A recent work indicates that the EphA2 receptor endocytosis is also regulated by the 
ANKS (Ankyrin repeat domain containing and Sam) protein family (Kim et al., 2010). 
This class of proteins includes Odin (Pandey et al., 2002) and AIDA1b (AβPP 
intracellular domain-associated protein 1B) (Ghersi et al., 2004), and is characterized 
by the presence of two Sam domains in tandem (Sam1 and Sam2). In particular, 
Odin over-expression in MDA-MB-231 human breast carcinoma cells and MEFs 
(Mouse Embryonic Fibroblast) inhibits EphA2 internalization and degradation after 
ligand stimulation, whereas a Sam domain deletion mutant of Odin impairs this 
function (Kim et al., 2010). 
Within this work package, the solution structure of the first Sam domain of Odin 
(Odin-Sam1) was determined by means of NMR structural studies. Indeed, studies of 
Odin-Sam1/EphA2-Sam complex were carried out by means of NMR, SPR (Surface 
Plasmon Resonance), ITC and molecular docking techniques.  
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2.2.  MATERIALS AND METHODS 
 
2.2.1. Protein expression 
Recombinant proteins were expressed in Escherichia Coli, using constructs provided 
with a tail of six His and a thrombin cleavage site at the N-terminus. Genes were 
cloned into the PET15B plasmids and transformed using BL21-Gold (DE3) 
competent cells (Stratagene). The following PET15B-constructs were used in this 
study: residues 1199-1258 of human Ship2 (UniprotKB/TrEMBL code: O15357), 
residues 691-770 of human Odin (UniprotKB/TrEMBL code: Q92625), residues 901-
976 of human EphA2 (Swiss-Prot/TrEMBL code: P29317), EphA2-Sam double 
mutant (H924N, R950A corresponding to H45N, R71A according to our sequence 
number), and EphA2-Sam triple mutant (K917A, R957A, Y960S corresponding to 
K38A, R78A, Y81S according to our sequence number). Synthetic genes coding for 
these proteins were all purchased from Celtek Bioscience (Nashville, TN). 
Unlabeled proteins expression was achieved by growing bacteria at 37°C in LB 
medium until OD600=0.6. Protein over-expression was induced by IPTG (Isopropyl β-
D-thiogalactopyranoside) at a concentration of 1 mM, overnight at 25°C. Expression 
of 15N/13C double labeled and 15N uniformly labeled proteins was carried out in M9 
minimal medium supported with 2 g/L of 13C-Glucose and/or 0.5 g/L of 15NH4Cl. M9 
medium containing 3.6 g/L of 12C-glucose (natural abundance) and 0.4 g/L of 13C-
glucose was implemented to achieve 10% fractional 13C labeling for stereo-specific 
assignments of Leu-CH31,2/Val-CH31,2 methyl groups (Neri et al., 1989). The 
expression protocol for labeled proteins was identical to that used for unlabeled 
protein production. Proteins were purified with an AKTA prime FPLC system by 
affinity chromatography on a nickel column (Amersham). 
 
2.2.2. Resonance assignment  
Experiments for resonance assignments were acquired at 25 °C on a Varian Unity 
Inova 600 MHz spectrometer equipped with a cold probe. NMR samples were made 
up of 15N or 15N/13C labeled Odin-Sam1 (900 M) in phosphate buffer saline (PBS, 10 
mM phosphates, 138 mM NaCl, 2.7 mM KCl) (Fisher) at pH=7.7, 0.2% NaN3 with 
volumes of 600 L (95% H2O/5% D2O). In Figure 1 the [
1H,15N] HSQC 
(Heteronuclear Single Quantum Coherence) spectrum of 15N labeled Odin-Sam1 is 
shown, and indicates that the protein is folded and not degraded. 
Backbone assignments were carried out through analysis of triple resonance 
experiments (HNCA (Figure 2A), HN(CO)CACB, HNCACB) (Grzesiek and Bax, 
1993). (H)CC(CO)NH and HCCH-TOCSY spectra were used to identify carbon side 
chains. Proton side chains were assigned analyzing the HCCH-TOCSY spectrum or 
by comparing 3D 15N resolved-[1H, 1H] NOESY (100 ms mixing time) (Figure 2B) 
and 3D 15N resolved-[1H, 1H] TOCSY (70 ms mixing time) experiments. 2D [1H, 1H] 
NOESY (mixing time 100 ms) and 2D TOCSY (mixing time 70 ms) experiments, 
recorded with samples of Odin-Sam1 dissolved in 99% D2O, were recorded in order 
to obtain aromatic side chains assignments. Stereo-specific assignments for Leu-
CH3
1,2 and Val-CH3
1,2 methyl groups were obtained analyzing a [1H, 13C] HSQC 
experiment acquired on a fractionally 13C labeled Odin-Sam1 sample (500 M) (Neri 
et al., 1989). 
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Figure 1. [
1
H,
15
N] HSQC spectrum of 
15
N labeled Odin-Sam1. Each peak corresponds to HN backbone 
atoms and side chains HN from Asn, Gln and Trp. 
 
 
 
 
 
 
Figure 2. (A) A portion of the Odin-Sam1 HNCA spectrum encompassing residues from Ser31 to 
Gly40. Arrows indicate correlations between the Catoms of adjacent residues. (B) The region Ser31-
Gly40 of Odin-Sam1 showed in its 3D 
15
N resolved-[
1
H, 
1
H] NOESY spectrum. Arrows indicate 
sequential correlations between HN backbone atoms. 
  
 
24 
 
To gain backbone assignments of the Odin-Sam1/EphA2-Sam complex, HNCA and 
3D 15N resolved-[1H, 1H] NOESY (100 ms mixing time) spectra were recorded on 
samples including either 15N/13C double labeled Odin-Sam1 (450 M) and unlabeled 
EphA2-Sam (~1 mM), or double labeled EphA2-Sam (350 M) and unlabeled Odin-
Sam1 (900 M).  
NMR spectra were processed with Varian software (Vnmrj version 1.1D) and 
analyzed with NEASY as implemented in the program Cara (Bartels et al., 1995).  
 
2.2.3. Relaxation measurements 
The aggregation state of Odin-Sam1 in solution was analyzed by means of backbone 
15N R1 and R2 nuclear spin relaxation rates measurements at 25 °C and 600 MHz. 
These measurements were performed on 15N uniformly labeled Odin-Sam1 samples 
at the concentrations of 100 M and 900 M, and on a sample containing uniformly 
15N labeled Odin-Sam1 (450 M) and unlabeled EphA2-Sam (1 mM).  
A series of 1D spectra (4K data points and 2K or 4K transients) were acquired to 
obtain R1 and R2 relaxation data: five relaxation delays (0.01, 0.1, 0.3, 0.6, 1.0 s) 
were used for R1 measurements and seven relaxation delays were implemented for 
R2 data sets (0.01, 0.03, 0.05, 0.07, 0.09, 0.11, 0.15, 0.19 s). The decrease in signal 
intensity as function of relaxation delay allowed to estimate average R1 and R2 
values; then average R1/R2 ratios were used as input for the software tmest (A. G. 
Palmer III, Columbia University) (Kay et al., 1989) in order to calculate the rotational 
correlation time (C). 
 
2.2.4. DOSY (Diffusion Ordered Spectroscopy) experiments 
The diffusion-ordered NMR spectroscopy was carried out with the Pulsed Gradient 
Spin-Echo (PSGE) NMR technique (Morris and Johnson, 1992). The following 
relationship correlates the translational self-diffusion coefficient, D, to the NMR 
parameters  : I=I0 exp[-(D
G(-/3)], where I0 is the measured peaks intensity of a 
particular group of resonances at the smaller gradient strength, I is the corresponding 
observed peak intensity, D is the translational self-diffusion constant,  is the proton 
gyromagnetic ratio, is the diffusion gradient duration, G is the gradient strength, and 
 is the time gap between two gradients (Price et al., 1997).  
Series of spectra were acquired with 512 scans and 16 K data points. DOSY 
experiments of Odin-Sam1 samples at the concentrations of 100 M and 900 M 
were recorded. The hydrodynamic radius rH of the protein was evaluated with the 
Stokes-Einstein equation D=kBT/f, where f=6rH is the translational friction 
coefficient, η is the viscosity of the solution, kB is the Boltzmann constant, T is the 
temperature in K. 
 
2.2.5. Structure calculation and analysis of Odin-Sam1 
In order to collect distance constraints for structure calculations, a 3D 15N resolved-
[1H, 1H] NOESY-HSQC spectrum (Talluri et al., 1996) (100 ms mixing time), a 3D 13C 
resolved-[1H, 1H] NOESY-HSQC spectrum (100 ms mixing time) and a 2D [1H, 1H] 
NOESY spectrum (Kumar et al., 1980) (100 ms mixing time) for the aliphatic to 
aromatic region, acquired after dissolving the lyophilized protein sample in 99% D2O, 
were used. The software CYANA version 2.1 (Herrmann et al., 2002) was employed 
to calculate the solution structure of Odin-Sam1, and angular constraints were 
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generated with the GRIDSEARCH module of CYANA. Structure calculations were 
initiated from 100 random conformers; the 20 structures with the lowest CYANA 
target functions were analyzed with the programs MOLMOL (Koradi et al., 1996) and 
validated with iCING (http://proteins.dyndns.org/cing/iCing.html).  
 
2.2.6. Odin-Sam1/EphA2-Sam binding studies 
For chemical shift perturbation studies (Pellecchia, 2005) 2D [1H,15N] HSQC 
experiments were recorded; residues close to the binding site can be identified by 
monitoring changes in the HSQC spectra of a protein upon addition of a ligand. The 
addition of ligand is stopped only when the saturation point is reached (i.e.: at this 
point any further addition of the binding partner does not produce other changes in 
the spectra).  
Thus, to map the Odin-Sam1 binding interface for EphA2-Sam, 2D [1H,15N] HSQC 
spectra of 15N labeled Odin-Sam1 (160 M) were acquired in presence and in 
absence of unlabeled EphA2-Sam (80M, 160 M, 240 M, 400 M). To recognize 
the binding site of EphA2-Sam for Odin-Sam1, 2D [1H, 15N] HSQC spectra of a 15N 
labeled EphA2-Sam sample (63 M) were recorded in absence and presence of 
unlabeled Odin-Sam1 (360 M and 600 M). Chemical shift perturbation experiments 
were also performed to verify the binding of EphA2-Sam double (H45N, R71A) and 
triple (K38A, R78A, Y81S) mutants to Odin-Sam1. For this purpose, 15N labeled 
Odin-Sam1 (50-100 M) and unlabeled double and triple EphA2-Sam mutants 
(concentrations ranging from 200 M to 2 mM) samples were used. 
Furthermore, displacement experiments were carried out, in which a 2D [1H,15N] 
HSQC spectrum of 15N labeled Odin-Sam1 (150 M) in its unbound state, after 
addition of unlabeled EphA2-Sam (363 M), and next further addition of unlabeled 
Ship2-Sam (ratio Odin-Sam1/EphA2-Sam/Ship2-Sam equal to 1/2.4/13) were 
recorded. 
Analysis of titration experiments and overlays of 2D spectra were generated with the 
program Sparky (Goddard and Kneller, SPARKY 3, University of California, San 
Francisco). 
 
2.2.7. SPR experiments 
SPR experiments were carried out at 25 °C and a constant 20 L/min flow rate, using 
as running buffer a solution of Hepes 10 mM, pH=7.4, NaCl 150 mM, surfactant P20 
0.05% v/v (90 L injected for each experiment). EphA2-Sam was immobilized in 10 
mM acetate buffer pH 5.0 (flow rate 5 L/min, time injection 7 min) on a CM5 Biacore 
sensor chip, using EDC/NHS chemistry (Johnsson et al., 1991), while Odin-Sam1 
was used as an analyte at different concentrations in the range of 0.1-400 M. 
Residual reactive groups were deactivated with 1 M ethanolamine hydrochloride, 
pH=8.5; the reference channel was prepared by activating with EDC/NHS and 
deactivating with ethanolamine. Immobilization levels were: 940, 1313, 1480 RU for 
EphA2-Sam wild-type, double and triple mutants, respectively. The BIA evaluation 
analysis package (version 4.1, GE Healthcare, Milano, Italy) was used to subtract the 
signal of the reference channel and to estimate KD (Dissociation constant) values. 
RUmax (Resonance Units) values of each experiment versus Odin-Sam1 
concentration were fit by non-linear regression analysis with GraphPad Prism, 
version 4.00 (GraphPad Software, San Diego, California) (Rich et al., 2001). 
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2.2.8. ITC experiments 
ITC studies were performed at 25 °C with an iTC200 calorimeter (MicroCal/GE 
Healthcare, Milano, Italy). A solution of EphA2-Sam at a concentration of 257 M 
was titrated into a solution of Odin-Sam1 10 M concentrated. Before ITC 
measurements both proteins were widely dialyzed in the same buffer (PBS, pH 7.7). 
Fitting of data to a single binding site model was carried out with the Origin software 
as supplied by GE HealthCare.  
 
2.2.9. Docking studies 
Docking studies were carried out by using the NMR structures (first conformers) of 
both Odin-Sam1 (PDB code: 2LRM (Mercurio et al., 2012)) and EphA2-Sam (PDB 
code: 2E8N, Riken Structural Genomic Initiative). Models of the Odin-Sam1/EphA2-
Sam complex were generated with the Haddock web server (de Vries et al., 2010). 
Ambiguous interaction restraints were generated from chemical shift perturbation 
data: residues of Odin-Sam1 and EphA2-Sam with the highest chemical shift 
variations and large solvent exposure, or which could potentially supply important 
intermolecular contacts, as revealed by structural homologies with other Sam-Sam 
complexes, were set as active. For Odin-Sam1 active residues are: L49, L50, N51, 
F53, D54, D55, V56, H57, F58, Q67, D68, R70, D71. For EphA2-Sam residues K38, 
R71, G74, H75, K77, R78, Y81 were set up as active. The regions encompassing 
residues 51-65 of Odin-Sam1 and residues 74-81 of EphA2-Sam (corresponding to 
amino acids 59-66 according to the sequence numbers of the PDB file 2E8N) were 
set as semi-flexible. The C-terminal and N-terminal tails of both Odin-Sam1 and 
EphA2-Sam were considered fully flexible during all the docking stages. In all the 
docking runs, passive residues were set automatically by the Haddock web server 
and the solvated docking mode was used (van Dijk and Bonvin, 2006). 
The docking protocol included a first step (i.e.: the rigid body energy minimization) in 
which 1000 structures were calculated, in the second step the best 200 solutions 
were subjected to semi-flexible simulated annealing, then a final refinement in water 
was performed.  
With all 200 final Haddock models a visual screening was carried out, with MOLMOL 
(Koradi et al., 1996), and solutions not compatible with our experimental data and/or 
containing atypical protein orientations were discarded. Seventy-eight structures 
were selected and further analyzed and compared with experimental structures of 
other heterotypic Sam-Sam complexes (such as the AIDA-1b Sam tandem, PDB 
code: 2KIV (Kurabi et al., 2009)), to identify common features. Finally, 22 models 
representing the possible EphA2-Sam/Odin-Sam1 complex conformations were 
chosen. The selected ensemble was clustered using a RMSD (Root Mean Square 
Deviation) cutoff value of 2 Å by using MOLMOL (Koradi et al., 1996). This clustering 
procedure was performed by superimposing the structures on the backbone atoms of 
the putative binding interfaces of EphA2-Sam (regions 36-41, 62-65, 70-81) and 
Odin-Sam1 (region 48-73), indicating the presence of 5 families of structures (See 
Appendix 1). 
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2.3.  RESULTS AND DISCUSSION 
 
EphA2 receptor tyrosine kinase is considered a promising target in drug discovery for 
cancer therapies; in fact, it is over-expressed in many aggressive tumors and exhibits 
several pro-malignancy activities. In particular the process of receptor endocytosis 
has been exploited as a possible route to reduce tumor malignancy (Pasquale, 2010; 
Surawska et al., 2004). Recent evidences have shown that Sam domains, small 
protein binding modules made up of a five helix bundle, are crucial for anchorage of 
protein regulators of endocytosis at the receptor site (Kim et al., 2010; Zhuang et 
al.,2007). The lipid phosphatase Ship2 is engaged in a heterotypic Sam-Sam 
interaction with the receptor and is able to inhibit its endocytosis in cancer cells 
(Zhuang et al.,2007). Sam domains of proteins belonging to the ANKS family also 
play an important role in the process, possibly by regulating ubiquitination 
mechanisms (Kim et al., 2010). Among ANKS family members, herein attention was 
focused on Odin (Pandey et al., 2002), which in cancer cells inhibits EphA2 
endocytosis, whereas its mutant, lacking Sam domains, does not (Zhuang et al., 
2010). Odin contains two Sam domains in tandem at the C-terminal side, Odin-Sam1 
and Odin-Sam2. For Odin-Sam1 I have carried out a complete structural 
characterization by NMR. Moreover, due to the high sequence identity between 
Ship2-Sam and Odin-Sam1, as well as the common function of regulators of EphA2 
endocytosis, I have investigated if Odin-Sam1 could directly bind EphA2-Sam as 
Ship2-Sam does. 
 
2.3.1. Analysis of the aggregation state of Odin-Sam1 
 
Before starting a complete structure calculation, I have investigated the aggregation 
state of Odin-Sam1 in solution by means of 15N R1 and R2 nuclear spin relaxation 
rates measurements and DOSY experiments.  
Odin-Sam1 has a rotational correlation time (c), estimated by the R2/R1 average 
value, of 7.4  0.7 ns at a protein concentration of 100 M, which does not increase 
at a protein concentration of 900 M (7.3  0.6 ns). These values are rather close to 
those reported for monomeric Sam domains such as Ship2-Sam (6.7 ns) (Leone et 
al., 2008) and Arap3 (Arf GAP, Rho GAP, Ankyrin repeat and PH domain)-Sam (8.2 
ns) (Leone et al., 2009) at similar concentrations and buffer conditions. 
The c of Odin-Sam1 bound to EphA2-Sam increases instead to 11  1 ns, reflecting 
the raise in molecular weight upon association; moreover this value is close to the c 
measured for Ship2-Sam/EphA2-Sam (11.2  0.5 ns) (Leone et al., 2008) and Ship2-
Sam/Arap3-Sam (11  1 ns) (Leone et al., 2009) complexes, thus suggesting that 
Odin-Sam1 and EphA2-Sam are forming a complex with a 1:1 stoichiometry. 
By means of DOSY experiments I have measured a diffusion coefficient (D) for the 
diluted Odin-Sam1 sample (100 M) of 1.46 10-10 m2 s-1, corresponding to a 
hydrodynamic radius (rH) value of 16.7 Å, and a D for the more concentrated Odin-
Sam1 sample (900 M) equal to 1.40 10-10 m2 s-1 , corresponding to a rH of 17.5 Å. 
DOSY measurements show that the hydrodynamic radius of the protein (i.e.: ~17 Å) 
results comparable with that of compact proteins of similar size (Wilkins et al., 1999). 
The results obtained from relaxation and DOSY studies indicate that aggregation 
phenomena can be excluded under the conditions that have been used to calculate 
the NMR structure (i.e.: 900 M) and confirm the Sam domains weak tendency to 
associate in solution through homotypic interactions (Thanos et al., 1999). 
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2.3.2. NMR solution structure of Odin-Sam1 
 
To identify closely related Sam domains, a blastp search against the PDB database 
(Altschul et al., 1997) was carried out by using Odin-Sam1 sequence as input query. 
Odin-Sam1 (UniprotKB/TrEMBL code: Q92625, residues 696-762) presents with 
AIDA1b-Sam1 (UniprotKB/TrEMBL code: Q7Z6G8, residues 810-876) the maximum 
sequence identity (57%). Odin-Sam1 has also good sequence identity with Ship2-
Sam (48%, UniprotKB/TrEMBL code: O15357, residues 1196-1258). A similar blastp 
search conducted by using Odin-Sam2 sequence (UniprotKB/TrEMBL code: 
Q92625, residues 770-837) indicates highest identity with AIDA1b-Sam2 (59%, 
UniprotKB/TrEMBL code: Q7Z6G8, residues 884-949) and 38% of sequence identity 
with EphA2-Sam (Swiss-Prot/TrEMBL: P29317, residues 904- 971) (Figure 3). 
 
 
 
 
 
Figure 3. (A) Sequence alignment of human Odin-Sam1 with AIDA1b-Sam1 and Ship2-Sam. 
Secondary structure elements of Odin-Sam1 and residues contributing to ML surface are indicated. 
(B) Sequence alignment of Odin-Sam2 with AIDA1b-Sam2 and EphA2-Sam. Secondary structure 
elements and regions corresponding to the EH interface of EphA2-Sam are indicated with parenthesis 
and arrows respectively. Alignments have been generated with the T-COFFEE server (Notredame et 
al., 2000). Red residues correspond to highly reliable portions of the multiple alignment. The Cons line 
is a consensus, it indicates the average reliability value for each column. 
 
 
The 3D solution structure of Odin-Sam1 was calculated with the program CYANA 
(Herrmann et al., 2002), which performs simulated annealing with torsion angle 
dynamics by using distance constraints from NOESY experiments. Odin-Sam1 
solution structure consists of 5 helices (Figure 4A), and is a canonical Sam domain 
helix bundle, in agreement with the high homologies with other Sam domains 
revealed by blastp (Figure 3). The final CYANA structure calculation includes 1206 
upper distance constraints (393 intra-residue, 239 short-range, 275 medium-range, 
299 long-range), 372 angle constraints (Figure 4C), and information on 
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stereospecific assignments for methyl groups of Val32, Val56, Val63, Leu36, Leu48 
and Leu84.  
 
 
 
 
 
Figure 4. (A) Ribbon representation of Odin-Sam1 solution structure (first conformer). It contains the 
following  helical segments: 1 (residues 32-39), 2 (residues 42-50), 4 (residues 66-72), 5 
(residues 77-88) (B) Superposition on the backbone atoms (region 30-90) of Odin-Sam1 NMR 
structures. (C) Structure features of Odin-Sam1 solution structure: CYANA (Herrmann et al., 2002) 
and PROCHECK_NMR (Laskowski et al., 1996) statistics for residues 30-90. 
 
 
2.3.3. Odin-Sam1/EphA2-Sam interaction studies 
 
The interaction between Odin-Sam1 and EphA2-Sam was investigated by means of 
NMR, SPR and ITC studies. A clear association of the two proteins is evident from 
analysis of all the different binding assays. 
To map the Odin-Sam1 binding interface for EphA2-Sam, 2D [1H,15N] HSQC spectra 
of 15N labeled Odin-Sam1 were acquired in presence and in absence of unlabeled 
EphA2-Sam. Average 1H and 15N chemical shifts variations were estimated with the 
equation Δ=[(ΔHN)
2+(0.17 x Δ15N)2]1/2 (Farmer et al., 1996). Amino acids presenting 
largest Δ are expected to contribute to the binding surface. In particular, largest Δ 
(values> 0.2 ppm) were mainly found in the middle part of the protein, including the 
C-terminal portion of 2 helix ,the 3 helix and the N-terminal portion of the 4 helix 
(Figure 5).  
Similar titration experiments were acquired to identify the binding interface of EphA2-
Sam for Odin-Sam1, by using 15N labeled EphA2-Sam and unlabeled Odin-Sam1. 
Residues affected by the interaction were assessed by analyzing the normalized 
chemical shift deviations. The largest variations were observed for residues 
belonging to the 5 helix and the adjacent 23 and 45 loop regions (Figure 6). 
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Figure 5: (A) Comparison of [
1
H, 
15
N] HSQC spectra of Odin-Sam1 (150 M) in its unbound form 
(cyan) and after addition of EphA2-Sam (363 M) (magenta). (B) Histogram showing normalized 
chemical shift deviations as function of the residue number. Residues G33, L49, L50, N51, G52, F53, 
D54, D55, H57, F58, L59, G60, M64, E65, Q67, D68, R70, D71, I72, I74, Q85, R88, V93 present 
normalized deviations with values higher than 0.2 ppm. Δ values equal to 0 have been assigned to 
residues Q43, V56, N62 (their peaks only appear in the spectrum of the complex), S61 and S75 
(unassigned), P77 and P91. (C) Residues with normalized chemical shifts deviation higher than 0.2 
ppm are represented in dark violet on the 3D solution structure of Odin-Sam1 (PDB code: 2LMR 
(Mercurio et al., 2012)) in its ribbon representation.  
 
 
These data seem to indicate that Odin-Sam1 and EphA2-Sam adopt for the 
heterotypic Sam-Sam interaction a Mid-Loop/End Helix model that is characteristic of 
Sam-Sam complexes (Kurabi et al., 2009; Rajakulendran et al., 2008; Ramachander 
et al., 2004; Stafford et al., 2011), in which Odin-Sam1 provides the Mid-Loop 
interface and EphA2-Sam provides the End-Helix interface. 
SPR and ITC experiments were also performed, and both confirmed a clear 
association of Odin-Sam1 and EphA2-Sam (Figure 7). 
For SPR experiments, EphA2-Sam was immobilized on the chip surface while Odin-
Sam1 was used as an analyte; kinetic experiments in which RUmax values of each 
experiment were plotted versus Odin-Sam1 concentration, both employing a 1:1 
interaction model, provided a dissociation constant (KD) for the Odin-Sam1/EphA2-
31 
 
Sam complex (Figure 7A, B) of 5.5 ± 0.9 M, obtained by best fitting of experimental 
data with a non-linear regression analysis (Figure 7B).  
ITC experiments indicated instead that Odin-Sam1 associated with EphA2-Sam with 
a 1:1 stoichiometry, and a KD equal to 0.62 ± 0.04 M (Figure 7C). 
 
 
 
 
 
Figure 6: (A) Comparison of [
1
H, 
15
N] HSQC spectra of EphA2-Sam (63 M) in its unbound form 
(magenta) and after addition of Odin-Sam1 (360 M) (green). (B) Histogram showing normalized 
chemical shift deviations as function of the residue number. T29, W33, S36, I37, K38, M39, Y42, F46, 
T52, A53, V58, K66, R71, L72, H75, Q76, K77, R78, A80, Y81, L83 present normalized deviations 
with values higher than 0.1 ppm. Δ values equal to 0 have been assigned to residues N62 and D63 
(unassigned), G74, Q41 (their peaks only appear in the spectrum of the complex), P73 and P96. (C) 
Residues with normalized chemical shifts deviations higher than 0.1 ppm are represented in green on 
the 3D solution structure of EphA2 (PDB code: 2E8N, RIKEN Structural Genomics Initiative) in its 
ribbon representation.  
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Figure 7. (A) SPR studies: overlay of sensorgrams representing the direct binding of Odin-Sam1 to 
immobilized EphA2-Sam (0.1-400 M) (B) A plot of RUmax from each binding versus Odin-Sam1 
concentration. (C) ITC studies: calorimetric curve relative to the titration of EphA2-Sam (257 M) with 
Odin-Sam1 (10 M) are showed. The row and the integrated data are reported in the top and bottom 
sections respectively. For data fitting (bottom) a single-binding model was applied (Mercurio et al., 
2012). 
 
 
Additional information on the binding mode of EphA2-Sam to Odin-Sam1 were 
derived by further NMR and SPR experiments with a triple mutant (K38A, R78A, and 
Y81S) and a double mutant (H45N and R71A) of EphA2-Sam. 
In the triple EphA2-Sam mutant residues located in the 5 helix and 12 loop, that 
constitute the putative interaction surface of EphA2-Sam for Odin-Sam1 according to 
the results of chemical shift perturbation experiments, were mutated (Figure 8). The 
type of amino acids replacements were planned to destroy potential key interactions 
at the dimer interface without perturbing the overall protein structure. Instead, in the 
H45N, R71A EphA2-Sam mutant, amino acids replacements were inserted in regions 
adjacent to the putative binding site (Figure 8). Both NMR (Figure 9A, B) and SPR 
experiments (Figure 9C, D) indicate that, compared with EphA2-Sam wild-type, the 
binding affinity of the triple mutant for Odin-Sam1 is lower, whereas EphA2-Sam 
double mutant preserves similar ability to interact with Odin as the wild-type protein 
(KD=3.8 ± 0.3 M). 
 
To recognize if EphA2-Sam was interacting with Odin-Sam1 and Ship2-Sam by using 
the same binding pocket, displacement experiments were carried out by means of 2D 
[1H,15N] HSQC spectra. A spectrum of 15N labeled Odin-Sam1 in its unbound state 
was first recorded. After addition of unlabeled EphA2-Sam to this sample, changes in 
the 2D [1H,15N] HSQC characteristic of the Odin-Sam1/EphA2-Sam complex could 
be observed. The spectrum of unbound form of Odin-Sam1 could be restored by 
further addition of unlabeled Ship2-Sam (ratio Odin-Sam1/EphA2-Sam/Ship2-Sam 
equal to 1/2.4/13) (Figure 10).  
These data highlight that the dissociation of the Odin-Sam1/EphA2-Sam complex is 
followed by capture of EphA2-Sam by Ship2-Sam and thus show that EphA2-Sam 
presents one identical binding pocket for Odin-Sam1 and Ship2-Sam.  
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Figure 8. Ribbon representation of EphA2-Sam NMR solution structure (first conformer, PDB code: 
2E8N), with residues corresponding to the binding interface for Odin-Sam1 highlighted in orange. The 
side chain of amino acids replaced in EphA2-Sam triple and double mutants are shown in neon 
representation (yellow and red respectively).  
 
 
Figure 9. (A) Overlay of 2D [
1
H,
15
N] HSQC spectra of 
15
N labeled Odin-Sam1 in absence (green) and 
in presence (yellow) of EphA2-Sam triple mutant. (B) 2D [
1
H,
15
N] HSQC spectra of 
15
N labeled Odin-
Sam1 in its unbound form (green) and after addition of EphA2-Sam double mutant (red). (C) Overlay 
of sensorgrams relative to the direct binding of Odin-Sam1 to immobilized EphA2-Sam triple mutant 
(1-200 M). Saturation was not reached (Mercurio et al., 2012). (D) Overlay of sensorgrams relative to 
the direct binding of Odin-Sam1 to immobilized EphA2-Sam double mutant (1-200 M). In the right 
inset a plot of RUmax from each binding versus Odin-Sam1 concentrations is reported; data were fitted 
by non-linear regression analysis (Mercurio et al., 2012). 
R71A
Y81S
R78A
H45N
K38A
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Figure 10. (A) Overlay of 2D [
1
H, 
15
N] HSQC spectra of 
15
N labeled Odin-Sam1 (150 M) in the apo 
form (green) and bound to EphA2-Sam (363 M) (purple). (B) The spectrum of unbound Odin-Sam1 is 
restored by addition of unlabeled Ship2-Sam (red). 
 
 
 
2.3.4. Molecular docking of the Odin-Sam1/EphA2-Sam complex 
 
A model of the Odin-Sam1/EphA2-Sam complex was built by molecular docking with 
the Haddock web server (de Vries et al., 2010), by using the 3D structures of both 
Odin-Sam1 (PDB code: 2LMR) and EphA2-Sam (PDB code: 2E8N).  
These modeling studies, based on chemical shift perturbation data, indicate that the 
Odin-Sam1/EphA2-Sam complex possesses a head-to-tail topology, also called Mid-
Loop (ML)/End-Helix (EH) (Kim et al., 2002), in which Odin-Sam1 and EphA2-Sam 
provides the ML (i.e.: central region of the Sam domain) and EH (i.e.: C-terminal 5 
helix and adjacent loops) binding interfaces, respectively. Mainly intermolecular 
interactions consist of H-bonds and electrostatic contacts in between positively 
charged residues of EphA2-Sam and negatively charged residues of Odin-Sam1 
(Figure 11). Cation- and - interactions also occur in a few Haddock solutions, and 
involve Phe53 and Phe58 on Odin-Sam1 surface and Tyr81 on the EphA2-Sam EH 
site (Figure 11).  
Mutagenesis studies indicate indeed that Tyr81, together with Lys38 and Arg77 on 
the EH surface of EphA2 are likely providing essential interactions, in fact, concurrent 
mutations of the Tyr to Ser, Lys and Arg to Ala, highly attenuate the binding affinity 
for Odin-Sam1 (Figure 9A, C). Indeed, in most of our docking solutions these three 
residues are involved in intermolecular contacts (See Appendix 1). 
As previously reported, Tyr81, Lys38 and Arg78 are also important for the interaction 
of EphA2-Sam with the Sam domain of the lipid phosphatase Ship2 (Ship2-Sam) 
(Leone et al., 2008). These earlier studies have pointed out that Ship2-Sam and 
EphA2-Sam bind to each other with a KD=0.75 Mprobably adopting a ML/EH 
binding topology, in which Ship2-Sam and EphA2-Sam are providing the ML and EH 
sites respectively (Leone et al., 2008). Indeed, the same interaction has been 
recently studied by means of different experimental conditions, providing further 
elucidations about the structural details of the interaction interfaces (Lee et al., 2011). 
The binding mode occurring between Ship2-Sam and EphA2-Sam, and the type of 
stabilizing interactions, are very similar to those observed for the complex Odin-
Sam1/EphA2-Sam. Indeed, the above mentioned NMR based-displacement 
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experiment (See Paragraph 2.3.3) shows that Ship2-Sam and Odin-Sam1 share a 
common binding site on the surface of the EphA2 receptor (Figure 10). 
A comparison of our Odin-Sam1/EphA2-Sam model with the NMR structure of the 
tandem Sam domain of AIDA1b (PDB code: 2KIV, (Kurabi et al., 2009)) indicates 
analogies in between the two Sam-Sam associations. This tandem has a Mid-
Loop/End-Helix topology in which AIDA1b-Sam1 and AIDA1b-Sam2 contributes the 
ML and EH binding surfaces respectively (Kurabi et al., 2009) (See Figure 6, Chapter 
1). The high sequence homology in between the Sam domains of AIDA1b and Odin 
(Figure 3), suggests that in the tandem Odin Sam1-Sam2, the two domains may 
bind with an analogous ML/EH model in which Odin-Sam1 supplies the ML interface. 
Clearly, if in the full length Odin protein the ML surface of Odin-Sam1 is engaged in 
the interaction with Odin-Sam2, uncoupling of the two Sam domains from the tandem 
may take place to allow Sam1 binding to EphA2-Sam. Indeed, it has already been 
hypothesize opening of the AIDA1b-tandem to allow AIDA1b-Sam1 to interact with 
other proteins and explicate its functions (Kurabi et al., 2009).  
 
 
 
 
 
Figure 11. Haddock (de Vries et al., 2010) model (second ranked structure) of the EphA2-Sam/Odin-
Sam1 complex, belonging to the most populated docking cluster. Protein binding interfaces, according 
to NMR chemical shift perturbation data, are colored blue, and side chains of a few residues providing 
interactions at the dimer interface are shown. 
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2.4.  CONCLUSIONS 
 
In this study, I have determined the Odin-Sam1 NMR solution structure and 
investigated the interaction between Odin-Sam1 and EphA2-Sam, demonstrating that 
the two domains bind with a dissociation constant in the low micromolar range, by 
forming a Mid-Loop/End-Helix hetero-dimer that looks highly stabilized by 
electrostatic interactions. In this model, the central part of Odin-Sam1 and the C-
terminal helix, together with close loop regions of EphA2-Sam, supply the Mid-Loop 
and End-Helix binding sites respectively. Finally, I have implemented NMR-based 
displacement experiments and molecular docking studies to show that Ship2-Sam 
and Odin-Sam1 adopt very similar binding modes for the heterotypic Sam-Sam 
interactions with EphA2.  
These data clarify molecular features related to an association involving the EphA2 
receptor, which may be relevant in its endocytosis regulation during pathological 
processes. However more structural and biochemical studies are needed to shed 
light on the complex mechanisms regulating the network of interactions of Odin-
Sam1 and EphA2-Sam. 
It could be interesting to design, based on the structural information obtained here 
and in previous work, antagonists of Odin-Sam1/EphA2-Sam interaction which can 
modulate EphA2 receptor endocytosis and play a role as therapeutic agents.  
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3. STUDIES OF THE HETEROTYPIC SAM-SAM INTERACTION BETWEEN ODIN 
AND ARAP3 
 
Sam (Sterile alpha motif) domains are small helical modules which mediate protein-
protein interaction, and are made up of approximately 70 residues. In spite of a very 
similar fold, these domains are characterized by a high versatility regarding binding 
preferences and function (Kim and Bowie, 2003; Qiao and Bowie, 2005). Many Sam 
domain functions are mediated by formation of homo and heterotypic Sam-Sam 
associations (Meruelo and Bowie, 2009); in particular Sam domains can associate by 
forming dimers, oligomers and polymers (Meruelo and Bowie, 2009), by adopting 
head-to-head, tail-to-tail, and even head-to-tail topologies (Smalla et al., 1999; 
Thanos et al., 1999; Kim et al., 2001; Leone et al., 2008; Rajakulendran et al., 2008; 
Leone et al., 2009). This last binding mode is called Mid-Loop (ML)/End-Helix (EH) 
because residues from the central part of one Sam domain (Mid-Loop Interface) form 
intermolecular contacts with residues from the C-terminal helix and close loop 
regions of another Sam domain (End-Helix Interface). 
Associations between the Sam domain from the PI3K effector protein Arap3 (Arap3-
Sam) and the lipid phosphatase Ship2 (Ship2-Sam) (Leone et al., 2009), and 
between the first Sam domain of Odin (Odin-Sam1) and the Sam domain from the 
EphA2 receptor (EphA2-Sam) (Mercurio et al., 2012), were previously characterized, 
and shown that these complexes may adopt the head-to-tail topology of binding. This 
study focuses on analysis of the Odin-Sam1/Arap3-Sam interaction. 
 
 
3.1.  BACKGROUND  
 
Arap3 (ArfGAP with Rho GAP domain, Ankyrin repeat and PH domain 3) is a 
phosphatidylinositol 3 kinase (PI3K) effector protein (Krugmann et al., 2002). It works 
as a GTPase activating protein for Arf6 and RhoA, and is involved in biological 
processes related to formation of lamellipodia, cell adhesion and spreading, 
regulation of actin cytoskeleton (I et al., 2004; Krugmann et al., 2006). In particular, 
Arap3 has been correlated to developmental angiogenesis (Gambardella et al., 2010) 
and scirrhous gastric carcinoma (Yagi et al., 2011).  
Arap3 contains in its primary sequence a Sam domain (Kim and Bowie, 2003). In a 
yeast two-hybrid screen two Sam domains containing proteins were identified as 
possible Arap3 regulators: Ship2 (Src homology 2 domain-containing 
phosphoinositide-5-phosphatase 2) and ANKS1 (ANKyrin repeat and Sam domain 
containing 1) (Raaijmakers et al., 2007). The NMR (Nuclear Magnetic Resonance) 
solution structure and the Sam-Sam interaction between Arap3 and Ship2 have 
already been characterized (Leone et al., 2009; Raaijmakers et al., 2007). Arap3-
Sam and Ship2-Sam bind to each other with a dissociation constant in the nanomolar 
range (Raaijmakers et al., 2007), and protein-protein association is mainly stabilzed 
by salt bridges (Leone et al., 2009). Docking studies, together with NMR and 
mutagenesis data, show that Ship2-Sam and Arap3-Sam interact by means of a 
head-to-tail topology of binding, called Mid-Loop (ML)/End-Helix (EH) model 
(Raaijmakers et al., 2007; Ramachander and Bowie, 2004; Stafford et al., 2001). To 
date detailed analyses on the interaction between Arap3-Sam and ANKS1 protein 
Sam domains have not been reported. However, I have studied the heterotypic 
association between Odin-Sam1 and EphA2-Sam (See Chapter 2) (Mercurio et al., 
2012), that represents an interaction probably significant for EphA2 receptor 
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endocytosis (Kim et al., 2010). Odin is a protein belonging to the ANKS family that 
owns two Sam domains in tandem (Sam1 and Sam2) (Emaduddin et al., 2008). Due 
to the rather high sequence homology between EphA2-Sam and Arap3-Sam (58%), 
I have investigated if Arap3-Sam could interact with Odin-Sam1. To verify and 
thoroughly characterize the binding of the two proteins, NMR, ITC (Isothermal 
Titration Calorimetry), SPR (Surface Plasmon Resonance), molecular docking, and 
mutagenesis studies have been conducted.  
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3.2.  MATERIALS AND METHODS 
 
 
3.2.1. Protein expression 
 
Sam domains were expressed in Escherichia Coli as recombinant proteins, using 
constructs provided with a tail of six His and a thrombin cleavage site at the N-
terminus. Genes were cloned into the PET15B plasmids and transformed using 
BL21-Gold (DE3) competent cells (Stratagene). PET15B-constructs encoding human 
Arap3-Sam wild-type (residues 4-68, UniprotKB/TrEMBL code: Q8WWN8), Arap3-
Sam triple (H37D, R77D, R80D) mutant, Odin-Sam1 (residues 691-770 of human 
Odin, UniprotKB/TrEMBL code: Q92625) and EphA2-Sam (residues 901-976 of 
human EphA2, Swiss-Prot/TrEMBL code: P29317) were purchased from Celtek 
Bioscience (Nashville, TN). 
Unlabeled proteins expression was achieved by growing bacteria at 37°C in LB 
medium until OD600=0.6. Protein over-expression was induced by IPTG (isopropyl β-
D-thiogalactopyranoside) at a concentration of 1 mM, overnight at 25°C. Expression 
of 15N/13C double labeled and 15N uniformly labeled proteins was carried out in M9 
minimal medium supported with 2 g/L of 13C-Glucose and/or 0.5 g/L of 15NH4Cl. 
Purification of His-tag provided proteins was performed on a nickel column with an 
AKTA Purifier FPLC apparatus (Amersham). 
 
3.2.2. Backbone resonance assignments of the Odin-Sam1/Arap3-Sam 
 complex 
 
NMR experiments were performed at 25 °C on a Varian Unity Inova 600 MHz 
spectrometer equipped with a cold probe.  
In order to obtain resonance assignments for the backbone H, N and C atoms of the 
Odin-Sam1/Arap3-Sam complex, HNCA and 3D 15N resolved-[1H, 1H] NOESY (100 
ms mixing time) spectra were analyzed, acquired with samples containing 15N/13C 
double labeled Odin-Sam1 (620 M) in presence of unlabeled Arap3-Sam (~3 mM), 
or doubly labeled Arap3-Sam (600 M) in presence of unlabeled Odin-Sam1 (1.2 
mM). NMR samples (600 L volumes) consisted of phosphate buffer saline (PBS, 10 
mM phosphates, 138 mM NaCl, 2.7 mM KCl) (Fisher) at pH=7.7 with 0.2% NaN3 and 
5% D2O. Spectra were processed with the Varian software (Vnmrj version 1.1D) and 
analyzed with NEASY, as implemented in the program Cara (Bartels et al., 1995) 
(http://www.nmr.ch/). 
 
3.2.3. Relaxation measurements 
 
The evaluation of backbone 15N longitudinal (R1) and transversal (R2) relaxation 
rates were performed by means of NMR experiments acquired at 25 °C on a Varian 
Unity Inova 600 MHz spectrometer provided with a cold probe. Measurements were 
performed with two samples consisting of 15N-13C double labeled Odin-Sam1 (620 
M) with unlabeled Arap3-Sam (3 mM), and 15N-13C double labeled Arap3-Sam (100 
M) with unlabeled Odin-Sam1 (~ 300 M). 
R1 and R2 relaxation data were collected as 1D spectra (4 K data points and 1- 4 K 
transients), recorded with five relaxation delays for R1 measurements (0.01, 0.1, 0.3, 
0.6, 1.0 s), and seven relaxation delays for R2 measurements (0.01, 0.03, 0.05, 0.07, 
0.09, 0.11, 0.15, 0.19 s).  
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The decrease in signal intensity as function of relaxation delay allowed to estimate 
average R1 and R2 values; then average R1/R2 ratios were used as input for the 
software tmest (A. G. Palmer III, Columbia University) (Kay et al., 1989) in order to 
calculate the rotational correlation time (C). 
 
3.2.4. Odin-Sam1/Arap3-Sam binding studies 
 
To study the protein-protein interaction chemical shift perturbation studies 
(Pellecchia, 2005) were performed, recording 2D [1H,15N] HSQC experiments. The 
Odin-Sam1 binding interface for Arap3-Sam was evaluated by analysis of 2D [1H, 
15N] HSQC spectra of 15N labeled Odin-Sam1 (80 M) in the unbound-form and after 
addition of unlabeled Arap3-Sam (120 M, 370 M, 620 M). To map the binding site 
of Arap3-Sam for Odin-Sam1 2D [1H, 15N] HSQC spectra of a 15N labeled Arap3-Sam 
sample (90 M), in absence and presence of unlabeled Odin-Sam1 (100 M, 300 M 
and 800 M), were acquired. 
Similar NMR chemical shift perturbation experiments were conducted to assess the 
binding of Arap3-Sam (H37D, R77D, R80D) mutant to Odin-Sam1, by using 15N 
labeled Arap3-Sam triple mutant (200 M) and unlabeled Odin-Sam1 (200 and 300 
M). 
An NMR displacement experiment was also carried out, in which 2D [1H, 15N] HSQC 
spectra were recorded for a 15N labeled Arap3 protein sample (50 M) in its unbound 
form, after addition of Odin-Sam1 (150 M), and in presence of both Odin-Sam1 and 
EphA2-Sam (final protein ratio Arap3-Sam/Odin-Sam1/EphA2-Sam is 1: 3: ~40). 
Analyses of titration experiments and overlays of 2D spectra were obtained with the 
program Sparky (T. D. Goddard and D. G. Kneller, SPARKY 3, University of 
California, San Francisco). 
 
3.2.5. SPR experiments 
 
SPR experiments were carried out at 25 °C and a constant 20 L/min flow rate, using 
as running buffer a solution of Hepes 10 mM, pH=7.4, NaCl 150 mM, surfactant P20 
0.05% v/v (90 L injected for each experiment). Arap3-Sam was immobilized in 10 
mM acetate buffer pH 5.0 (flow rate 5 L/min, time injection 7 min) on a CM5 Biacore 
sensor chip, using EDC/NHS chemistry (Johnsson et al., 1991), while Odin-Sam1 
was used as analyte at different concentrations in the range of 0.2-40 M. Residual 
reactive groups were deactivated with 1 M ethanolamine hydrochloride, pH=8.5; the 
reference channel was prepared by activating with EDC/NHS and deactivating with 
ethanolamine. Immobilization level for Arap3-Sam was 1840 RU. The BIA evaluation 
analysis package (version 4.1, GE Healthcare, Milano, Italy) was used to subtract the 
signal of the reference channel and to estimate KD (Dissociation constant) values. 
RUmax (Resonance Units) values of each experiment versus Odin-Sam1 
concentration were fit by non-linear regression analysis with GraphPad Prism, 
version 4.00 (GraphPad Software, San Diego, California) (Rich et al., 2001). 
 
3.2.6. ITC experiments 
 
ITC experiments were performed with an iTC200 calorimeter 
(Microcal/GEHealthcare, Milan, Italy). Arap3-Sam (250 M) was titrated into a 
solution of Odin-Sam1 (10 M). Before ITC measurements both proteins were widely 
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dialyzed in the same buffer (PBS, pH 7.7). Similar ITC studies were conducted with a 
solution of Arap3-Sam (H37D, R77D, R80D) triple mutant (250 M in PBS pH=7.7) 
and Odin-Sam1 (10 M in PBS pH=7.7). 
Fitting of data to a single binding site model was carried out with the Origin software 
as supplied by GE HealthCare.  
 
3.2.7. Docking studies 
 
Docking studies were performed through the Haddock web server (de Vries et al., 
2010). To generate 3D models of the Odin-Sam1/Arap3-Sam complex, the first 
conformer of Odin-Sam1 NMR structures (PDB code: 2LMR (Mercurio et al., 2012)) 
was used and first five conformers of Arap3-Sam NMR ensemble (PDB code: 2KG5 
(Leone et al., 2009)). The C-terminal flexible tail of Arap3-Sam (corresponding to 
residues 90-100) was not included in the docking procedure. Ambiguous interaction 
restraints were generated from chemical shift perturbation data: for both Odin-Sam1 
and Arap3-Sam I set as active and passive those amino acids with higher normalized 
chemical shift deviationsand large solvent exposure, or which could potentially 
supply important intermolecular contacts, as revealed by structural homologies with 
other Sam-Sam complexes (for example the AIDA-1b tandem Sam domain, PDB 
code: 2KIV (Kurabi et al., 2009)). Hence, Odin-Sam1 residues set as active are L50, 
N51, F53, D54, D55, F58, E65, E66, D68, D71, whereas passive residues are L49, 
G52, V56, H57, S61, N62, V63, M64, Q67, R70. For Arap3-Sam I set residues G73, 
H74, K76, R77 as active, and residues R75, L79 as passive. Regions from L50 to 
E66 of Odin-Sam1 and T72-R80, V36-L38 of Arap3-Sam were set as semi-flexible. 
Finally, the N and C-terminal tail of Odin-Sam1 and the N-terminal tail of Arap3-Sam 
were put as fully flexible during all the docking stages. 
The solvated docking mode was implemented (van Dijk and Bonvin, 2006). During 
the first phase of the docking protocol (the rigid body energy minimization) 1000 
structures were generated; in the second step the best 200 solutions were subjected 
to semi-flexible simulated annealing, then a final refinement in water was performed.  
During a first selection, the final 200 Haddock solutions were visually analyzed with 
MOLMOL (Koradi et al., 1996), and models appearing in divergence with 
experimental NMR data or presenting non canonical Sam-Sam orientations, were 
discarded. The 106 selected Haddock models were inspected with MOLMOL (Koradi 
et al., 1996), and compared with experimental structures of other heterotypic Sam-
Sam complexes. At the end of this screening, 23 models were chosen as 
representative of the possible conformations of the Arap3-Sam/Odin-Sam1 complex. 
The selected ensemble was clustered using an RMSD (Root Mean Square 
Deviation) cutoff value of 2.6 Å by using MOLMOL (Koradi et al., 1996). This 
clustering procedure was performed by superimposing the models on the backbone 
atoms of the secondary structure elements of both Arap3-Sam (residues 29-34, 39-
47, 61-66, 72-83) and Odin-Sam1 (residues 32-39, 42-49, 57-60, 66-72, 77-88), and 
indicated the presence of 4 clusters of structures (See Appendix 2). 
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3.3. RESULTS AND DISCUSSION 
 
3.3.1. Odin-Sam1/Arap3-Sam interaction studies 
 
Firstly, chemical shift perturbation studies with 2D [1H, 15N] HSQC experiments were 
conducted to verify the association between Odin-Sam1 and Arap3-Sam. NMR 
spectra of a 15N uniformly labeled Odin-Sam1 sample in the unbound form and in 
presence of unlabeled Arap3-Sam were acquired and compared. Several changes 
occur in the HSQC spectra of Odin-Sam1 recorded in presence of increasing 
amounts of Arap3-Sam, clearly indicating that an interaction takes place between 
these Sam domains (Figure 1A). Once reached saturation conditions (i.e., no more 
changes could be detected in the HSQC spectrum of Odin-Sam1 after further 
addition of Arap3-Sam), in order to identify the interaction surface of Odin-Sam1 the 
equation = [(HN)
2 + (0.17 * 15N2]1/2 (Farmer et al., 1996) was applied to evaluate 
proton and nitrogen normalized chemical shift deviations (Figure 1B). Largest 
variations, values ≥ 0.2 ppm, can be revealed in the central portion of Odin-Sam1, 
surrounding helices 3, 4 and the C-terminal portion of 2; changes also occur in 
the C-terminal flexible tail, presumably because residues from this region come in 
closeness with the main binding interface (Figure 1C). 
The graph of chemical shift deviations against residue number obtained for Odin-
Sam1 in complex with Arap3-Sam (Figure 1B), is very similar to the one of the 
protein in complex with EphA2-Sam (See Figure 5, Chapter 2). 
The binding surface of Arap3-Sam for Odin-Sam1 was also mapped, using NMR 
experiments performed with 15N labeled Arap3-Sam and unlabeled Odin-Sam1 
(Figure 2A). Largest chemical shift deviations (values ˃0.1 ppm) affect the 5 
helix and the close 12 and 45 loop areas (Figure 2B, C). Interestingly, the 
binding between Arap3-Sam and Ship2-Sam take place by means of analogues 
regions (Leone et al., 2009). 
NMR perturbation data reveal for the Odin-Sam1/Arap3-Sam complex an head-to-tail 
topology of binding, where the central region of Odin-Sam1 and the 5 helix of 
Arap3-Sam, together with the adjacent loop regions, mainly provide the binding 
interfaces (Figures 1-2).  
 
To establish the binding stoichiometry of Odin-Sam1/Arap3-Sam complex, 15N 
longitudinal (R1) and transversal (R2) nuclear spin relaxation rates measurements 
were carried out: the evaluation of the R2/R1 average values enabled us to 
determine the correlation time (c) of both Sam domains bound to each other (Farrow 
et al., 1994).  
The c of Arap3-Sam and Odin-Sam1 in their bound state result 10  1 ns and 9.9  
0.8 ns respectively, these values are higher with respect to those evaluated for the 
proteins in their unbound forms (i.e., 7.3 ± 0.7 ns for Odin-Sam1 (Mercurio et al., 
2012) and 8.2 ± 0.4 ns for Arap3-Sam (Leone et al., 2009)), due to the increased 
dimension of the complex and the consequent slower tumbling. Moreover, the c 
estimates, ~10 ns, are comparable to those evaluated for Odin-Sam1/EphA2-Sam 
(Mercurio et al., 2012) and Ship2-Sam/Arap3-Sam (Leone et al., 2009) complexes 
(i.e. 11 ns), as well as the AIDA1b Sam1-Sam2 tandem (9.1 ns (Kurabi et al., 2009)) 
and indicate a 1:1 binding stoichiometry for the Odin-Sam1/Arap3-Sam interaction. 
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Figure 1. (A) Comparison of [
1
H, 
15
N] HSQC spectra of Odin-Sam1 (80 M) in its unbound form 
(purple) and after addition of Arap3-Sam (370 M) (green). (B) Histogram showing normalized 
chemical shift deviations as function of the residue number. Residues G33, L48, L49, L50, N51, G52, 
F53, D54, D55, H57, F58, L59, G60, V63, E65, Q67, D68, R70, D71, I72, I74, Q85, R88, S89, L90 
V93, K94, A95 have normalized deviations ≥ 0.2 ppm. A Δ equal to 0 has been assigned to residues 
Q43, V56, N62 whose peaks appear only in the spectrum of the complex, S61, M64 and S75 
(unassigned), P77 and P91. (C) Residues with normalized chemical shifts deviation ≥ 0.2 ppm are 
represented in red on the 3D solution structure of Odin-Sam1 (PDB code: 2LMR (Mercurio et al., 
2012)) in its ribbon representation.  
 
 
To better investigate the Odin-Sam1/Arap3-Sam binding affinity, SPR and ITC 
experiments were performed. SPR binding assays (Figure 3A) were conducted by 
immobilizing Arap3-Sam on the chip surface and using Odin-Sam1 as analyte; a plot 
of RUmax values as function of Odin-Sam1 concentration, together with kinetic 
experiments, both implemented with a 1:1 binding model, gave a dissociation 
constant value (KD) of 2.9 ± 0.4 M. (Figure 3B).  
ITC experiments (Figure 3C) resulted in rather good agreement with SPR studies 
and in fact, provided a KD=0.37 ± 0.08 M. ITC data indicated a single binding site 
model, as also shown by 15N relaxation measurements. The calculated KD values are 
similar to those determined in our previous SPR and ITC experiments for the Odin-
Sam1/EphA2-Sam complex (5.5 ± 0.9 M and 0.62 ± 0.04 M through the two 
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techniques respectively) (Mercurio et al., 2012), suggesting comparable binding 
affinities of Arap3-Sam and EphA2-Sam for Odin-Sam1.  
 
 
 
 
 
 
Figure 2. (A) Comparison of [
1
H, 
15
N] HSQC spectra of Arap3-Sam (90 M) in its unbound form (red) 
and after addition of Odin-Sam1 (300 M) (blue). (B) Histogram showing normalized chemical shift 
deviations as function of the residue number. W32, V36, H37, L38, E39, Q40, F45, R57, A71, H74, 
R75, K76, R77, I78, L79, R80, Q83, T84, G85 have deviations with values ˃ 0.1 ppm. Δ values equal 
to 0 have been attributed to residues T72, G73 (their peaks can be only seen in the spectrum of the 
complex), and P24. (C) Residues with normalized chemical shifts deviations ˃ 0.1 ppm are 
represented in blue on the 3D solution structure of Arap3 (PDB code: 2KG5 (Leone et al., 2009)) in its 
ribbon representation.  
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Figure 3. (A) SPR studies: overlay of sensorgrams representing the direct binding of Odin-Sam1 to 
immobilized Arap3-Sam (0.2-40 M) (B) A plot of RUmax from each binding as function of Odin-Sam1 
concentration. (C) ITC studies: calorimetric curve of the titration of Arap3-Sam (250 M) with Odin-
Sam1 (10 M) is showed. The row and the integrated data are reported in the top and bottom sections 
respectively. For data fitting (bottom) a single-binding model was applied (Mercurio et al., 2012). 
 
 
 
3.3.2. Molecular docking of the Odin-Sam1/Arap3-Sam complex 
 
To assess the pattern of possible intermolecular interactions characterizing the Odin-
Sam1/Arap3-Sam binding interface, I have performed docking studies with the 
Haddock web-server (de Vries et al., 2010) and built 3D models of the complex 
starting from chemical shift perturbation data and analysis of experimentally 
determined structures of other heterotypic Sam-Sam associations. The models 
suggest for the Odin-Sam1/Arap3-Sam complex a Mid-Loop/End-Helix topology, in 
which the Mid-Loop interface is provided by Odin-Sam1, whereas the End-Helix 
surface resides on Arap3-Sam (Figure 4). 
Electrostatic interactions appear important for this association, since Arap3-Sam 
binding region is rich in positively charged residues, and, on the other hand, Odin-
Sam1 surface contains many negatively charged amino acids (Figure 4). 
 
To better assess this point, binding of the Arap3-Sam (H37D, R77D, R80D) triple 
mutant (Leone et al., 2009) to Odin-Sam1 was investigated. In this mutant the charge 
of three residues that are positioned in the presumed Arap3-Sam End-Helix binding 
site were reversed (Figure 5). 
NMR and ITC experiments show that the triple mutant does not interact with Odin-
Sam1 (Figure 6A, B), and let speculate that either the mutated residues are 
supplying crucial interactions at the Sam-Sam interface, and/or are causing 
conformational changes in the binding region that void association.  
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Figure 4. Haddock (de Vries et al., 2010) model (number 57) of the Odin-Sam1/EphA2-Sam complex, 
from the most populated docking cluster. Protein binding interfaces, according to NMR chemical shift 
perturbation data, are colored blue, and side chains of a few residues making contacts at the dimer 
interface are shown. 
 
 
 
 
 
 
 
Figure 5. Ribbon representation of Arap3-Sam NMR solution structure (first conformer, PDB code: 
2KG5 (Leone et al., 2009)), with residues corresponding to the binding interface for Odin-Sam1 
highlighted in cyan. The side chain of amino acids replaced in Arap3-Sam triple mutant are shown in 
neon representation. 
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Figure 6. (A) Overlay of 2D [
1
H,
15
N] HSQC spectra of 
15
N labeled Arap3-Sam (H37D, R77D, R80D) 
triple mutant in absence (magenta) and in presence (cyan) of Odin-Sam1. (B) ITC data relative to 
Odin-Sam1 (10 M) titration with Arap3-Sam triple mutant (250 M) (Mercurio et al., 2013). 
 
 
Mutagenesis data could be better interpreted by studying interactions pattern 
revealed in docking models. 
Above all, Arg77 in most of the docking solutions (See Appendix 2) is engaged in 
electrostatic interactions with either Asp54 and/or Asp55; His37 and Arg80 seem less 
important. However, in a few models His37 makes a salt bridge with Asp55 and 
Arg80 may form a catio- interaction with Phe58 or a salt bridge with Asp68 (See 
Appendix 2). The Arap3-Sam (H37D, R77D and R80D) mutant is also not capable of 
binding the Sam domain of the lipid phosphatase Ship2 (Leone et al., 2009), that 
instead can associate with wild-type Arap3-Sam with a ML/EH binding model in 
which Arap3-Sam furnishes the EH interface (Leone et al., 2009). 
Another possible interaction on which to speculate in the Odin-Sam1/Arap3-Sam 
docking models is related to the residue Gly73, located on the EH surface of Arap3-
Sam. The peak corresponding to the HN of Gly73 can be only visualized in the [
1H, 
15N] HSQC spectrum of Arap3-Sam associated to Odin-Sam1 (Figure 2A), so 
indicating that this Gly, subsequent to complex formation, may become buried due to 
a possible engagement in an intermolecular contact. In fact, in a few docking 
solutions (See Appendix 2) Gly73 forms an intermolecular H-bond through its 
backbone HN atom with the backbone CO atom of Asn51 (Figure 4: Gly73 and Asn51 
are colored magenta).  
The interaction between the backbone amide proton of a Gly positioned at the base 
of the 5 helix on the EH interface, and the backbone carbonyl oxygen of another 
residue located at the C-terminal end of the 2 helix belonging to a ML surface, is 
present in a number of Sam-Sam complexes structures that have been 
experimentally determined (See PDB codes: 1PK1 (Kim et al., 2005), 2KIV (Kurabi et 
al., 2009), 3BS5 (Rajakulendran et al., 2008), 3SEI (Stafford et al., 2011), 3SEN 
(Stafford et al., 2011)). It has been speculated that a Gly residue in that position of an 
EH interface can facilitate the approach toward the ML binding region (Kurabi et al., 
2009). 
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The Odin-Sam1/Arap3-Sam models reveal a resemblance to the docked structures 
of the Odin-Sam1/EphA2-Sam complex that are reported into our previous work (See 
Figure 11, Chapter 2), in which EphA2-Sam is providing the EH binding surface, and 
several intermolecular salt bridges occur at the Sam-Sam interface.  
Moreover, a displacement assay performed with NMR techniques, indicated that 
Odin-Sam1 adopts the same ML binding mode to interact with both EphA2-Sam and 
Arap3-Sam (Figure 7), thus reflecting a similar behavior with respect to the Sam 
domain from the lipid phosphatase Ship2 (Ship2-Sam) (Leone et al., 2009). In fact, 
Ship2-Sam binds with its ML site both Arap3-Sam and EphA2-Sam (Leone et al., 
2009; Leone et al., 2008). 
 
 
 
 
 
Figure 7 (A) Overlay of 2D [
1
H, 
15
N] HSQC spectra of 
15
N labeled Arap3-Sam (50 M) in the apo form 
(red) and bound to Odin-Sam1 (150 M) (green). (B) The spectrum of unbound Arap3-Sam is re-
established by addition of unlabeled EphA2-Sam (cyan). 
 
 
The common structural features between heterotypic associations of Arap3-Sam and 
EphA2-Sam are probably a sign of the high sequence homology in between these 
two Sam domains (Figure 8), and point to a mutual protein interaction network. 
 
Since EphA2 receptor endocytosis regulation (Kim et al., 2010; Zhuang et al., 2007) 
is related to Sam-Sam interactions between EphA2 and both Odin and Ship2, it 
cannot be excluded that Arap3-Sam is involved in this process by sequestering two 
essential regulators, but up to now the complex mechanism at the head of these 
heterotypic associations is not completely understood.  
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Figure 8. Sequence alignment of Arap3-Sam (Swiss-Prot/TrEMBL: Q8WWN8, residues 4-68) with 
EphA2-Sam (UniprotKB/TrEMBL code: P29317, residues 904-968), Odin-Sam2 (UniprotKB/TrEMBL 
code: Q92625, residues 770-837) and AIDA1b-Sam2 (UniprotKB/TrEMBL code: Q7Z6G8, residues 
884-949). Secondary structure elements and regions corresponding to EH interface of Arap3-Sam are 
indicated with parenthesis and arrows respectively. Alignments have been generated with the T-
COFFEE server (Notredame et al., 2000). Red residues correspond to highly reliable portions of the 
multiple alignment. The Cons line is a consensus, it indicates the average reliability value for every 
column. 
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3.4. CONCLUSIONS 
 
In this project I have investigated the heterotypic Sam-Sam interaction between Odin 
and Arap3, revealing that the two proteins bind with a dissociation constant in the low 
micromolar range, a 1:1 stoichiometry, and implementing a structural model that 
closely resembles other ML/EH complexes, such as Ship2-Sam/Arap3-Sam (Leone 
et al., 2009) and Odin-Sam1/EphA2-Sam (Mercurio et al., 2012). In our model, the 
central part of Odin-Sam1 and the C-terminal helix together with adjacent loop 
regions of Arap3-Sam provide the ML and EH binding sites respectively. 
Even if more experimental structural analyses need to be carried out, our preliminary 
results let hypothesize that interaction between Odin-Sam1 and Arap3-Sam may 
necessitate opening of the Odin Sam1-Sam2 tandem in the integral protein, as we 
have also supposed it is needed for the association between EphA2-Sam and Odin-
Sam1 to occur (Mercurio et al., 2012).  
Moreover, this report, in conjunction with earlier data, indicates for Arap3-Sam strict 
similarity to EphA2-Sam, in fact, both proteins bind with analogous structural 
topology either Ship2-Sam and Odin-Sam1 and share the same binding interfaces. 
Since Odin and Ship2 are both regulators of EphA2 receptor endocytosis (Kim et al., 
2010; Zhuang et al., 2007), the exposed analogies might suggest a possible role of 
Arap3-Sam in this process. To date the functional consequences of the association 
between Arap3-Sam and Odin-Sam1 are unknown, thus our aim for the near future 
will be to generate new peptide/peptidomimetic molecules that could specifically 
antagonize Arap3-Sam heterotypic complexes, and be employed in cell-based 
assays to elucidate the functional implications of these interactions. 
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4. NMR STRUCTURAL CHARACTERIZATION OF THE SAM3 PEPTIDE 
 
4.1. BACKGROUND 
 
Odin is a member of the ANKS (Ankyrin repeat domain containing and Sam) protein 
family characterized by the presence of two Sam domains in tandem (Pandey et al., 
2002).  
Sam domains of ANKS proteins are potential inhibitors of tyrosine kinase EphA2 
receptor degradation (Kim et al., 2010). It has been suggested a fine regulation of 
EphA2 receptor signaling by a balance between the activity of c-Cbl E3 ubiquitin 
ligase (a protein involved in Eph receptors degradation) and ANKS proteins (Kim et 
al., 2010).  
The endocytosis and subsequent degradation of EphA2 and its connection with pro-
cancer activities is under investigation; indeed enhanced receptor internalization and 
degradation are associated with decreased malignant cell behavior (Zhuang et al., 
2007). 
I have determined the Odin-Sam1 NMR (Nuclear Magnetic Resonance) solution 
structure and investigated the interaction between Odin-Sam1 and EphA2-Sam 
(Chapter 2) (Mercurio et al., 2012), demonstrating that the two domains bind with a 
dissociation constant in the low micromolar range, by forming a Mid-Loop/End-Helix 
hetero-dimer that looks highly stabilized by electrostatic interactions.  
I have also investigated the heterotypic Sam-Sam interaction between Odin and the 
PI3K effector protein Arap3 (Chapter 3) (Mercurio et al., 2013); this study has 
revealed that the two proteins bind by implementing a structural model that closely 
resembles that occurring between Odin-Sam1 and EphA2-Sam (Chapter 2) 
(Mercurio et al., 2012).  
On the basis of the structural knowledge acquired in the above mentioned studies, a 
peptide of 43 residues, named Sam3, which reproduces the sequence 715-758 of 
Odin-Sam1 (UniProtKB code Q92625) (Figure 1A) was designed. This peptide 
includes the central portion of Odin-Sam1 which is involved in the association with 
EphA2-Sam and Arap3-Sam, together with the 5 C-terminal helix (Figure 1B, C). 
This last region was added to induce the peptide to fold in a similar way with respect 
to the intact Odin-Sam1 domain.  
 
Here, I report NMR studies on the conformational properties of Sam3 in PBS 
(Phosphate Buffer Saline) and H2O/TFE (Trifluoroethanol) mixtures. 
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Figure 1. Sam3 primary sequence (A). Ribbon (B) and surface (C) representations of Odin-Sam1 with 
the region corresponding to the peptide highlighted in yellow. 
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4.2.  MATERIALS AND METHODS 
 
The acetylated-N-terminus and amidated-C-terminus peptide Sam3 was obtained in 
batch by Fmoc (Fluorenylmethyloxycarbonyl) standard chemistry protocol on Rink-
amide 4-methylbenzhydrylamine (MBHA) resin. Peptide purification was achieved by 
RP-FPLC (Reversed Phase-High Performance Liquid Chromatography), and its 
integrity was confirmed by LC–MS (Liquid Chromatography-Mass Spectrometry) 
(Finnigan Surveyor, Thermo Electron Corporation).  
NMR experiments were performed at 298 K on a Varian Unity Inova 600 MHz 
spectrometer equipped with a cold probe.  
A first NMR sample was made up of Sam3 dissolved at a concentration of 730 M in 
550 L of phosphate buffer saline (PBS, 10 mM phosphates, 138 mM NaCl, 2.7 mM 
KCl) (Fisher) at pH=7.7, plus 50 L D2O (98% D, Armar Scientific, Switzerland). For 
this sample, the following two dimensional (2D) NMR experiments were acquired: 2D 
[1H, 1H] TOCSY (Total Correlation Spectroscopy) (Griesinger et al, 1988), and 2D 
[1H, 1H] NOESY (Nuclear Overhauser Effect Spectroscopy) (Kumar et al., 1980). 
2D proton NMR spectra were also recorded in TFE/H2O (70/30 v/v). The sample was 
prepared by dissolving the peptide (630 M concentration) in 420 L TFE (2,2,2-
Trifluoroethanol-D3- 99.5% isotopic purity, Sigma-Aldrich) and 180 L H2O. For this 
sample, 2D [1H, 1H] TOCSY (Griesinger et al, 1988) (Figure 2A), 2D [1H, 1H] NOESY 
(Kumar et al., 1980) (Figure 2B), and 2D [1H, 1H] DQFCOSY (Double Quantum-
Filtered Correlated Spectroscopy) (Piantini et al., 1982) were recorded. The process 
of proton resonance assignments was performed by following the Wüthrich protocol 
(Wüthrich,1986).  
TSP (Trimethylsilyl-3-propionic acid sodium salt-D4, 99% D, Armar Scientific, 
Switzerland) was used as internal standard for chemical shifts referencing (0.0 ppm). 
2D experiments were generally acquired with 16-64 scans, 128-256 FIDs in the 1 
dimension, 1024-2048 data points in the 2 dimension.  
TOCSY spectra were acquired with 70 ms mixing time, NOESY experiments with 200 
and 300 ms mixing times.  
Water suppression was achieved with the DPFGSE (Double Pulsed Field Gradient 
Selective Echo) sequence (Dalvit, 1998). Spectra were processed with VNMRJ 1.1D 
(Varian, Italy) and analyzed with NEASY (Bartels et al 1995) contained in the CARA 
software (http://www.nmr.ch/).  
In order to evaluate temperature coefficients 2D [1H, 1H] TOCSY experiments were 
recorded at different temperatures: 298, 301, 304, 307, 310 K. A linear regression 
analysis of chemical shifts versus temperature was conducted (See Table 2, 
Appendix 3) with the program GraphPad Prism version 5.04 (GraphPad Software 
Inc., San Diego, USA).  
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Figure 2. 2D [
1
H, 
1
H] TOCSY (A) and 2D [
1
H, 
1
H] NOESY (B) spectra of Sam3 recorded in H2O/TFE, 
expansions containing signals from HN and aromatic protons are showed. 
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4.3.  RESULTS AND DISCUSSION 
 
In my previous studies I have analyzed the molecular features at the basis of Odin-
Sam1/EphA2-Sam and Odin-Sam1/Arap3-Sam complexes formation. The achieved 
results have been used to design a series of peptides reproducing Sam-Sam binding 
interfaces, with the purpose to evaluate their potential properties as antagonists of 
heterotypic Odin-Sam1 interactions.  
The binding between two proteins is often characterized by a large interface, lacking 
a significant single binding pocket (Fletcher and Hamilton, 2006; Lo Conte et al., 
1999), as occurs in the Odin-Sam1/EphA2-Sam and Odin-Sam1/Arap3-Sam 
associations (Mercurio et al., 2012; Mercurio et al., 2013). Thus, peptides, which are 
generally flexible and rather large molecules, are natural candidates in a rational 
design of biotechnological relevant compounds which, by mimicking the interacting 
area, could have inhibitory functions (Nieddu and Pasa, 2007; Parthasarathi et al., 
2008). 
The peptide Sam3 encompasses the central portion of the Odin Sam domain, which 
interacts with both EphA2-Sam and Arap3-Sam, and the 5 C-terminal helix (Figure 
1). I have implemented NMR spectroscopy to study the solution structure of the 
peptide under different experimental conditions. 
I have first investigated the conformational preferences of Sam3 in aqueous buffer 
(i.e., PBS). 
In this solvent system the peptide is rather disordered and does not contain canonical 
secondary structure elements. In fact, the NOESY spectrum, acquired in PBS, has 
only a few cross peaks and is lacking NOE pattern characteristic of secondary 
structure elements (Figure 3A).  
Further NMR experiments were recorded in presence of 70% TFE, which is 
frequently used as a folding agent in peptide conformational studies (Cammers-
Goodwin et al., 1996). The effect of TFE on peptide conformation is most likely 
related to its ability to aggregate around the solute and exclude water, favoring the 
formation of intra-molecular hydrogen bonds and secondary structures (Roccatano et 
al., 2002). 
Due to the high quality of the 2D spectra recorded for Sam3 in TFE/H2O (70:30), I 
was able to achieve complete proton resonance assignments (Wüthrich, 1986). In 
detail, I have identified spin systems in 2D [1H, 1H] TOCSY and DQFCOSY spectra 
then, I have sequentially correlated them by analysis of the 2D [1H, 1H] NOESY 
experiments. In particular, NOESY spectra revealed the presence of NOE contacts 
attributable to helical secondary structures (Figure 3B): HNi-HNi+1 cross-peaks were 
identified between amide protons HN of all sequential residues (the pattern is 
obviously broken by Pro32); Hi-NHi+3, and Hi-Hi+3 NOEs were mainly found in the 
regions Phe8-Arg25 and Gln33-Ala42, while Hi-NHi+4 contacts were principally 
present in the segments Asn18-Arg25 and Gln33-Arg43 (Figure 4). In major detail, 
the NOE pattern points to an helix conformation in large part of the molecule, 
interrupted in the segment extending from Ile27 to Gln33, due to the presence of 
Pro32 (the Pro is an helix-breaker (MacArthur and Thornton, 1991)) (Figure 4). The 
contact Hi-Hi+1 in between the H proton of Asp31 and the Hprotons of Pro32 
indicates that the Pro is in trans configuration (Wüthrich, 1986).  
Proton chemical shifts for the peptide Sam3 in TFE/H2O (70/30) are reported in the 
Appendix 3. 
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Figure 3. Comparison between Sam3 NOESY spectra recorded in PBS (A) and in TFE/H2O (B). This 
last spectrum contains HNi-HNi+1 NOE cross-peaks (inside the red rectangle), which are characteristic 
of helical secondary structures. 
 
 
The Sam3 helical conformation, induced by TFE, is further supported by the CH 
proton chemical shift deviations from random coil values (Figure 5).  
NMR chemical shifts are highly sensitive probes for the local secondary structures of 
peptides and proteins (Wishart et al., 1991). In particular, those of CH protons of all 
natural amino acids experience an upfield shift with respect to random coil values 
when in a helical configuration, and a downfield shift when in a β-strand extended 
configuration (Wishart et al., 1991).  
As showed in the diagram of CH chemical shift deviations versus residue number, 
almost all Sam3 residues present an upfield shift, thus further confirming helical 
secondary structures. The most evident exception (Figure 5) is present in the region 
Ile28-Pro32, where a helix interruption is likely to take place because of the Pro 
residue. 
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Figure 4. NOE pattern of Sam3 in TFE/H2O. 
 
 
 
 
 
 
 
Figure 5. Chemical shift deviations from random coil values, evaluated in TFE/H2O for Sam3 CH 
protons (Wishart et al., 1991). 
 
 
To assess the degree of solvent exposure of the Sam3 backbone amide protons in 
TFE, I have evaluated the temperature coefficients (T), by following chemical 
shifts variations as function of temperature (from 298 to 310 K) (Table 2, Appendix 
3).  
Chemical shifts of amide proton resonances have a temperature dependence; 
generally they shift upfield as the temperature increases (negative temperature 
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coefficients), and when the amide group is hydrogen-bonded because is involved in a 
structural motif, this effect occurs to a lesser extend (Baxter and Williamson, 1997). 
In proteins, generally temperature coefficient values more positive than -5 ppb/K 
indicate that the amide proton is involved in hydrogen bonding, whereas values 
ranging from -6 to -10 ppb/K suggest that the amide proton is solvent exposed 
(Baxter and Williamson, 1997).  
T values for most of the Sam3 amide protons at the C-terminal side (from Ser30 
to Arg43) are included in the range from -1 to -5 ppb/K (Baxter and Williamson, 
1997), thus indicating that HN protons in this region have low solvent exposure and 
are likely hydrogen bonded. On the other hand, T values more negative than -6 
ppb/K are present in the stretch Phe8-Gly15, and may point towards a loss of 
secondary structure by increasing the temperature. 
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4.4.  CONCLUSIONS 
 
Within this work package I have investigated the conformational properties of a 
peptide, named Sam3, encompassing a large region of Odin-Sam1 including its 
binding sites for EphA2-Sam and Arap3-Sam. 
The peptide structural analysis was carried out by means of NMR techniques. 
Sam3 is disordered in PBS buffer, but after addition of TFE it shows a propensity to 
assume an helical structure. This result is supported by NMR methods which are 
predictive of peptides and proteins secondary structure: CH chemical shift 
deviations from random coil values, NOE pattern. 
Additional studies are ongoing to determine the Sam3 three-dimensional solution 
structure. Moreover, the ability of the Sam3 peptide to interact with Odin-Sam1 
binding partners (EphA2-Sam and Arap3-Sam) and be implemented as a diagnostic 
or therapeutic tool, is under investigation. 
The preliminary data acquired on the Sam3 peptide will be further used to design 
smaller and more constrained peptidomimetics. Our ultimate goal is to obtain 
molecule antagonists of Odin-Sam1/EphA2-Sam and Odin-Sam1/Arap3-Sam 
interactions that, by preserving some ordered secondary structure elements in 
aqueous buffer, could efficiently interfere with biological functions related to these 
Sam-Sam complexes. 
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5. CONCLUSIONS AND FUTURE PERSPECTIVES 
 
In this PhD thesis, an interdisciplinary approach involving different experimental and 
computational techniques, such as NMR (Nuclear Magnetic Resonance), SPR 
(Surface Plasmon Resonance), ITC (Isothermal Titration Calorimetry), molecular 
docking, mutagenesis was undertaken, to thoroughly study the solution structure and 
the intermolecular interactions of a few Sam domains.  
Sam domains are small protein modules made up of about 70-80 amino acids with a 
tertiary structure consisting of a five helix bundle; they are among the most abundant 
protein-protein interaction motives in the organisms (Qiao et al., 2005), and are 
characterized by high versatility as concerning their binding properties (Kim and 
Bowie, 2003).  
My researches deal with the analysis of protein-protein interactions mediated by Sam 
domains, and the study of solution conformational features of peptides 
encompassing the corresponding interaction surfaces. 
 
In the first work package (Chapter 2), the NMR solution structure of the N-terminal 
Sam domain of Odin (Odin-Sam1) was solved, and interaction studies with the Sam 
domain of the EphA2 receptor (EphA2-Sam) were performed. 
The tyrosine kinase receptor EphA2 is able to regulate important biological 
processes related to cell motility (Egea and Klein, 2007; Himanen et al., 2007; 
Pasquale, 2005), and play a fundamental role in pathological processes such as 
cancer (Pasquale, 2008). In particular, the process of receptor endocytosis is widely 
studied for its possible involvement in tumoral processes, in which EphA2 is 
overexpressed (Pasquale, 2010; Surawska et al., 2004). Regulation of receptor 
endocytosis in a few cases takes place by means of proteins binding EphA2 through 
heterotypic Sam-Sam interactions (Kim et al., 2010; Zhuang et al., 2007). Among 
them, it was reported that the lipid phosphatase Ship2 (Src homology 2 domain-
containing phosphoinositide-5-phosphatase 2) can inhibit the EphA2 receptor 
endocytosis, with a consequent increase in tumor cell invasiveness and metastatic 
potential (Zhuang et al., 2007). Previous NMR and ITC studies of the interaction 
between the Sam domain of Ship2 (Ship2-Sam) and EphA2-Sam were carried out 
(Leone et al., 2008), and showed that EphA2-Sam associates with Ship2-Sam with a 
high binding affinity, by adopting a topology common to several Sam-Sam complexes 
called "Mid-Loop/End-Helix" (Kurabi et al., 2009; Rajakulendran et al., 2008; 
Ramachander et al., 2004; Stafford et al., 2011). Furthermore, docking studies 
showed that this complex is mainly stabilized by electrostatic interactions between 
positively charged residues on the EphA2-Sam surface and negatively charged 
amino acids on the Ship2-Sam interface. 
A recent work indicates that the EphA2 receptor endocytosis is also regulated by the 
ANKS (Ankyrin repeat domain containing and Sam) protein family (Kim et al., 2010). 
Among proteins belonging to this family, Odin is characterized by the presence of two 
Sam domains in tandem, and its first Sam domain presents high sequence homology 
(about 69%) with Ship2-Sam; so we decided to investigate the possible interaction 
between Odin-Sam1 and EphA2-Sam.  
The first step of these studies was the characterization of the Odin-Sam1 solution 
structure, by means of 2D and 3D NMR spectra acquired with 15N labeled and 
15N/13C double labeled protein samples. Odin-Sam1 solution structure consists of five 
 helices, arranged in a canonical Sam domain fold. 
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Afterwards, binding studies with EphA2-Sam were carried out. SPR and ITC 
experiments revealed a low micromolar binding affinity between the two proteins. 
NMR chemical shift perturbation experiments were conducted to identify the 
interaction surfaces between Odin-Sam1 and EphA2-Sam. These data were used for 
docking studies, to build 3D models of the complex. These models exhibit some 
similarities with the EphA2-Sam/Ship2-Sam complex, and with other, previously 
described, Sam-Sam hetero-dimers (Kurabi et al., 2009; Rajakulendran et al., 2008; 
Ramachander et al., 2004; Stafford et al., 2011). In fact, even in this case the binding 
topology turns out to be the "Mid-Loop/End-Helix" one, in which Odin-Sam1 provides 
the Mid-Loop surface that interacts with the EphA2-Sam End-Helix interface; the 
complex is mainly stabilized by electrostatic interactions. 
Models obtained by molecular docking were validated by mutagenesis experiments. 
In particular an EphA2-Sam triple mutant (K38A/R78A/Y81S) (Leone et al., 2008), in 
which the End-Helix region was perturbed with suitable amino acid replacements, 
presents lower ability to bind Odin-Sam1.  
Odin-Sam1/EphA2-Sam models have been compared with NMR experimental 
structures deposited in the PDB (Protein Data Bank), in particular the tandem Sam 
domain of AIDA1b. AIDA1b, like Odin, is a protein belonging to the ANKS protein 
family (Kurabi et al., 2009). The AIDA1b Sam tandem presents a Mid-Loop/End-Helix 
topology in which the Sam1 and Sam2 domains are providing the Mid-Loop and End-
Helix binding surfaces respectively (Kurabi et al., 2009). Because of the high 
sequence homology between AIDA1b and Odin (See Figure 3, Chapter 2), we 
assume that the two Odin Sam domains in tandem may adopt a similar ML/EH 
topology of interaction in which the ML interface is provided by Odin-Sam1. This 
scenario let speculate that opening of the Odin Sam1-Sam2 tandem domain may be 
required to allow association with EphA2-Sam.  
 
The second work package focused on study of the interaction between Odin-Sam1 
and Arap3-Sam. Arap3 (Arf GAP, Rho GAP, Ankyrin repeat and PH domains) is a 
protein involved in phosphoinositol-3-kinase (PI3K) signaling pathways and contains 
a Sam domain in its primary sequence (Krugmann et al., 2002). It was reported that 
among Sam domains containing proteins, both Ship2 and Odin can interact with 
Arap3-Sam (Raaijmakers et al., 2007). The Ship2-Sam/Arap3-Sam complex has 
already been characterized (Leone et al., 2009): the binding occurs with high affinity, 
through the "Mid-Loop/End-Helix" topology. Because of the high sequence homology 
between Arap3-Sam and EphA2-Sam (approximately 58%), the possible Odin-
Sam1/Arap3-Sam complex formation was investigated. For this purpose, I have 
adopted techniques similar to those applied in the first work package. SPR and ITC 
experiments indicated a binding affinity between the two proteins in the low 
micromolar range. Subsequently, by NMR chemical shift perturbation experiments I 
have identified the putative binding interfaces in between the two Sam domains. 
Finally, these data were used to build 3D models of the Odin-Sam1/Arap3-Sam 
complex by computational docking calculations. The results indicate that these 
proteins associate by means of the "Mid-Loop/End-Helix" model, stabilized by 
electrostatic interactions, likewise to other complexes mentioned here.  
The formulated hypotheses about the Arap3-Sam interaction surface against Odin-
Sam1 were further validated with mutagenesis experiments. Indeed, a triple Arap3-
Sam mutant (H37D, R77D, R80D) (Leone et al., 2009), characterized by amino acid 
substitutions in the “End-Helix” region, loses the ability to bind Odin-Sam1. These 
results let hypothesize that also the interaction between Odin-Sam1 and Arap3-Sam 
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may necessitate separation of the Odin Sam1-Sam2 tandem in the integral protein, 
as we have also supposed it is needed for the association between EphA2-Sam and 
Odin-Sam1. 
 
Once analyzed the structural factors distinctive of Odin-Sam1/EphA2-Sam and Odin-
Sam1/Arap3-Sam complexes, a few peptides of different sizes were designed, 
including the putative interaction regions between these Sam domains. Among them, 
the peptide Sam3 was analyzed in greater detail by means of NMR techniques. 
Sam3 is a peptide of 43 residues, reproducing the sequence 715-758 of Odin-Sam1 
(UniProtKB code: Q92625), corresponding to the central portion of the domain which 
from my previous studies resulted involved in complexes formation with EphA2-Sam 
and Arap3-Sam, together with the 5 C-terminal helix (See Figure 1, Chapter 4). 
Sam3 was produced by solid phase synthesis; proton bi-dimensional NMR spectra 
were acquired to obtain resonance assignments of single residues.  
NMR spectra recorded in phosphate buffer indicate that Sam3 is quite disordered 
and without canonical secondary structure elements. On the other hand, as revealed 
by further NMR experiments, Sam3 shows a propensity to adopt more ordered 
helical structures in presence of trifluoroethanol (TFE), which is frequently used as a 
folding agent in peptide conformational analysis (Cammers-Goodwin et al., 1996).  
Ongoing studies are evaluating the possible interaction between Sam3 and the Odin-
Sam1 binding partners, i.e. EphA2-Sam and Arap3-Sam. 
 
Based on the knowledge acquired within this thesis, about structural features 
significant to heterotypic Sam-Sam complexes formation, in the near future libraries 
of biotechnological relevant molecules (peptides and peptido-mimetics), that could 
selectively interfere with Odin-Sam1/EphA2-Sam or Odin-Sam1/Arap3-Sam 
associations, will be designed. Particularly, antagonists of the Odin-Sam1/EphA2-
Sam interaction are expected to modulate EphA2 receptor endocytosis and play a 
role as therapeutic agents in diseases such as cancer. These assumptions will be 
validated through appropriate cell-based assays.  
With regard to the Odin-Sam1/Arap3-Sam complex, the designed molecules will be 
implemented in cellular assays to identify new biological functions related to Arap3-
Sam. 
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APPENDIX 1: Docking solutions of the EphA2-Sam/Odin-Sam1 complex. 
 
Cluster analysis of the docking solutions indicated the presence of 5 families of 
structures (See Chapter 2 for details about the clusterization protocol): 
 
Cluster 1: structures n. 2, 5, 26, 55, 61, 71, 73, 75, 84, 91, 116, 118, 130 
Cluster 2: n. 8, 23, 113 
Cluster3: n. 16, 42, 109, 157 
Cluster4: n. 20 
Cluster5: n. 49 
 
Structures are numbered according to the Haddock score (i.e., the lowest the better). 
Representative models from different conformational families are shown, together 
with lists of H-bonds and non-bonded contacts. 
 
 
Structure n. 2. Haddock score=-129.34  
 
 
 
 
 
        H-bond contacts 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
36 S O 61 S HG 2.31 
38 K HZ1 54 D OD1 1.65 
38 K HZ3 55 D OD2 1.59 
74 G HN 50 L O 2.45 
77 K HZ1 68 D OD1 1.84 
77 K HZ2 71 D OD1 1.90 
77 K HZ3 67 Q O 2.37 
78 R HH12 55 D OD2 1.67 
78 R HH22 55 D OD1 1.68 
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        Non-bonded contacts 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
37 I CA 58 F CE2 3.29 
37 I CB 58 F CE2 3.83 
37 I CG2 58 F CE2 3.85 
37 I C 58 F CE2 3.66 
38 K CG 57 H CE1 3.51 
74 G CA 51 N CA 3.18 
74 G CA 51 N CB 3.85 
74 G CA 51 N CG 3.35 
74 G CA 51 N C 3.44 
75 H CD2 52 G CA 3.46 
78 R CG 58 F CZ 3.61 
78 R CD 58 F CZ 3.68 
78 R CZ 55 D CZ 3.89 
78 R CZ 58 F CG 3.84 
78 R CZ 58 F CD1 3.61 
78 R CZ 58 F CE1 3.63 
78 R CZ 58 F CZ 3.86 
81 Y CZ 63 V CG1 3.80 
 
 
 
Structure n. 71. Haddock score=-101.61 
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        H-bond contacts 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
36 S O 61 S HG 2.09 
38 K HZ1 55 D OD2 2.45 
38 K HZ3 55 D OD1 1.92 
38 K HZ3 55 D OD2 2.25 
74 G HN 51 N O 2.30 
77 K HZ1 68 D OD1 1.56 
78 R HH12 55 D OD1 2.06 
78 R HH21 52 G O 1.78 
 
        Non-bonded contacts 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
38 K CE 57 H CB 3.68 
73 P CG 51 N CA 3.77 
74 G CA 51 N C 3.81 
74 G CA 53 F CZ 3.64 
75 H CD2 52 G CA 3.71 
78 R CG 58 F CE1 3.86 
78 R CG 58 F CZ 3.52 
78 R CZ 58 F CG 3.74 
81 Y CE1 63 V CG1 3.90 
81 Y CZ 63 V CB 3.89 
 
 
 
Structure n. 8. Haddock score=-122.35 
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        H-bonds 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
38 K HZ1 54 D OD1 1.94 
38 K HZ2 55 D OD1 2.38 
38 K HZ2 55 D OD2 1.58 
77 K HZ1 68 D OD1 1.60 
77 K HZ2 71 D OD1 1.69 
77 K HZ3 67 Q O 2.36 
78 R HH12 55 D OD1 1.65 
78 R HH21 52 G O 1.70 
78 R HH22 54 D OD2 2.47 
78 R HH22 55 D OD1 2.29 
81 Y HH 61 S O 1.80 
  
        Non-bonded contacts  
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
38 K CE 55 D CG 3.89 
74 G CA 51 N CG 3.73 
74 G CA 53 F CE2 3.86 
75 H CD2 52 G CA 3.82 
77 K CD 68 D CG 3.84 
 
 
 
Structure n. 16. Haddock score=-116.60 
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        H-bonds 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
38 K HZ1 54 D OD1 1.62 
38 K HZ1 54 D OD2 2.14 
38 K HZ3 55 D OD2 1.56 
74 G HN 51 N OD1 2.30 
77 K HZ3 68 D OD1 1.76 
77 K HZ3 68 D OD2 2.49 
78 R HH11 55 D OD1 1.78 
 
        Non-bonded contacts 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
73 P CG 71 D CG 3.87 
74 G CA 53 F CE2 3.87 
74 G CA 53 F CZ 3.47 
75 H CD2 51 N C 3.44 
75 H CD2 52 G CA 3.48 
78 R CA 58 F CE1 3.84 
78 R CZ 58 F CB 3.77 
78 R CZ 58 F CD1 3.57 
81 Y CB 58 F CE1 3.83 
81 Y CB 58 F CZ 3.66 
81 Y CD2 58 F CZ 3.77 
81 Y CD2 61 S CB 3.88 
81 Y CE2 61 S CB 3.53 
 
 
Structure n. 20. Haddock score=-114.57 
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        H-bonds 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
38 K HZ1 54 D OD1 1.57 
74 G HN 51 N OD1 2.34 
75 H HN 51 N O 2.04 
77 K HZ1 61 S O 2.16 
77 K HZ2 62 N OD1 1.90 
78 R HE 55 D OD1 1.74 
78 R HH22 54 D OD2 1.70 
81 Y OH 57 H HE2 2.39 
 
        Non-bonded contacts 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
74 G CA 52 G C 3.68 
74 G CA 53 F CE2 3.90 
74 G C 52 G CA 3.64 
74 G C 52 G C 3.68 
75 H CG 52 G CA 3.68 
75 H CD2 52 G CA 3.76 
75 H CE1 50 L C 3.74 
75 H CE1 52 G CA 3.76 
77 K CB 58 F CE1 3.65 
77 K CB 58 F CZ 3.81 
77 K CD 62 N CG 3.67 
77 K C 58 F CE2 3.83 
77 K C 58 F CZ 3.44 
78 R CA 58 F CE2 3.61 
81 Y CB 58 F CZ 3.32 
81 Y CE2 57 H CD2 3.72 
81 Y CZ 57 H CD2 3.63 
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Structure n. 49. Haddock score=-106.39 
 
 
 
 
 
        H-bonds 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
38 K HZ1 49 L O 1.82 
38 K HZ2 54 D OD2 1.61 
74 G HN 71 D OD1 2.29 
77 K HZ1 68 D OD2 1.62 
77 K HZ3 65 E OE2 1.58 
78 R HH12 51 N OD1 1.73 
78 R HH21 68 D OD1 1.63 
81 Y HH 61 S O 2.13 
 
        Non-bonded contacts  
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
37 I CG2 58 F CE2 3.53 
37 I CG2 58 F CZ 3.64 
38 K CD 52 G CA 3.32 
78 R CZ 53 F CE2 3.80 
78 R CZ 53 F CZ 3.64 
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APPENDIX 2: Docking solutions of the Odin-Sam1/Arap3-Sam complex. 
 
Docking solutions were subjected to a clusterization protocol (See Paragraph 3.2.7), 
from which 4 families of structures were obtained: 
 
Cluster 1: structures n. 35, 45, 56, 57, 73, 89, 142, 166, 170, 175 
Cluster 2: n. 69, 71, 104, 105, 120, 139, 151, 196 
Cluster 3: n. 94,165,185,195 
Cluster 4: n. 95 
 
Structures are numbered according to the Haddock score (i.e., the lowest the better). 
The best models of each cluster, and corresponding tables of H-bond and non-
bonded contacts, as determined by the Haddock web server (de Vries et al., 2010), 
are reported below. 
 
 
Structure n. 35. Haddock score=-110.39 
 
 
 
 
 
        H-bond contacts 
EphA2-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
36 S O 61 S HG 2.31 
38 K HZ1 54 D OD1 1.65 
38 K HZ3 55 D OD2 1.59 
74 G HN 50 L O 2.45 
77 K HZ1 68 D OD1 1.84 
77 K HZ2 71 D OD1 1.90 
77 K HZ3 67 Q O 2.37 
78 R HH12 55 D OD2 1.67 
78 R HH22 55 D OD1 1.68 
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        Non-bonded contacts 
Arap3-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
73 G CA 51 N CA 3.09 
73 G CA 51 N CG 3.72 
73 G CA 51 N C 3.43 
73 G C 51 N C 3.88 
74 H CE1 50 L CB 3.81 
74 H CE1 50 L CD2 3.81 
76 K CE 68 D CG 3.76 
77 R CZ 52 G CA 3.42 
77 R CZ 52 G C 3.83 
 
 
 
Structure n. 69. Haddock score=-100.42 
 
 
 
 
 
        H-bond contacts 
Arap3-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
37 H HD1 55 D OD2 1.67 
73 G HN 50 L O 2.35 
74 H HE2 54 D OD2 2.38 
76 K HZ1 71 D OD1 1.54 
77 R HH12 55 D OD1 1.67 
77 R HH22 52 G O 1.90 
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        Non-bonded contacts 
Arap3-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
73 G CA 51 N CA 3.49 
73 G CA 51 N C 3.42 
74 H CE1 52 G CA 3.29 
77 R CD 58 F CE1 3.83 
77 R CD 58 F CZ 3.77 
77 R CZ 58 F CD1 3.72 
77 R CZ 58 F CE1 3.62 
 
 
 
Structure n. 94. Haddock score=-92.72 
 
 
 
 
 
        H-bond contacts 
Arap3-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
76 K HZ1 71 D OD1 1.67 
76 K HZ2 68 D OD1 1.61 
76 K HZ3 51 N OD1 1.83 
77 R HH12 55 D OD2 1.80 
77 R HH21 52 G O 2.28 
77 R HH22 55 D OD1 1.62 
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       Non-bonded contacts  
Arap3-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
76 K CD 53 F CE1 3.69 
76 K CE 71 D CG 3.82 
77 R CG 58 F CE1 3.77 
77 R CG 58 F CZ 3.58 
77 R CZ 55 D CG 3.60 
80 R CD 63 V CB 3.87 
 
 
 
Structure n. 95. Haddock score=-92.71 
 
 
 
 
        H-bond contacts 
Arap3-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
74 H HE2 50 L O 2.18 
76 K HZ2 71 D OD2 1.57 
77 R HH12 52 G O 1.98 
77 R HH21 51 N OD1 2.12 
77 R HH22 52 G O 2.15 
 
        Non-bonded contacts 
Arap3-Sam Odin-Sam1 
Residue 
number 
Residue 
type 
atom 
Residue 
number 
Residue 
type 
atom 
Distance 
(Å) 
37 H CE1 55 D CG 3.90 
74 H CD2 51 N C 3.57 
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APPENDIX 3 
 
Table 1. Chemical shifts list (± 0.01 ppm) of the peptide Sam3 evaluated at 298 K in TFE/H2O (70:30). 
 
Residue HN Hα Hβ Hγ Others 
1 S 7.55 4.41 
4.02 
3.86 
 Acetyl 2.07 
2 K 8.231 4.14 
1.91 
1.86 
1.59 
1.51 
H 1.75 
H 3.02 
3 L 7.65 4.20 
1.76 
1.64 
1.69 CH3 0.98, 0.92 
4 L 7.55 4.24 
1.78 
1.69 
1.73 CH3 0.97, 0.92 
5 L 7.87 4.27 
1.78 
1.71 
1.79 CH3 0.92 
6 N 8.17 4.61 
2.93 
2.91 
 H 7.49, 6.63 
7 G 8.17 3.95    
8 F 8.30 4.41 
3.31 
3.25 
 
H 7.25, 7.24 
H 7.30 
9 D 8.63 4.57 
3.18 
3.00 
  
10 D 8.47 4.63 
3.22 
2.92 
  
11 V 8.27 3.87 2.16 
CH3 
1.09, 0.92 
 
12 H 8.04 4.36 
3.25 
3.15 
 
H 7.12 
H8.03 
13 F 8.46 4.44 
3.36 
3.32 
 
H 7.31 
Hε 7.37 
14 L 8.50 4.13 
1.89 
1.71 
1.87 CH3 0.98 
15 G 8.47 3.86    
16 S 7.98 4.29 4.02   
17 N 7.81 4.51 
2.86 
2.66 
 H 6.91, 5.70 
18 V 8.20 3.73 2.23 
CH3 
1.09, 0.99 
 
19 M 8.13 4.22 2.22 
2.71 
2.60 
 
20 E 8.13 4.13 
2.30 
2.21 
2.60 
2.51 
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21 E 8.22 4.06 2.30 
2.70 
2.51 
 
22 Q 8.29 4.02 
2.30 
2.23 
2.51 H 7.08, 6.48 
23 D 8.38 4.51 
3.20 
2.86 
  
24 L 8.30 4.15 
2.01              
1.91 
1.91 CH3 0.97, 0.93 
25 R 8.10 4.09 2.01 
1.91 
1.67 
H 3.24 
 
26 D 8.28 4.56 
2.97 
2.94 
  
27 I 8.26 3.89 2.02 
1.81, 1.22 
CH3 0.99 
H 0.92 
28 G 8.20 3.95    
29 I 7.96 4.11 2.01 
1.64, 1.33 
CH3 0.98 
H 0.91 
30 S 7.88 4.40 
4.05 
3.97 
  
31 D 7.96 4.92 3.00   
32 P  4.31 
2.44 
2.01 
2.18 
2.13 
H 4.03, 3,97 
33 Q 8.19 4.16 2.13 
2.47 
2.42 
H 7.24, 6.52 
34 H 8.05 4.47 
3.46 
3.42 
 
H 7.30 
H  8.56 
35 R 8.23 4.06 1.99 
1.84 
1.70 
H 3.29 
H 7.20 
36 R 8.21 4.07 
1.97 
1.83 
1.70 
H 3.22 
H 7.19 
37 K 7.84 4.16 1.99 
1.64 
1.54 
H 1.75 
H  3.01 
38 L 7.84 4.16 
1.85 
1.73 
1.84 CH3 0.93 
39 L 8.03 4.14 
1.88 
1.63 
1.82 
CH3 0.92 
 
40 Q 8.01 4.08 
2.24 
2.20 
2.56 
2.41 
H 7.20, 6.52 
41 A 8.03 4.22 1.56   
42 A 8.09 4.24 1.53   
43 R 7.78 4.31 
2.01 
1.90 
1.82 
1.75 
H 3.23 
H 7.13 
CONH2  7.26, 6.77 
78 
 
Table 2. Sam3 HN temperature coefficients (/T). For Gly7, Leu24, Gly28 and Arg36 residues /T 
values cannot be calculated. The Pro32 is not included in the table. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Residue -Δδ/ΔT (ppb/K)
1 S -3.0 ± 0.3
2 K -8.7 ± 0.1
3 L -1.2 ± 0.3
4 L -3.0  ± 0.3
5 L -6.6 ± 0.2
6 N -5.7 ± 0.2
7 G ---
8 F -9.0 ± 0.4 
9 D -11.9 ± 0.3
10 D -9.2 ± 0.2
11 V -11.0 ± 0.3
12 H -3.47 ± 0.08
13 F -12.2 ± 0.2
14 L -13.5 ± 0.4
15 G -11.9 ± 0.3
16 S -5.2 ± 0.3
17 N 2.2 ± 0.2
18 V -9.0 ± 0.2
19 M -6.1 ± 0.4
20 E -5.1 ± 0.2
21 E -4.8 ± 0.4
Residue -Δδ/ΔT (ppb/K)
22 Q -5.2 ± 0.3
23 D -5.7 ± 0.2
24 L ---
25 R -6.6 ± 0.2
26 D -6.5 ± 0.3
27 I -8.0 ± 0.3
28 G ---
29 I -8.1 ± 0.2
30 S -3.4 ± 0.3
31 D -3.0 ± 0.2
33 Q -1.7 ± 0.2
34 H -1.6 ± 0.3
35 R -3.2 ± 0.4
36 R ---
37 K -1.6 ± 0.2
38 L -4.5 ± 0.3
39 L -7.4 ± 0.2
40 Q -4.6 ± 0.3
41 A -5.4 ± 0.3
42 A -7.3 ± 0.3
43 R -4.1 ± 0.2
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ABSTRACT: The EphA2 receptor plays key roles in many
physiological and pathological events, including cancer. The
process of receptor endocytosis and the consequent de-
gradation have attracted attention as possible means of over-
coming the negative outcomes of EphA2 in cancer cells and
decreasing tumor malignancy. A recent study indicates that
Sam (sterile alpha motif) domains of Odin, a member of
the ANKS (ankyrin repeat and sterile alpha motif domain-
containing) family of proteins, are important for the regulation of
EphA2 endocytosis. Odin contains two tandem Sam domains
(Odin-Sam1 and -Sam2). Herein, we report on the nuclear
magnetic resonance (NMR) solution structure of Odin-Sam1;
through a variety of assays (employing NMR, surface plasmon
resonance, and isothermal titration calorimetry techniques), we clearly demonstrate that Odin-Sam1 binds to the Sam domain of
EphA2 in the low micromolar range. NMR chemical shift perturbation experiments and molecular modeling studies point out
that the two Sam domains interact with a head-to-tail topology characteristic of several Sam−Sam complexes. This binding mode
is similar to that we have previously proposed for the association between the Sam domains of the lipid phosphatase Ship2 and
EphA2. This work further validates structural elements relevant for the heterotypic Sam−Sam interactions of EphA2 and
provides novel insights for the design of potential therapeutic compounds that can modulate receptor endocytosis.
Eph receptors represent a large subgroup of the receptortyrosine kinase family and together with their ephrin ligands
play relevant roles in several physiological and pathological
processes.1,2 Interestingly, these receptors are differentially ex-
pressed in unhealthy versus normal tissues and, thus, considered
attractive targets in drug discovery.3 Among them, EphA2 has
received a great amount of attention.
The most recent work has associated EphA2 with cata-
racts4−6 and entry of the hepatitis C virus into the host cell.7
However, EphA2 has long been related to cancer, and even if its
role in this disease has been described as both complex and
controversial, many of its procancer activities have been well
characterized.1
The processes of enhanced EphA2 endocytosis and
subsequent degradation have been correlated with weakened
malignant cell behavior.1 Recent studies have focused on the
regulation mechanisms at the basis of EphA2 receptor
endocytosis.8,9 First, lipid phosphatase Ship2 (Src homology
2 domain-containing phosphoinositide-5-phosphatase 2) has
been identified as a prominent regulator of this process.8 In
vitro experiments have demonstrated that Ship2 overexpression
in malignant breast cancer cells increases EphA2 stability, while
decreased levels of Ship2 facilitate receptor internalization and
degradation. To exert its function, Ship2 needs to be engaged at
the receptor site by means of a heterotypic interaction between
its sterile alpha motif (Sam) domain and the Sam domain of
EphA2 (EphA2-Sam).8
Sam domains are protein binding modules containing ∼70
amino acids that form a five-helix bundle and are involved in
many biological processes mainly via homo- and heterodime-
rization or polymerization processes.10,11
The nuclear magnetic resonance (NMR) solution struc-
ture of the Sam domain of Ship2 [Ship2-Sam, Protein Data
Bank (PDB) entry 2K4P] and binding studies with the Sam
domain from the EphA2 receptor (EphA2-Sam) have pre-
viously been reported.12 ITC (isothermal titration calorimetry)
experiments have indicated that the two domains interact with a
dissociation constant in the low micromolar range. Further-
more, chemical shift perturbation experiments have revealed
Received: January 31, 2012
Published: February 14, 2012
Article
pubs.acs.org/biochemistry
© 2012 American Chemical Society 2136 dx.doi.org/10.1021/bi300141h | Biochemistry 2012, 51, 2136−2145
the reciprocal binding interfaces of Ship2-Sam and EphA2-Sam
and, together with modeling studies, have shown that this inter-
action may adopt a mid loop (ML)/end helix (EH) model,
characteristic of other Sam−Sam complexes.12−15
A recent work indicates that EphA2 endocytosis is also re-
gulated by ANKS (ankyrin repeat and Sam domain-containing)
family proteins.9 This class of proteins includes Odin16 and
AIDA1b (AβPP intracellular domain-associated protein 1B),17
which possess in addition to six ankyrin repeats and a PTB (phos-
photyrosine binding) domain, two Sam domains in tandem (Sam1
and Sam2).
Overexpression of Odin in MDA-MB-231 human breast
carcinoma cells and MEFs (mouse embryonic fibroblasts) pro-
tects EphA2 from undertaking internalization and degradation
after ligand stimulation, while a Sam domain deletion mutant of
Odin lacks this function.9
Herein, we describe solution structure studies of the first Sam
domain of Odin (Odin-Sam1) and binding studies with EphA2-
Sam. Through a variety of assays relying on NMR, surface
plasmon resonance (SPR), and ITC techniques, we clearly
demonstrate that Odin-Sam1 and EphA2-Sam interact with low
micromolar affinity and a 1:1 stoichiometry. NMR chemical
shift perturbation experiments allow identification of the
reciprocal binding interfaces of the two proteins; moreover,
NMR-based displacement experiments and molecular docking
studies show that Ship2-Sam and Odin-Sam1 share a common
binding site on the surface of EphA2-Sam and adopt similar
binding modes for these heterotypic Sam−Sam interactions.
Our work sheds additional light on the structural features
that are relevant for heterotypic Sam−Sam complexes involv-
ing EphA2 and provides novel information for the design of
therapeutic compounds that can modulate receptor endocy-
tosis.
■ MATERIALS AND METHODS
Protein Expression. Recombinant proteins were expres-
sed in Escherichia coli. The following PET15B constructs were
used for this study: Ship2-Sam (residues 1199−1258 of human
Ship2, UniprotKB/TrEMBL entry O15357), Odin-Sam1
(residues 691−770 of human Odin, UniprotKB/TrEMBL
entry Q92625), and Odin-Sam2 (residues 761−840 of human
Odin, UniprotKB/TrEMBL entry Q92625). Constructs de-
signed for wild-type human EphA2-Sam (Swiss-Prot/TrEMBL
entry P29317) and its double (H45N/R71A) and triple (K38A/
R78A/Y81S) mutants have been previously described.12,18
Synthetic genes encoding these proteins were all purchased
from Celtek Bioscience (Nashville, TN) and contain an
N-terminal His tag and a thrombin cleavage site.
Genes were transformed using BL21-Gold (DE3) competent
cells (Stratagene). Protein expression and purification protocols
implemented for labeled and unlabeled Sam domain pro-
duction have previously been reported.18
To express unlabeled proteins, bacteria were grown in
LB medium. M9 minimal medium supplemented with 2 g/L
[13C]glucose and/or 0.5 g/L 15NH4Cl was prepared for
expression of 15N- and 13C-labeled or 15N-labeled proteins,
respectively. M9 medium containing 3.6 g/L [12C]glucose
(natural abundance) and 0.4 g/L [13C]glucose was used to
achieve 10% fractional 13C labeling for stereospecific assign-
ments of Leu CH3
δ1,2 and Val CH3
γ1,2 groups.19 Expression
protocols for uniformly or selectively labeled proteins were
identical to those followed for unlabeled protein production.
Briefly, bacteria were grown at 37 °C; protein overexpression was
induced at a cell optical density OD600 of 0.6 nm with isopropyl β-
D-thiogalactopyranoside (IPTG, 1 mM) at 25 °C overnight.
Proteins were purified with an AKTA Purifier FPLC system
by affinity chromatography on a nickel column (GE Healthcare,
Milan, Italy).
Resonance Assignments. Resonance assignment experi-
ments were conducted at 25 °C on a Varian Unity Inova
600 MHz spectrometer equipped with a cold probe. NMR
samples consisted of 15N-labeled or 15N- and 13C-labeled
Odin-Sam1 (∼900 μM) in phosphate-buffered saline (PBS)
(10 mM phosphates, 140 mM NaCl, and 2.7 mM KCl)
(Fisher) at pH 7.7 and 0.2% NaN3 with volumes of 600 μL
(95% H2O/5% D2O).
Backbone assignments were made via analysis of triple-
resonance experiments [HNCA, HN(CO)CACB, and
HNCACB].20 Carbon side chains were identified in (H)CC-
(CO)NH and HCCH-TOCSY spectra. Proton side chains were
assigned in the HCCH-TOCSY spectrum or by comparing
three-dimensional (3D) 15N-resolved 1H−1H NOESY (100 ms
mixing time) and 3D 15N-resolved 1H−1H TOCSY (70 ms
mixing time) spectra. Aromatic side chains were identified by
combined analysis of two-dimensional (2D) 1H−1H NOESY
(100 ms mixing time) and 2D TOCSY (70 ms mixing time)
spectra recorded for samples of Odin-Sam1 dissolved in 99%
D2O. Stereospecific assignments for Leu CH3
δ1,2 and Val
CH3
γ1,2 groups of Odin-Sam1 were obtained from a 1H−13C
HSQC experiment of a fractionally 13C-labeled Odin-Sam1
sample (500 μM).19
To obtain the nearly complete backbone resonance assign-
ments of the Odin-Sam1−EphA2-Sam complex, HNCA and
3D 15N-resolved 1H−1H NOESY (100 ms mixing time) spectra
were acquired with samples containing either 15N- and 13C-
labeled Odin-Sam1 (450 μM) and unlabeled EphA2-Sam
(∼1 mM) or doubly labeled EphA2-Sam (350 μM) and un-
labeled Odin-Sam1 (900 μM).
NMR spectra were processed with Varian software (Vnmrj
version 1.1D) and analyzed with NEASY21 (http://www.nmr.ch/).
Relaxation Measurements. Backbone 15N longitudinal
(R1) and transverse (R2) relaxation rates were evaluated at
25 °C and 600 MHz. Measurements were taken with two
15N-labeled Odin-Sam1 samples at concentrations of 100 and
900 μM and a sample of the Sam−Sam complex consisting of
labeled Odin-Sam1 (450 μM) and unlabeled EphA2-Sam
(∼1 mM).
R1 and R2 relaxation data were collected as one-dimensional
spectra (4K data points and 2K or 4K transients). R1 data sets
were recorded with relaxation delays of 0.01, 0.1, 0.3, 0.6, and
1.0 s; R2 data sets were acquired with relaxation delays of 0.01,
0.03, 0.05, 0.07, 0.09, 0.11, 0.15, and 0.19 s. Average R1 and
R2 values were estimated by the decrease in signal intensity
as function of relaxation delay. To calculate the rotational
correlation time, we used average R2/R1 ratios as input for
the software tmest (A. G. Palmer, III, Columbia University,
New York, NY).22
DOSY (Diffusion-Ordered Spectroscopy). Diffusion-
ordered NMR spectroscopy was conducted with the pulsed
gradient spin−echo (PGSE) NMR technique.23 The transla-
tional self-diffusion coefficient D can be calculated with the
equation I = I0 exp[−Dγ2δ2G2(Δ − δ/3)], where I0 is the
measured signal intensity of a set of resonances at the smaller
gradient strength, I is the corresponding observed peak intensity,
D is the diffusion constant, γ is the proton gyromagnetic ratio, δ is
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the diffusion gradient length, G is the gradient strength, and Δ is
the diffusion delay.24
Series of spectra were acquired with 512 scans and 16K
data points. We conducted DOSY experiments with Odin-
Sam1 samples at concentrations of 100 and 900 μM. The
hydrodynamic radius (rH) of the protein was evaluated with
the Stokes−Einstein equation: Dt = kBT/f, where f (=6πηrH) is
the translational friction coefficient, η is the viscosity of the
solution, kB is Boltzmann's constant, and T is the temperature
in kelvin.
Structure Calculations and Analysis for Odin-Sam1.
Analysis of a 3D 15N-resolved 1H−1H NOESY-HSQC spec-
trum25 (100 ms mixing time), a 3D 13C-resolved 1H−1H
NOESY-HSQC spectrum (100 ms mixing time), and a 2D
1H−1H NOESY spectrum26 (100 ms mixing time), for the
aliphatic to aromatic region, that was acquired after dissolving
the lyophilized protein sample in 99% D2O, was used to collect
distance constraints for structure calculations. CYANA version
2.127 was employed to calculate the solution structure of Odin-
Sam1. Angular constraints were generated with the GRID-
SEARCH module of CYANA. The final structure calculation
includes 1206 upper distance constraints (393 intraresidue, 239
short-range, 275 medium-range, and 299 long-range), 372 angle
constraints, and information about stereospecific assignments
for methyl groups of Val32, Val56, Val63, Leu36, Leu48, and
Leu84. Structure calculations were initiated from 100 random
conformers; the 20 structures that better satisfy experimental
constraints (i.e., lowest CYANA target functions) were further
inspected with MOLMOL28 and iCING (http://proteins.
dyndns.org/cing/iCing.html). Surface representations were
generated with PVM 1.5.6rc1.29
NMR Binding Studies. Protein−protein interaction studies
were conducted by means of NMR titration experiments and
analysis of 2D 1H−15N HSQC spectra. To identify the Odin-
Sam1 binding interface for EphA2-Sam, 2D 1H−15N HSQC
spectra of 15N-labeled Odin-Sam1 (160 μM) were recorded for
the protein in the unbound form and after addition of un-
labeled EphA2-Sam (80, 160, 240, and 400 μM). To recognize
the binding site of EphA2-Sam for Odin-Sam1, 2D 1H−15N
HSQC spectra of a 15N-labeled EphA2-Sam sample (63 μM)
were recorded in the absence and presence of unlabeled Odin-
Sam1 (360 and 600 μM).
To verify the binding of EphA2-Sam mutants to Odin-Sam1,
NMR chemical shift perturbation experiments were performed
with 15N-labeled Odin-Sam1 samples (50−100 μM) and un-
labeled double (H45N/R71A) and triple (K38A/R78A/Y81S)
EphA2-Sam mutants (concentrations ranging from 200 μM to
2 mM) (see the Supporting Information).
Analysis of titration experiments and overlays of 2D spectra
were performed with SPARKY 3 (T. D. Goddard and D. G.
Kneller, University of California, San Francisco).
Surface Plasmon Resonance. EphA2-Sam proteins were
immobilized in 10 mM acetate buffer (pH 5.0, flow rate of
5 μL/min, injection time of 7 min) on a CM5 Biacore sensor
chip, using EDC/NHS chemistry, following the manufacturer’s
instructions.30 Residual reactive groups were deactivated with
1 M ethanolamine hydrochloride (pH 8.5); the reference chan-
nel was prepared by activation with EDC/NHS and deactiva-
tion with ethanolamine. Immobilization levels were 940,
1313, and 1480 resonance units (RU) for wild-type EphA2-
Sam and double (H45N/R71A) and triple (K38A/R78A/
Y81S) mutants, respectively. Experiments were conducted at
25 °C and a constant flow rate of 20 μL/min using as running
buffer a solution of 10 mM Hepes (pH 7.4), 150 mM NaCl,
and surfactant P20 (0.05%, v/v, 90 μL injected for each
experiment). Binding experiments were conducted with Odin-
Sam1 at various concentrations in the range of 0.1−400 μM.
The BIA evaluation analysis package (version 4.1, GE
Healthcare) was used to subtract the signal of the reference
channel and to estimate KD values. RUmax values as a function
of protein concentration were fit by nonlinear regression
analysis with GraphPad Prism, version 4.00 (GraphPad Soft-
ware, San Diego, CA).31
Isothermal Titration Calorimetry (ITC). ITC studies were
performed at 25 °C with an iTC200 calorimeter (MicroCal/GE
Healthcare, Milan, Italy). A solution of EphA2-Sam at a
concentration of 257 μM was titrated into a solution of Odin-
Sam1 (10 μM). Both proteins were extensively dialyzed in the
same buffer (PBS, pH 7.7) prior to ITC measurements. Fitting
of data to a single-binding site model was conducted with the
Origin software as supplied by GE Healthcare. ITC runs were
repeated twice to evaluate the reproducibility of the results.
Docking Studies. Models of the Odin-Sam1−EphA2-Sam
complex were generated with the Haddock web server.32 NMR
structures (first conformers) of both Odin-Sam1 [Protein Data
Bank (PDB) entry 2LMR] and EphA2-Sam (PDB entry 2E8N,
RIKEN Structural Genomics Initiative) were used in these
studies. Ambiguous interaction restraints were generated from
chemical shift perturbation data. For Odin-Sam1, active
residues (i.e., L49, L50, N51, F53, D54, D55, V56, H57, F58,
Q67, D68, R70, and D71) were chosen among those with the
highest chemical shift variations because they either possess
high solvent exposure or could potentially supply important
intermolecular contacts as revealed by structural homology with
other Sam−Sam complexes. For EphA2-Sam, we adopted
similar selection criteria for active residues (i.e., K38, R71, G74,
H75, K77, R78, and Y81). The C-terminal and N-terminal tails
of Odin-Sam1 (residues 21−24 and 95−101, respectively) were
considered fully flexible during all the docking stages, whereas
the region encompassing residues 51−65 was set as semi-
flexible. For EphA2-Sam, fully flexible segments include the
N-terminal and C-terminal tails; the portion of C-terminal α5
helix covering residues 74−84 of EphA2-Sam (corresponding
to amino acids 59−69 according to the sequence numbers of
PDB entry 2E8N) was considered semiflexible.
In all of the docking runs, passive residues were set auto-
matically by the Haddock web server and the solvated docking
mode was turned on.33
In the first iteration of the docking protocol (i.e., the rigid
body energy minimization), 1000 structures were calculated; in
the second iteration, the 200 best solutions were subjected to
semiflexible simulated annealing, and a final refinement in water
was also performed.
The final 200 Haddock models were all visually inspected,
and solutions not compatible with our experimental data and/
or containing highly unusual protein orientations were soon
removed. This first selection screening reduced the number of
structures to 78. The resultant solutions were further analyzed
with MOLMOL28 and compared with experimental structures
of other heterotypic Sam−Sam complexes (for example, the
AIDA1 Sam tandem, PDB entry 2KIV34), to recognize char-
acteristic features. At the end of this analysis, 22 models were
chosen as being representative of the possible EphA2-Sam−
Odin-Sam1 conformations. Solutions were clustered using
a pairwise root-mean-square deviation (rmsd) cutoff of 2 Å
and at least one structure per cluster. The rmsd values were
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calculated with MOLMOL28 by superimposing the structures
on the backbone atoms of residues 36−41, 62−65, and 70−81
of EphA2-Sam and residues 48−73 of Odin-Sam1. This
clusterization procedure indicated the presence of five families
of structures in the selected ensemble (see Figure S3 of the
Supporting Information).
■ RESULTS
NMR Solution Structure of Odin-Sam1. To assess the
quaternary structure of Odin-Sam1 in solution, we have con-
ducted 15N R1 and R2 nuclear spin relaxation rate measure-
ments along with DOSY (diffusion-ordered spectroscopy) ex-
periments.
The rotational correlation time, τc, of the protein at 100 μM,
estimated by relaxation data (R2/R1 average value), is 7.4 ±
0.7 ns and does not change when the protein concentration is
increased to 900 μM (i.e., 7.3 ± 0.6 ns). The τc of Odin-Sam1
bound to EphA2-Sam increases instead to 11 ± 1 ns.
DOSY measurements23 indicate for a more diluted Odin-
Sam1 sample (100 μM) a diffusion coefficient (Dt) equal to
(1.5 ± 0.1) × 10−10 m2 s−1 and a corresponding hydrodynamic
radius (rH) of 16.7 Å. For an Odin-Sam1 sample at a higher
concentration (900 μM), we obtained similar diffusion
parameters [Dt = (1.40 ± 0.07) × 10
−10 m2 s−1, and rH =
17.5 Å].
These studies clearly demonstrate that under the exper-
imental conditions used to calculate Odin-Sam1 NMR structure
(∼900 μM) aggregation processes can be ignored.
The Odin-Sam1 solution structure is a canonical Sam do-
main helix bundle (Figure 1), and the region encompassing the
α3 helix lacks ordered secondary structure elements; however, a
reduced number of constraints could be collected for residues
in this portion of the protein.
Relevant structural parameters for Odin-Sam1 conformers
are listed in Table 1.
Odin-Sam1−EphA2-Sam Interaction. Binding of Odin-
Sam1 to EphA2-Sam was first monitored by means of chemical
shift perturbation studies.35 2D 1H−15N HSQC experiments
were recorded for a uniformly 15N-labeled Odin-Sam1 sample
in the presence and absence of unlabeled EphA2-Sam (Figure 2A).
Proton- and nitrogen-normalized chemical shift variations
were evaluated with the equation Δδ = [(ΔHN)2 + (0.17 ×
Δ15N)2]1/2 (Figure 2B).36 Upon heterotypic association, many
changes affect the spectrum; however, the greatest Δδ values
(>0.2 ppm) occur in the middle region of the protein, including
helices α3, α4, and to a lesser extent α2 (Figure 2C,D).
Similar NMR experiments with 15N-labeled EphA2-Sam and
unlabeled Odin-Sam1 were conducted to map the binding
surface of EphA2-Sam for Odin-Sam1 (Figure 3A). We
estimated normalized chemical shift deviations to identify the
residues of the receptor participating in the interaction with
Odin-Sam1 (Figure 3B). The largest deviations are localized at
the interface between helix α5 and the adjacent α1−α2 and
α4−α5 loop regions (Figure 3C).
Chemical shift mapping data suggest that Odin-Sam1 and
EphA2-Sam may adopt a mid loop/end helix binding model
that is characteristic of Sam−Sam complexes.13,14,34,37
SPR and ITC experiments were also performed, and both
confirmed a clear association of Odin-Sam1 and EphA2-Sam
(Figure 4). For SPR experiments, EphA2-Sam was efficiently
immobilized on the chip surface while Odin-Sam1 was used as
analyte; kinetic experiments along with a plot of RUmax values
of each experiment versus Odin-Sam1 concentration, both
employing a 1:1 interaction model, provided a low micromolar
dissociation constant value for the Odin-Sam1−EphA2-Sam
complex (Figure 4A,B). Specifically, a KD value of 5.5 ± 0.9 μM
could be obtained by best fitting of experimental data via
nonlinear regression analysis (Figure 4B).
ITC experiments also indicated that Odin-Sam1 associated
with EphA2 with a 1:1 stoichiometry and a KD of 0.62 ±
0.04 μM (Figure 4C).
NMR and SPR studies with EphA2-Sam mutants12 were
conducted to gain additional insight into the mode of binding
of Odin-Sam1 to EphA2-Sam (Figures S1 and S2 of the
Supporting Information). Details about the design of the two
mutant proteins were previously described.12 Briefly, in the
triple (K38A/R78A/Y81S) EphA2-Sam mutant, we mutat-
ed residues located in helix α5 and the α1−α2 loop that
constitute part of the putative interaction surface of EphA2-Sam
for Odin-Sam1 (i.e., regions undergoing major chemical
shift changes upon binding of Odin-Sam1 to the receptor)
Figure 1. Superposition of the backbone atoms (residues 30−90) of
Odin-Sam1 NMR structures (left). Odin-Sam1, first conformer, is
shown in ribbon representation (right), including the following
α-helical segments: α1 (residues 32−39), α2 (residues 42−50),
α4 (residues 66−72), and α5 (residues 77−88). The disordered
N-terminal tail encompassing residues 21−27 has been omitted for the
sake of clarity.
Table 1. Statistics for the Odin-Sam1 Solution Structure
no. of NOE upper distance limits 1206
no. of angle constraints 372
residual target function (Å2) 0.79 ± 0.08
no. of residual NOE violations
no. >0.1 Åa 2
maximum (Å) 0.205 ± 0.07
no. of residual angle violations 0
atomic pairwise rmsd (Å)
backbone atoms (amino acids 30−90) 0.26 ± 0.07
heavy atoms (amino acids 30−90) 0.74 ± 0.09
Procheck analysisb (%)
residues in core regions 84.6
residues in allowed regions 15.1
residues in generous regions 0.3
residues in disallowed regions 0
aMaximal number of CYANA27 violations. bPROCHECK_NMR46
statistics for residues 30−90.
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(Figure 3C and Figure S1 of the Supporting Information), and
amino acid replacements were planned to destroy potential key
interactions at the dimer interface without perturbing the over-
all protein structure. In the H45N/R71A EphA2-Sam construct,
mutations were instead inserted in regions adjacent to the putative
binding site (Figure 3C and Figure S2 of the Supporting
Information).
NMR and SPR experiments revealed for the triple (K38A/
R78A/Y81S) mutant a binding affinity lower than that of the
wild-type protein for Odin-Sam1 (Figure S1 of the Supporting
Information). On the other hand, the EphA2-Sam double
(H45N/R71A) mutant preserved an ability to associate with
Odin-Sam1 similar to that of the wild-type protein (Figure S2
of the Supporting Information).
Molecular Modeling of the Odin-Sam1−EphA2-Sam
Complex. A speculative model of the Odin-Sam1−EphA2-
Sam complex was built by molecular docking with Haddock
version 2.032,38 (See Materials and Methods for details).
A representative structure (corresponding to the second best
Haddock solution) is shown in Figure 5A. These modeling
studies, in agreement with chemical shift perturbation data,
indicated for the complex a head-to-tail topology also known as
mid loop (ML)/end helix (EH) binding mode,13,14 in which
Odin-Sam1 and EphA2-Sam are providing the ML and EH
binding interfaces, respectively. Intermolecular interactions
mainly include a network of H-bonds and electrostatic contacts
between positively charged residues of EphA2-Sam and nega-
tively charged residues of Odin-Sam1 (Figure 5A and Figure S3
of the Supporting Information). Cation−π and π−π inter-
actions also occur in a few Haddock solutions and involve
mainly Phe58 on the surface of Odin-Sam1 and to a lesser
extent Tyr81 (EphA2-Sam EH site) and Phe53 (Odin-
Sam1 ML site) (Figure 5A and Figure S3 of the Supporting
Information).
■ DISCUSSION
EphA2 receptor tyrosine kinase is considered a promising target
in drug discovery for cancer therapies, and the process of
receptor endocytosis has been exploited as a possible route to
reduce tumor malignancy.1 Recent evidence has shown that
Sam domains are crucial for anchorage of protein regulators of
endocytosis at the receptor site.8,9
The Sam domain of lipid phosphatase Ship2 is engaged in a
heterotypic interaction with the Sam domain of the receptor
and is able to inhibit its endocytosis in cancer cells.8 Proteins of
the ANKS family also play a prominent role in the process
through their Sam domains, possibly by regulating ubiquitina-
tion mechanisms.9
In this study, we focus our attention on Odin,16 an ANKS
family member that in cancer cells increases receptor stability.39
Figure 2. (A) Overlay of 1H−15N HSQC spectra of Odin-Sam1 (150 μM) before (green) and after addition of EphA2-Sam (363 μM) (red). (B)
Graph of chemical shift deviations {Δδ = [(ΔHN)2 + (0.17 × Δ15N)2]1/2} vs residue number. A Δδ value equal to 0 has been assigned to residues
Q43, V56, and N62, whose peaks can be seen only in the spectrum of Odin-Sam1 bound to EphA2-Sam, S61 and S75 (unassigned), P77, and P91.
(C and D) Surface (C) and ribbon (D) representations of Odin-Sam1 (conformer 1); residues with Δδ values higher than 0.2 ppm (i.e., G33, L49,
L50, N51, G52, F53, D54, D55, H57, F58, L59, G60, M64, E65, Q67, D68, R70, D71, I72, I74, Q85, R88, and V93) are colored red.
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Odin contains at the C-terminal side two Sam domains in
tandem, Odin-Sam1 and Odin-Sam2. We attempted to express
both isolated Sam domains (data not shown), but we could
obtain only soluble Odin-Sam1 protein. However, difficulties in
expression of the Sam2 domain of AIDA1b, another member of
the ANKS protein family with a sequence highly homologous
with that of Odin, were previously encountered.9,34 For Odin-
Sam1, we conducted a complete structural characterization by
NMR.
Sam domains exhibit a generally weak tendency to associate
in solution through homotypic interactions.12,18,40 Our studies
of the aggregation state of Odin-Sam1 confirm this trend. In
fact, the correlation time of Odin-Sam1 (τc = 7.3 ns at a protein
concentration of 900 μM), evaluated by 15N relaxation data, is
rather close to that reported for monomeric Sam domains such
as Ship2-Sam (6.7 ns)12 and Arap3 (Arf GAP, Rho GAP,
ankyrin repeat, and PH domain)-Sam (8.2 ns) at similar con-
centrations and under similar buffer conditions.18 The presence
of one single Odin-Sam1 monomeric species in solution is
further supported by DOSY experiments.23 In particular, the
hydrodynamic radius of the protein (i.e., ∼17 Å) measured by
DOSY23 is comparable with that of compact proteins of a
similar size.41
The correlation time of Odin-Sam1 bound to EphA2-Sam
increases instead to ∼11 ns, thus reflecting the increase in
molecular weight upon association and suggesting that the two
proteins may bind with a 1:1 stoichiometry;12,18,34 in fact, for
the AIDA1-Sam1/Sam2 tandem, a similar correlation time
value equal to 9.1 ns has been reported.34
To identify closely related Sam domains, we conducted a
blastp search against the PDB42 by using the Odin-Sam1 se-
quence as the input query (Figure S4 of the Supporting
Information). The results show that Odin-Sam1 presents the
highest sequence identity (57%) with AIDA1-Sam1 (PDB entry
2EAM, RIKEN Structural Genomics Initiative); however, it
possesses good homology also with Ship2-Sam (48% identical
sequence, PDB entry 2K4P12) and EphA2-Sam (31% identical
sequence, PDB entry 2E8N). A similar blastp search of Odin-
Sam2 sequence indicates the highest identity with AIDA1-Sam2
(59%); sequence identities with EphA2-Sam and Ship2-Sam are
instead 38 and 20%, respectively (Figure S4 of the Supporting
Information).
In agreement with the high levels of homology revealed by
blastp, Odin-Sam1 (Figure 1) presents the canonical Sam
domain fold, and its structure is rather similar to that of AIDA1-
Sam1 (PDB entries 2EAM and 2KE7); in fact, differences can
be revealed only in the intrinsically disordered regions.
Interaction between Odin-Sam1 and EphA2-Sam and
Comparison with Other Heterotypic Sam−Sam Associ-
ations. Because of the high sequence identity between Ship2-
Sam and Odin-Sam1 as well as the common function of
regulators of EphA2 endocytosis, we have investigated if Odin-
Sam1 could directly bind EphA2-Sam as Ship2-Sam does.
Figure 3. (A) Superposition of 1H−15N HSQC spectra of EphA2-Sam (63 μM) in the apo form (maroon) and bound to Odin-Sam1 (330 μM)
(green). (B) Histogram of normalized chemical shift deviations vs residue number. The largest variations (Δδ values >0.1 ppm) are observed for
residues T29, W33, S36, I37, K38, M39, Y42, F46, T52, A53, V58, K66, R71, L72, H75, Q76, K77, R78, A80, Y81, and L83. Data are set equal to 0
for residues N62 and D63 (unassigned), G74 and Q41 (their peaks are visible only in the spectrum of the bound protein), P73, and P96. (C) Ribbon
representation of EphA2-Sam (conformer 1, PDB entry 2E8N, from RIKEN Structural Genomics Initiative); residues with Δδ values >0.1 ppm are
colored green. Side chains of amino acids involved in mutagenesis studies are colored green (EphA2-Sam triple mutant) and coral (EphA2-Sam
double mutant).
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The interaction between Odin-Sam1 and EphA2-Sam has
been studied by SPR, ITC, and NMR experiments. A clear
association of the two proteins is evident from analysis of all
the different binding assays. The dissociation constant esti-
mated by SPR is in good agreement with that obtained by ITC
(Figure 4). ITC data also clearly indicate, in agreement with the
relaxation data, that the two Sam domains bind according to a
single-binding site model (Figure 4C).
NMR chemical shift perturbation experiments (Figures 2 and 3)
have revealed the reciprocal binding surfaces of the proteins
and suggested that they may adopt a mid loop (ML)/end helix
(EH) binding mode.43 By having available the 3D structures of
both Odin-Sam1 (PDB entry 2LMR) and EphA2-Sam (PDB
entry 2E8N) and to recognize possible key intermolecular
interactions stabilizing the complex, we have conducted mol-
ecular docking studies with the Haddock web server.32 Docking
trials have been coupled to mutagenesis studies. The latter
indicate that Tyr81, Lys38, and Arg78 on the EH surface of
EphA2 are likely providing important interactions; in fact, con-
current mutations of Tyr to Ser and Lys and Arg to Ala
attenuate the binding affinity for Odin-Sam1 (Figure S1 of the
Supporting Information). Indeed, in most of our docking solu-
tions, these residues are involved in intermolecular contacts
(Figure 5 and Figure S3 of the Supporting Information). The
K38A, R78A, and Y81S mutations in EphA2-Sam also decrease
the binding affinity of the receptor for Ship2-Sam.12 We have
previously reported the NMR solution structure of Ship2-Sam
and characterized its binding to EphA2-Sam with NMR and
ITC techniques.12 These earlier studies have pointed out that
Ship2-Sam and EphA2-Sam bind to each other by adopting a
ML/EH binding topology;12 very recently, the same interaction
has been studied under different experimental conditions, and
the structural details of the binding interface have been further
elucidated.44
The Ship2-Sam/EphA2-Sam binding mode and the type of
possible stabilizing interactions12,44 appear similar to that we
can observe for the Odin-Sam1−EphA2-Sam complex. Indeed,
an NMR-based displacement experiment shows that Ship2-Sam
and Odin-Sam1 share a common binding site on the surface of
the receptor (Figure S5 of the Supporting Information).
Next, we compared our Odin-Sam1−EphA2-Sam model with
the NMR structure of the tandem Sam domain of AIDA1 (PDB
Figure 4. (A and B) SPR studies. Overlay of sensorgrams relative to the direct binding of Odin-Sam1 to immobilized EphA2-Sam (0.1−400 μM)
(A). Plot of RUmax from each binding vs Odin-Sam1 concentration (B); data were fit by nonlinear regression analysis. (C) ITC studies. Calorimetric
curve showing titration of EphA2-Sam (257 μM) with Odin-Sam1 (10 μM). The top and bottom sections report the raw and integrated data,
respectively. A single-binding site model was applied for data fitting (bottom).
Biochemistry Article
dx.doi.org/10.1021/bi300141h | Biochemistry 2012, 51, 2136−21452142
entry 2KIV34) (Figure 5B). Analogies between the two Sam−
Sam associations are evident. Interestingly, the tandem presents
a mid loop/end helix topology in which AIDA1-Sam1 and
AIDA1-Sam2 are supplying the ML and EH binding surfaces,
respectively34 (Figure 5A).
On the basis of the high degree of sequence homology
between AIDA1 and Odin (see above), we suppose that the
two Odin Sam domains in tandem may bind with an analogue
ML/EH topology in which Odin-Sam1 supplies the ML inter-
face. It is clear that if the ML surface of Odin-Sam1 is engaged
in the interaction with Odin-Sam2 in the full-length protein,
uncoupling of the Sam2 domain from the tandem may be
needed to permit binding of Sam1 to EphA2-Sam. Indeed, it
has already been hypothesized that the opening of the AIDA1
tandem is required for translocation of AIDA1 toward the
nucleus.34
However, more structural and biochemical studies are
needed to shed light on the complex mechanisms regulating
the network of interactions of Odin and EphA2-Sam.
Moreover, it is worth noting that recent findings have
associated a few mutations in EphA2-Sam with cataracts.6,45
Some of these EphA2-Sam mutations are located close to the
EH interface (i.e., the α4−α5 loop and the C-terminal portion
of helix α5) (Figure S4B of the Supporting Information);
whether they may cause perturbation in the structure of the
receptor Sam domain and thus influence its binding affinity for
Odin-Sam1 remains to be addressed.
In this regard, it could be appealing to design, based on the
structural information we have obtained here and in our pre-
vious work, novel molecular probes (small molecules or pep-
tides) able to antagonize Odin-Sam1−EphA2-Sam association
and study the outcomes in a cellular context, thus fully vali-
dating its relevance to either cancer or cataracts.
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Introduction
Arap3 (Arf GAP with Rho GAP domain, Ankyrin repeat and PH
domain 3) is a phosphatidylinositol 3 kinase (PI3K) effector pro-
tein that had originally been discovered by screening for novel
binders of PtdIns(3,4,5)P3 (phosphatidylinositol (3,4,5)P3).[1]
Arap3 works as a GTPase activating protein for Arf6 and RhoA;
it plays roles in biological processes associated with the forma-
tion of lamellipodia, cell adhesion and spreading, and regula-
tion of actin cytoskeleton.[2–5] In particular, recent reports have
associated Arap3 with developmental angiogenesis[6] and scir-
rhous gastric carcinoma.[7]
The Arap3 sequence includes, among others, a sterile alpha
motif (Sam) domain.[8] Two proteins containing Sam domains,
Ship2 (Src homology 2 domain-containing phosphoinositide-5-
phosphatase 2) and ANKS1 (ANKyrin repeat and Sam-domain-
containing 1), have been identified in a yeast two-hybrid
screen as possible Arap3 regulators.[4] The interaction between
Arap3 and Ship2 is mediated by Sam–Sam heterodimerization
and has been well characterized.[4,9] Arap3-Sam and Ship2-Sam
bind to each other with a dissociation constant of approxi-
mately 100 nm ;[4] protein–protein association is mainly driven
by specific electrostatic contacts.[9] A docking model of the
Ship2-Sam/Arap3-Sam complex, assisted by NMR and muta-
genesis data, shows that the two proteins adopt a head-to-tail
binding topology that is similar to that observed for many
Sam–Sam associations; this is called the mid-loop/end-helix
(ML/EH) model.[4,10, 11]
Similar analysis of the interactions between Arap3-Sam and
Sam domains from the ANKS1 protein have not been reported
so far. However, we have recently studied the heterotypic asso-
ciation between the first Sam domain of Odin (Odin-Sam1) and
EphA2-Sam;[12] this interaction is possibly relevant for EphA2
receptor endocytosis.[13] Odin (also called ANKS1 and ANKS1A)
is a protein belonging to the ANKS family, which has two
tandem Sam domains (Sam1 and Sam2).[14] In light of the rela-
tively high sequence homology between EphA2-Sam and
Arap3-Sam (~58%), we have investigated if Arap3-Sam could
associate with Odin-Sam1. To verify and characterize binding
between the two proteins we followed an approach compris-
ing several techniques (NMR spectroscopy, isothermal titration
calorimetry (ITC), surface plasmon resonance (SPR), molecular
docking, and mutagenesis). We show that Arap3-Sam interacts
with Odin-Sam1 with a dissociation constant in the low micro-
molar range and a 1:1 stoichiometry, and that it adopts a struc-
tural organization that closely resembles that of other ML/EH
complexes, such as Ship2-Sam/Arap3-Sam[9] and Odin-Sam1/
EphA2-Sam.[12]
Arap3 is a phosphatidylinositol 3 kinase effector protein that
plays a role as GTPase activator (GAP) for Arf6 and RhoA.
Arap3 contains a sterile alpha motif (Sam) domain that has
high sequence homology with the Sam domain of the EphA2-
receptor (EphA2-Sam). Both Arap3-Sam and EphA2-Sam are
able to associate with the Sam domain of the lipid phospha-
tase Ship2 (Ship2-Sam). Recently, we reported a novel interac-
tion between the first Sam domain of Odin (Odin-Sam1), a pro-
tein belonging to the ANKS (ANKyrin repeat and Sam domain
containing) family, and EphA2-Sam. In our latest work, we ap-
plied NMR spectroscopy, surface plasmon resonance (SPR) and
isothermal titration calorimetry (ITC) to characterize the associ-
ation between Arap3-Sam and Odin-Sam1. We show that these
two Sam domains interact with low micromolar affinity. More-
over, by means of molecular docking techniques, supported by
NMR data, we demonstrate that Odin-Sam1 and Arap3-Sam
might bind with a topology that is common to several Sam-
Sam complexes. The revealed structural details form the basis
for the design of potential peptide antagonists that could be
used as chemical tools to investigate functional aspects related
to heterotypic Arap3-Sam associations.
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These studies provide novel and significant structural in-
sights that should help the design of selective peptide/pepti-
domimetic molecules that could specifically antagonize Arap3-
Sam heterotypic complexes. Such molecular probes could
prove very useful in cell-based assays to shed light on the
functional implications of these interactions.
Results and Discussion
Sam domains represent small helical protein-interaction mod-
ules of approximately 70 residues, and are characterized, in
spite of a very similar fold, by high versatility concerning bind-
ing preference and function.[8,15] Many Sam domain functions
are mediated by the formation of homo- and heterotypic
Sam–Sam interactions.[16] From a structural point of view, Sam–
Sam associations can adopt head-to-head, tail-to-tail, or even
head-to-tail (ML/EH) topologies.[9, 17–21]
We previously characterized the associations between the
Sam domains of the PI3K effector protein Arap3 (Arap3-Sam)
and the lipid phosphatase Ship2 (Ship2-Sam),[9] and more re-
cently the interaction between the first Sam domain of Odin
(Odin-Sam1) and the Sam domain of the EphA2 receptor
(EphA2-Sam),[12] and showed that these associations might
adopt the head-to-tail topology. The current report focuses on
characterization of the Odin-Sam1/Arap3-Sam interaction.
Odin-Sam1 binds Arap3-Sam: Chemical Shift perturbation
Studies
To verify the association between Odin-Sam1 and Arap3-Sam
we first conducted chemical shift perturbation studies with 2D
1H,15N HSQC experiments.[22] We acquired and compared NMR
spectra of uniformly 15N-labeled Odin-Sam1, both in the free
state and bound to unlabeled Arap3-Sam (Figure 1A). Associa-
tion of the two Sam domains is clearly indicated by several
changes in the HSQC spectra of Odin-Sam1 recorded in pres-
ence of increasing amounts of Arap3-Sam. Once saturation
conditions had been reached (i.e. , no change could be detect-
ed in the HSQC spectrum of Odin-Sam1 upon further addition
of Arap3-Sam), the equation[23] Dd= [(DHN)
2+ (0.17·D15N)2]1/2
was applied to evaluate proton and nitrogen normalized
chemical shift deviations (Figure 1B) and to identify the inter-
action surface of Odin-Sam1 (Figure 2A). The greatest chemical
shift perturbations (Dd0.2 ppm) were for the central portion
of Odin-Sam1, encompassing helices a3 and a4 and the C-ter-
minal portion of a2. Changes also occurred at the C-terminal
tail, presumably because residues in this flexible portion come
into proximity with the main binding interface (Figures 1B and
2A).
The pattern of chemical shift variations versus residue
number observed for Odin-Sam1 in complex with Arap3-Sam
Figure 1. A) 1H,15N HSQC spectra of 15N-labeled Odin-Sam1 (80 mm) in the free state (green) and in association with Arap3-Sam (370 mm ; magenta). B) Chemical
shift deviations (Dd= [(DHN)
2+ (0.17·D15N)2]1/2) against Odin-Sam1 sequence numbers. Residues Q43, V56, N62 (their peaks are revealed only in the spectrum
of the Odin-Sam1/Arap3-Sam complex), S61, M64, S75 (unassigned), P77, and P91 were excluded from the analysis. C) Superposition of 1H,15N HSQC spectra
of 15N labeled Arap3-Sam (90 mm) in absence (cyan) and presence (violet) of unlabeled Odin-Sam1 (300 mm). D) Chemical shift deviations against Arap3-Sam
residue numbers. Data were set equal to 0 for residues T72 and G73 (identified only in the spectrum of the bound protein), and P24.
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(Figure 1B) closely resembles the one we previously detected
for the protein in complex with EphA2-Sam.[12]
NMR experiments with 15N-labeled Arap3-Sam and unlabeled
Odin-Sam1 were also conducted, to map the binding surface
of Arap3-Sam for Odin-Sam1 (Figure 1C and D). The largest
chemical shift changes (Dd0.1 ppm) were for residues of
helix a5 and the close a1/a2 and a4/a5 loop areas (Figures 1D
and 2B). Interestingly, these are the regions that participate in
the binding of Arap3-Sam to Ship2-Sam.[9]
NMR perturbation data suggest that Odin-Sam1 and Arap3-
Sam bind with a head-to-tail architecture, where the central
region of Odin-Sam1 and helix a5 of Arap3-Sam, along with
the adjacent loop regions, provide the main binding interfaces.
To get insights into the Odin-Sam1 and Arap3-Sam binding
stoichiometry, we carried out 15N longitudinal (R1) and trans-
versal (R2) nuclear spin relaxation rate measurements, evaluat-
ed the R2/R1 average values, and thus estimated the correla-
tion time tc of both Sam domains bound to each other.
[24]
The tc of Arap3-Sam and Odin-Sam1 in their associated
forms were (101) and (9.90.8) ns respectively. These values
are of course higher than those for the proteins in their free
states ((7.30.6) ns for Odin-Sam1, (8.20.4) ns for Arap3-
Sam)[9,12] because of the increased size of the complex and the
consequent slower tumbling. Moreover, the tc estimates (ca.
10 ns) are also comparable to those evaluated for Odin-Sam1
in complex with EphA2-Sam,[12] Ship2-Sam bound to Arap3-
Sam (11 ns),[9] as well as the AIDA1-Sam1/Sam2 tandem
(9.1 ns),[25] and point to a 1:1 binding stoichiometry for the
Odin-Sam1/Arap3-Sam interaction.
SPR and ITC studies
To further quantify the Odin-Sam1/Arap3-Sam binding affinity,
we performed SPR (Figure 3) and ITC experiments (Figure 4).
SPR binding assays were carried out by immobilizing Arap3-
Sam on the chip surface with Odin-Sam1 as the analyte. The
fitting of data obtained by plotting RUmax values against Odin-
Sam1 concentration, together with kinetic experiments imple-
mented with a 1:1 binding model, gave a dissociation constant
(KD) in the low micromolar range (Figure 3). Indeed KD= (2.9
0.4) mm was obtained with a nonlinear regression analysis of
experimental data (Figure 3).
In the ITC experiments (Figure 4), the exothermic heat peaks
exhibited a monotonic decrease with addition of Arap3-Sam
until saturation was reached. The data could be best fitted by
a nonlinear least-squares approach to the “one set of sites”
binding model (in agreement with 15N relaxation measure-
ments, see previous paragraph), which yielded KD= (0.37
0.08) mm (Figure 4 and Table S1 in the Supporting Information).
However, the estimated KD values are similar to those deter-
mined in our previous binding assays for the Odin-Sam1/
EphA2-Sam complex ((5.50.9) mm and (0.620.04) mm by
SPR and ITC techniques, respectively),[12] thus reflecting compa-
rable binding affinities of Arap3-Sam and EphA2-Sam for Odin-
Sam1.
Figure 2. Left : The first conformer of Odin-Sam1 NMR ensemble (PDB ID:
2LMR)[12] is shown in ribbon representation; backbone of residues with
chemical shift deviations 0.2 ppm are highlighted in magenta (G33, L48,
L49, L50, N51, G52, F53, D54, D55, V56, H57, F58, L59, G60, V63, E65, Q67,
D68, R70, D71, I72, I74, Q85, R88, S89, L90, V93, K94, A95). Right: Ribbon rep-
resentation of Arap3-Sam (NMR conformer number 1, PDB ID: 2KG5);[9] resi-
dues with Dd0.1 ppm are colored purple (W32, V36, H37, L38, E39, Q40,
F45, R57, A71, T72, G73, H74, R75, K76, R77, I78, L79, R80, Q83, T84, G85).
Side chains of amino acids in the mutagenesis studies are shown.
Figure 3. SPR Experiments. Superposition of sensorgrams corresponding to
the interaction of Odin-Sam1 with immobilized Arap3-Sam (0.20–40 mm).
Inset : plot of RUmax from each binding as function of Odin-Sam1 concentra-
tion; data were fitted by nonlinear regression analysis.
Figure 4. ITC Studies. Calorimetric curve for Odin-Sam1 (10 mm) titration with
Arap3-Sam (250 mm). Raw and integrated data are shown in the upper and
lower panels, respectively. In the lower section data fitting was achieved
with a single binding site model.
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Structural features of the Odin-Sam1/Arap3-Sam complex:
HADDOCK models
To shed light on the pattern of possible intermolecular con-
tacts as the basis of the Odin-Sam1/Arap3-Sam interactions,
we carried out molecular docking studies by using the HAD-
DOCK server.[26] These studies aimed at obtaining speculative
models of the complex by using information from chemical
shift perturbation studies and analysis of experimentally deter-
mined structures of other heterotypic Sam–Sam associations
(Figure 5, and Section S2 in the Supporting Information). Our
models present an ML/EH topology[12,25] in which the mid-loop
interface is provided by Odin-Sam1 and the end-helix surface
is on Arap3-Sam (Figure 5C and D, Section S2).
The Arap3-Sam binding region is rich in positively charged
residues, whereas the Odin-Sam1 surface contains many nega-
tively charged residues; thus, electrostatic interactions appear
to be important for this association (Figure 5C and D).
To further investigate this, we studied the binding of Odin-
Sam1 to an Arap3-Sam triple mutant (H37D, R77D, R80D).[9] In
this mutant we reversed the charge of three residues that are
in the presumed Arap3-Sam EH binding site (Figure 2B). NMR
and ITC assays failed to show significant binding of the triple
mutant to Odin-Sam1 (Figure S3) and led us to speculate that
these residues supply pivotal interactions at the Sam–Sam
interface and/or the mutations cause conformational changes
in the binding region that inhibit association. Intriguingly, in
most of the docking solutions, residue Arg77 in Arap3-Sam is
engaged in electrostatic interactions with Asp54 and/or Asp55
in Odin-Sam1 (Figure 5C).
Arap3-Sam residues His37 and Arg80 seem less important,
although in a few models His37 makes a salt bridge with Odin-
Sam1 Asp55 (Section S2), while Arg80 could form a cation–p
interaction with Odin-Sam1 Phe58 or a salt bridge with Odin-
Sam1 Asp68 (Section S2). The Arap3-Sam mutant (H37D, R77D,
R80D) was also unable to bind the Sam domain of the lipid
phosphatase Ship2 (this can associate with wild-type Arap3-
Sam by adopting an ML/EH
binding model in which Arap3-
Sam contributes the EH inter-
face).[9]
Another interaction to point
out in the Odin-Sam1/Arap3-
Sam docking models concerns
residue Gly73, which is posi-
tioned on the EH surface of
Arap3-Sam (Figure 5D and Sec-
tion S2). It is interesting that the
peak corresponding to the 1HN
of Gly73 can only be detected in
the 1H,15N HSQC spectrum of
Arap3-Sam in its bound form
(Figure 1C), thus indicating that
this Gly might become buried
and possibly engaged in inter-
molecular contact in the Odin-
Sam1/Arap3-Sam complex.
Indeed, in a few docking solu-
tions, the 1HN of Gly73 forms an
intermolecular H-bond (Sec-
tion S2). In particular, in the
Odin-Sam1/Arap3-Sam model,
the backbone HN atom of Gly73
(Figure 5C and D) makes an H-
bond with the backbone carbon-
yl oxygen atom of Odin-Sam1
residue Asn51. This kind of inter-
action between the backbone
amide proton of a Gly (at the
bottom of helix a5 on the EH in-
terface) and the backbone car-
bonyl oxygen of another residue (at the C-terminus of helix a2
in an ML surface) is present in several experimentally deter-
mined structures of Sam–Sam complexes (see PDB IDs:
1PK1,[27] 2KIV,[25] 3BS5,[20] 3SEI,[10] 3SEN[10]).
It has been proposed that a Gly residue at that position of
an EH interface is highly desirable as it can facilitate the ap-
proach towards an ML binding region.[25]
Indeed, recent NMR studies of the EphA2-Sam/Ship2-Sam
complex revealed intermolecular NOEs between the backbone
Figure 5. A) NMR structure of the AIDA-1-Sam domain tandem (PDB ID: 2KIV,[25] structure 1). B) Representative
HADDOCK[26] model (number 2) of the Odin-Sam1/EphA2-Sam complex.[12] The backbone of residues participating
in the interaction, (according to NMR chemical shift perturbation data) are colored green.[12] C) HADDOCK model
(number 57) of Odin-Sam1/Arap3-Sam complex; residues that undergo major chemical shift variations following
association are colored magenta and violet on the structures of Odin-Sam1 (green) and Arap3-Sam (cyan), respec-
tively. Side chains of some amino acids that could contribute to the interaction interface are identified. D) Detail
of the Odin-Sam1/Arap3-Sam HADDOCK model that better illustrates the H-bond between the backbone amide
proton of Gly73 (Arap3-Sam EH site) and the backbone carbonyl oxygen of Asn51 (Odin-Sam1 ML binding
region).
 2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2013, 14, 100 – 106 103
CHEMBIOCHEM
FULL PAPERS www.chembiochem.org
HN proton of Gly74 at the N terminus of helix a5 in the EphA2
receptor and the Hb protons of an Asn at the C terminus of
helix a2 in Ship2-Sam (PDB ID: 2KSO),[28] thus further confirm-
ing our hypotheses.
Next, we compared our Odin-Sam1/Arap3-Sam model with
the NMR structure of the AIDA1-Sam1/Sam2 tandem (PDB ID:
2KIV,[25] Figure 5A) and found high homology. Like Odin,[14]
AIDA1[29] belongs to the ANKS family; in the 3D structure of
the AIDA1-Sam tandem, Sam1 and Sam2 bind by providing
the ML and EH sites, respectively,[25] and, interestingly, a Gly
residue at the beginning of helix a5 on the binding interface
of Sam2 likely provides an intermolecular H-bond with an Asn
on the Sam1 interaction surface (Figure 5A). Moreover, our
Odin-Sam1/Arap3-Sam models resemble the docking struc-
tures we recently proposed for the Odin-Sam1/EphA2-Sam
complex (Figure 5B), in which EphA2-Sam provides the EH in-
teraction surface, several intermolecular salt bridges can take
place at the Sam–Sam interface, and a Gly at the N terminus of
helix a5 (on the EH side) might be involved in an intermolecu-
lar H-bond.[12]
In fact, a displacement assay with NMR techniques indicated
that Odin-Sam1 employs the same ML interaction site to bind
both EphA2-Sam and Arap3-Sam (Figure S4), and thus behaves
like the Sam domain of the lipid phosphatase Ship2 (Ship2-
Sam).[9] The ML site of Ship2-Sam binds both Arap3-Sam and
EphA2-Sam.[9,19] The structural similarities between heterotypic
associations of Arap3-Sam and EphA2-Sam probably reflect the
high sequence homology between these two Sam domains
(Figure S5) and appear to dictate a shared protein interactions
network. As heterotypic Sam–Sam interactions of EphA2-Sam
with either Odin and Ship2 are associated with EphA2 receptor
endocytosis,[13,30] we cannot exclude that Arap3-Sam might
play a role in this process by sequestering two crucial regula-
tors, but to date the intricate machinery that governs these
heterotypic associations is not completely comprehended.
Conclusions
A yeast two-hybrid screen previously identified ANKS1 protein
as a binding partner for the PI3K effector Arap3.[4] The ANKS
family includes Odin (also known as ANKS1 and ANKS1A) and
AIDA-1 (ANKS1B), which have two Sam domains in tandem.[14]
The NMR structure of the tandem Sam domains of AIDA-1 re-
veals a characteristic Sam–Sam head-to-tail topology in which
Sam1 and Sam2 bind with a mid-loop/end-helix model.[10,25]
The structure of Odin-Sam1 was solved by us with solution
NMR techniques,[12] whereas the experimental structure of the
tandem Sam domains of Odin is not yet available in the Pro-
tein Data Bank. However, because of the high sequence simi-
larity to AIDA-1, it is likely that the Odin Sam1–Sam2 tandem
adopts a similar ML/EH architecture.
Herein, we investigated the interaction between Odin-Sam1
and Arap3-Sam and demonstrated that the two domains bind
with a dissociation constant in the low micromolar range by
forming a ML/EH heterodimer that is seemingly stabilized by
electrostatic interactions. In our model, the central part of
Odin-Sam1 and the C-terminal helix, together with close loop
regions of Arap3-Sam, supply the ML and EH binding sites,
respectively. Taken together, our studies suggest that the inter-
actions between Odin-Sam1 and Arap3-Sam might require sep-
aration of Odin-Sam2 from the Odin-Sam1–Sam2 tandem in
the intact protein, similarly to our previous hypothesis for the
association between EphA2-Sam and Odin-Sam1.[12] Moreover,
our observations, in conjunction with earlier data, suggest that
Arap3-Sam adopts interaction patterns to Odin-Sam1 that
highly resemble those between EphA2-Sam and Ship2-Sam. As
both Odin and Ship2 are regulators of EphA2 receptor endocy-
tosis,[13, 30] the revealed analogies might indicate an involve-
ment of Arap3-Sam in this process. However, to date, the func-
tional consequences of the association between Arap3-Sam
and Odin-Sam1 are unknown. Thus, our immediate goals is to
generate, based on our structural models, new peptide/pepti-
domimetic molecules that can interfere selectively with Arap3
Sam–Sam interactions, and analyse the resulting phenotypic
alterations that such molecular probes induce in a cellular
environment.
Experimental Section
Protein expression: Sam domains were expressed as recombinant
proteins in E. coli. pET15B constructs encoding wild-type human
Arap3-Sam (residues 1–80; UniprotKB/TrEMBL code: Q8WWN8),[9]
Arap3-Sam triple mutant (H37D, R77D, R80D),[9] Odin-Sam1 (resi-
dues 691–770 of human Odin; UniprotKB/TrEMBL code:
Q92625),[12] and EphA2-Sam (residues 901–976 of human EphA2;
UniprotKB/TrEMBL code: P29317)[12] were purchased from Celtek
Bioscience (Nashville, TN).
Genes were transformed into BL21-Gold (DE3) competent cells
(Stratagene). Protein expression and purification procedures were
conducted as previously described.[9,12] In particular, to express un-
labeled proteins, bacteria were grown in LB medium; 15N,13C
doubly labeled and 15N-labeled proteins were expressed in M9
minimal medium containing [13C]glucose and/or [15N]NH4Cl respec-
tively. Bacteria were grown at 37 8C; b-d-thiogalactopyranoside
(IPTG; 1 mm) was used to induce protein over-expression at a cell
optical density OD600=0.6 nm (overnight induction, T=25 8C). Pu-
rification of His-tagged protein was performed on a nickel column
with an KTA Purifier apparatus (GE Healthcare).
Backbone resonance assignments of the Odin-Sam1/Arap3-Sam
complex: NMR experiments were performed at 25 8C on a Varian
Unity Inova 600 MHz spectrometer equipped with a cold probe.
HNCA and 3D 15N resolved 1H,1H NOESY spectra (100 ms mixing
time), acquired with samples containing either 15N,13C doubly la-
beled Odin-Sam1 (620 mm) and unlabeled Arap3-Sam (~3 mm), or
doubly labeled Arap3-Sam (600 mm) and unlabeled Odin-Sam1
(1.2 mm), were analyzed to obtain resonance assignments for the
backbone H, N, and Ca atoms of the Odin-Sam1/Arap3-Sam com-
plex. NMR samples (600 mL) were prepared in phosphate buffered
saline (PBS; phosphate (10 mm), NaCl (138 mm), KCl (2.7 mm),
pH 7.7; Fisher Scientific) with NaN3 (0.2%) and D2O (5%). Spectra
were processed with VnmrJ software (version 1.1D; Varian) and an-
alyzed with NEASY[31] (included in the software package CARA,
http://www.nmr.ch/).
Relaxation measurements: NMR experiments to evaluate back-
bone 15N longitudinal (R1) and transverse (R2) relaxation rates,
were performed at 25 8C on a Varian Unity Inova 600 MHz spec-
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trometer provided with a cold probe. Measurements were carried
out with two samples of Sam–Sam complexes: either 15N,13C
doubly labeled Odin-Sam1 (620 mm) plus unlabeled Arap3-Sam
(3 mm), or 15N,13C doubly labeled Arap3-Sam (100 mm) plus unla-
beled Odin-Sam1 (~300 mm).
R1 and R2 relaxation data were collected as 1D spectra (4 K data
points and 1–4 K transients). R1 data sets were recorded with the
following relaxation delays: 0.01, 0.1, 0.3, 0.6, 1.0 s; R2 data set re-
laxation delays: 0.01, 0.03, 0.05, 0.07, 0.09, 0.11, 0.15, 0.19 s. Aver-
age R1 and R2 values were estimated by monitoring the decrease
of signal intensity as function of the relaxation delays. The software
package tmest (A. G. Palmer III, Columbia University) was imple-
mented to calculate the rotational correlation time from average
R2/R1 ratios.[32]
NMR binding studies: NMR titration experiments with 2D
1H,15N HSQC spectra were carried out to study protein–protein in-
teraction. The Odin-Sam1 binding interface for Arap3-Sam was
identified by analysis of 2D 1H,15N HSQC spectra of 15N-labeled
Odin-Sam1 (80 mm), in the unbound form and after addition of un-
labeled Arap3-Sam (120, 370, and 620 mm). To recognize the bind-
ing site of Arap3-Sam for Odin-Sam1, 2D 1H,15N HSQC spectra of
a 15N-labeled Arap3-Sam sample (90 mm) were recorded in the ab-
sence or presence of unlabeled Odin-Sam1 (100, 300, and 800 mm).
Binding of Arap3-Sam mutant (H37D, R77D, R80D) to Odin-Sam1
was investigated by analogous NMR chemical shift perturbation ex-
periments conducted with either 15N-labeled Arap3-Sam triple
mutant (200 mm) and unlabeled Odin-Sam1 (200 and 300 mm), or
15N-labeled Odin-Sam1 (144 mm) and unlabeled Arap3-Sam mutant
(285 and 625 mm ; see the Supporting Information).
For the NMR displacement experiment, 2D 1H,15N HSQC spectra
were recorded for a 15N-labeled Arap3 protein sample (50 mm) in
its unbound form, after addition of Odin-Sam1 (150 mm), and in
the simultaneous presence of Odin-Sam1 and EphA2-Sam (protein
ratios after final dilutions: 1 (Arap3-Sam), 3 (Odin-Sam1), ~40
(EphA2-Sam)). Analysis of titration experiments and overlays of 2D
spectra were generated with the program Sparky (version 3, T. D.
Goddard and D. G. Kneller, University of California, San Francisco,
http://www.cgl.ucsf.edu/home/sparky/).
Surface plasmon resonance: Arap3-Sam in acetate buffer (10 mm,
pH 5.0) was immobilized (flow rate: 5 mLmin1, injection time:
7 min) on a CM5 Biacore sensor chip by using EDC/NHS chemis-
try.[33] Residual reactive groups were deactivated with ethanola-
mine hydrochloride (1m, pH 8.5) ; the reference channel was pre-
pared by activating with EDC/NHS and deactivating with ethanola-
mine. The immobilization level for Arap3-Sam was 1840 RU. Experi-
ments were conducted at 25 8C and with a constant flow rate
(20 mLmin1), with a running buffer of HEPES (10 mm, pH 7.4), NaCl
(150 mm), surfactant P20 (0.05% v/v) ; 90 mL injections for each ex-
periment. Binding assays were conducted by using Odin-Sam1 at
concentrations from 0.20 to 40 mm. The BIA evaluation analysis
package (version 4.1, GE Healthcare, Milan, Italy) was used to sub-
tract the reference channel signal and to evaluate KD values. Graph-
Pad Prism software (version 4.00; GraphPad Software, San Diego,
California) was used to fit RUmax data against protein concentra-
tions by nonlinear regression analysis.[34]
ITC studies: ITC experiments were carried out with an iTC200 calo-
rimeter (Microcal/GE Healthcare). Arap3-Sam (250 mm in PBS,
pH 7.7) was titrated into a solution of Odin-Sam1 (10 mm in PBS,
pH 7.7). Data were fitted to a single-binding-site model with Origin
software (GE Healthcare). Similar ITC studies were conducted with
a solution of the Arap3-Sam triple mutant (H37D, R77D, R80D;
250 mm in PBS, pH 7.7) and Odin-Sam1 (10 mm in PBS, pH 7.7).
Molecular modeling: Docking studies were conducted with the
HADDOCK web server.[26] Models of the Odin-Sam1/Arap3-Sam
complex were generated by starting from NMR structures (i.e. , first
conformer of Odin-Sam1: PDB ID: 2LMR,[12] and first five structures
of Arap3-Sam NMR ensemble: PDB ID: 2KG5).[9] For Arap3-Sam, the
flexible C-terminal tail (residues 90–100) was omitted from the
docking procedure. Ambiguous interaction restraints were generat-
ed from chemical shift perturbation data. For both Odin-Sam1 and
Arap3-Sam, active and passive residues were represented by
a subset of those with higher normalized Dd, filtered by evaluating
their solvent exposure and/or the possible involvement in intermo-
lecular interactions, as suggested by analysis of experimental struc-
tures of Sam–Sam complexes (e.g. , the AIDA-1 tandem Sam
domain, PDB ID: 2KIV).[25] For Odin-Sam1, residues L50, N51, F53,
D54, D55, F58, E65, E66, D68, D71 were set as active, while L49,
G52, V56, H57, S61, N62, V63, M64, Q67, R70 were considered pas-
sive; the region from L50 to E66 was set as “semiflexible” interface.
Finally, the N- and C-terminal tails (M21 to G24 and A95 to N101,
respectively) were set as “fully flexible” during all docking stages.
For Arap3-Sam, the docking procedure included: G73, H74, K76,
R77 as active residues; R75, L79 as passive residues; T72–R80 and
V36–L38 as semiflexible tails ; and H20–D26 as fully flexible region.
The solvated docking mode was implemented.[35] One thousand
structures were generated during the first phase of the docking
protocol (rigid body energy minimization); next, semiflexible simu-
lated annealing of the best 200 solutions was conducted; the last
stage consisted of refinement in water. The final 200 HADDOCK
solutions were visually analyzed, and “wrong” models (in disagree-
ment with experimental NMR data, or presenting noncanonical
Sam–Sam orientations) were discarded. After this first selection
strategy, 106 HADDOCK models were further inspected with the
MOLMOL software[36] and compared with experimental structures
of other heterotypic Sam–Sam complexes (reference PDB ID:
2KIV),[25] to identify relevant structural features. From these,
23 models were considered representative of the possible confor-
mations of the Arap3-Sam/Odin-Sam1 complex. Solutions were
clustered by using a pairwise RMSD cutoff value of 2.26  and at
least one structure per cluster. RMSD values were calculated with
MOLMOL[36] by superimposing the models on the backbone atoms
of the secondary structure elements of both Arap3-Sam and Odin-
Sam1 (i.e. , residues 29–34, 39–47, 61–66, 72–83 for Arap3-Sam,
and 32–39, 42–49, 57–60, 66–72, 77–88 for Odin-Sam1). Four clus-
ters were obtained from the selected solutions (see Section S2 in
the Supporting Information).
We also performed docking calculations with the more convention-
al HADDOCK protocol[26] (Section S6). For these studies, we chose
as active those exposed residues (solvent exposure evaluated with
MOLMOL 24.6%) of Odin-Sam1 and Arap3-Sam with chemical
shift variations 0.2 and 0.1 ppm, respectively. Passive residues
were set automatically by HADDOCK; calculations were started
from the initial ten conformers of both Sam domains; semiflexible
and fully flexible regions were chosen as above. The results are dis-
cussed in the Supporting Information and are in good agreement
with those obtained with the other described strategy, in which
we used instead a reduced set of active and passive residues.
It is obvious that our models, built only on the basis of chemical
shift perturbation data and analyzed by looking for structural anal-
ogies with other Sam–Sam heterocomplexes, need to be consid-
ered exploratory, as, of course, they do not have the precision of
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a structure calculated by using unambiguous restraints such as
intermolecular NOEs.
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